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Abstract 
 
The crystal growth of ibuprofen as a function of crystallisation environment is 
presented. Measurement of solubility as a function of solvent (ethanol 95%, ethyl 
acetate, acetonitrile and toluene) and temperature using UV/Vis spectroscopy and 
gravimetric analysis reveals less than ideal behaviour, consistent with strong solute-
solute interactions, particularly in the case of acetonitrile. Examination of the nucleation 
kinetics reveals a comparatively small metastable zone width (MSZW) (ΔT = 10.0 - 
13.9
o
C) with interfacial tensions in the range 2.56 – 5.52.10-3 (J/m2).  
 
The growth rates for the {001} and {011} faces of spontaneously nucleated single 
crystals are precisely measured in-situ using optical microscopy revealing that their 
growth rates increase with increasing supersaturation to different extents, depending on 
the solvent type with concomitant impact on the crystal habit. For similar 
supersaturations, the growth rate of {011} is lowest in ethanol and highest in 
acetonitrile, whilst that of {001} is lowest in toluene and highest in ethanol. The aspect 
ratios, as a function of supersaturation, are generally higher at the 15 mL than the 0.5 
mL crystalliser scale size. The data is consistent with a 2-D Birth and Spread growth 
model for both surfaces and scale sizes. This is in good agreement with the calculated 
surface entropy α factor. 
 
The measured growth rate dispersion for these faces is much less for these 
spontaneously nucleated crystals in stagnant, supersaturated solutions when compared 
to the literature data obtained for a stirred batch crystalliser. Additional higher index re-
entrant faces are found at high levels of supersaturation consistent with their alignment 
either parallel to the {012} or {112} face.  
 
The growth rate in the non-agitated jacketed vessel is found to be slightly higher than 
that for the agitated reactors with both being in quite in a good agreement with literature 
data suggesting that these results on single crystals will have utility in representative the 
growth rates of a population of crystals in an agitated crystallizer. 
 
Observations are is rationalised using molecular and crystallographic modelling 
revealing e.g.  that polar protic solvents inhibit the growth rate of faces containing 
vi 
 
available hydrogen bonding binding sites, such as carboxylic acid groups. Molecular 
conformational searching reveals the molecular structure in the solid-state to be close to 
that of molecules minimum intra-molecular energy. Conformer population analysis as a 
function of solvent reveals no significant solvent effect on the low energy conformer 
distribution indicative a low likelihood of polymorphic behaviour for this compound in 
good agreement with literature. 
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1 Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
The background underpinning this research together with aims and objectives of this 
study are presented. Details of the research’s project management and summary of the 
thesis plan is also provided. 
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1.1 Research Background 
 
Industry estimates that 70% of all chemical products manufactured involve a unit 
operation requiring solid particulate processing [1]. Within this, perspective 
crystallisation represents an important purification, separation and pre-formulation 
process in the pharmaceutical and fine chemical process industries. It is the primary 
method applied for the final stage production of a wide range of materials from 
inorganic compounds to high value-added organic materials such as active 
pharmaceutical ingredients (API) and specialty chemicals.  However, the crystallisation 
process associated with nucleation and the crystal growth process has often been 
considered more as an art rather than a science [2] reflecting the fact that it has been 
considered difficult to control due to its unpredictable behaviour.  
 
The 3D nature of a crystalline material combined with the complex molecular and 
crystal chemistry of many specialty compounds can conspire to produce a high degree 
of variability in product forms. For example, this may lead to production of a dispersion 
of non-equant particle morphologies which can be both difficult to both separate and 
purify. Such materials can also be problematic downstream in term of challenges in 
their powder flow, blending ability and formulation. Variation in crystallisation 
processes can also impact in terms of concomitant product crystal chemistry 
(polymorphism or solvate formation), leading, in turn, to significant changes in product 
quality, i.e. through factors such as the stability, bioavailability, processability, 
crystallinity and/or purity of a drug product. The latter can lead to quality assurance 
problems such as rejection in terms of product specification and performance. Such 
factors have been known to impact on the product economic profitability and viability 
leading, in turn, to the potential for loss of market share and in extreme cases product 
withdrawal. According to the Food and Drug Administration (FDA) (2004) [3], the 
number of new drug and biologic applications submitted to the FDA has declined 
significantly because the current drug product development path (Figure 1.1) is 
becoming increasingly challenging, inefficient, and costly. 
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Figure 1.1 Schematic of medical product development from basic research in lab to launching in 
the market [3]. 
 
Most of the cost increases are within the development phase, between discovery and 
launch. In this critical path, a new drug needs to prove safety, efficiency and 
industrialisation. Reflecting basic chemical engineering principles, the 
„industrialisation‟ stage must be feasible from lab concept to manufacturability as a 
high-quality product in mass production. The challenges involved in successful 
industrialization are complex including, unpredicted problems in physical design, 
characterization, manufacturing scale-up and quality control. The stages of the 
development of robust, reproducible and scalable crystallization processes are shown in 
Figure 1.2. 
 
 
Figure 1.2 A crystallisation process for non-specific pharmaceutical drug substance [4]. 
 
A crystallisation process starts from initial screens at microgram scale right through to 
plant scale operations. Variation of crystallisation parameters is tested on a ml scale size 
to generate growth kinetics data for further optimization and production to ensure a 
rapid development for a product. Hence, in order to isolate the crystals exhibiting the 
desired physical properties, the fundamental process of crystal growth and its associated 
kinetics need to be understood, characterised, controlled and be scalable. In addition, 
crystallisation parameters and testing process robustness are required to be validated.  
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Previously studies have mostly presented measurements of growth rate of individual 
faces for seed crystals grown at comparatively low supersaturations [4-10]. 
Alternatively, measurements have been made of the growth rates of a population of 
crystals as prepared under crystallisation reactor environment conditions e.g. through 
the measurement of the growth characteristic dimensions (such as length, width, and 
equivalent diameter etc.) of the crystals [11-18]. In the former case whilst this is 
measuring the individual growth faces, the influence on the measurements imposed 
either by the hydrodynamic environment associated with the measurements or by the 
selection of specific seeds [19] is unknown. Similarly, in the latter case, it is hard to 
extract out the kinetics associated with the growth of individual habit faces. Within this 
overall context, there have been surprisingly limited kinetic studies on the growth of the 
individual faces of spontaneously-nucleated crystals prepared under diffusion limited 
growth in stagnant solutions. Such measurements are helpful in that they provide 
baseline crystal growth kinetics with respect to which the impact of agitation and 
mixing can be assessed. Additionally, there have also been few detailed studies of the 
crystal growth-rates of populations of spontaneous nucleated single-crystals in 
particular through research seeking to probe growth-rate dispersion [20, 21].  
 
A significant factor in the scarcity of research resulting from investigations into the 
growth rate of individual single crystal growth perhaps lies in the lack of rapid and 
routine experimental methodologies, for studying this aspect mindful that the most 
common techniques available for crystallisation monitoring are intended for use at large 
scale and are aimed at measuring average growth rate values based on an assessment of 
a crystal population e.g. focused beam reflectance measurement (FBRM) [22-24], rather 
than face-specific growth rates for batches of individual crystals. FBRM gives a 
correlation between the number of counts per second, the cord-length distribution of 
particles and from these particle sizes can be inferred. However, such measurements do 
not provide the face-specific growth rate data needed for the „first-principle‟ 
understanding of the process and indeed from the FBRM approach it is hard to deduce 
quantitative kinetics. In addition, the population balance model (PBM) [25] was also 
developed and employed in the crystallisation process to study the evolution of crystal-
size distribution as a function of time to estimate the growth rate in the volume 
equivalence diameter. This does not take into account the effect of crystal shape. 
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However, though the particles possess the same volume equivalence diameter, they 
might present in completely different shapes associated with different surface areas. 
This significantly impact on dissolution and growth kinetic rates or downstream 
processing etc. Hence, a study of the fundamental growth kinetics governed by the face-
specific growth rate should be carried out on individual crystal habit faces, not by the 
dm/dt (mass overall growth rate) or dL/dt (the growth rate of characteristic dimension), 
described in PBM. A fundamental evaluation of the growth kinetics must be based on 
the growth rates of individual faces [26] for which the crystal shape is a crucial factor in 
the growth rate determination.  
The above scenario sets the backdrop to this PhD study which involves research related 
to the development of methodology and instrumentation for crystal growth 
characterisation at different scale-sizes. The facility developed in this work was used to 
understand the effect of crystallisation environment conditions (e.g. solvents and 
supersaturation) and scale-sizes on the crystallisation process itself and for obtaining 
fundamental data for process scale-up. From this the interface crystal growth kinetics 
are extracted and the growth mechanism was assessed. Although based on small-scale 
laboratory test work and optimized for enabling the design of reproducible processes, 
ideally such tools would also be designed for deriving some of the data needed for 
process scale-up to manufacturing. In addition, in this work, the above experimental 
strategy is complemented with molecular and crystallographic modelling studies, a 
revised approach is proposed whereby the shape-dependant features of both predicted 
and observed particle shapes were cross-correlated. In this, the solvent and 
supersaturation-dependant growth rate of crystal faces, which characterise the shapes of 
crystals, can be rationalized by molecular modelling, intermolecular interactions 
involved in the growth process through an analysis of the surface chemistry of crystal 
habit faces. Furthermore, according to Ma et al. [27], the growth rate of individual faces 
produced and the crystal morphology either obtained from experiments or 
morphological prediction can be imputed directly into a morphological population 
balance model to predict the evolution of crystal population in terms of surface area of 
individual crystal habit faces, crystal shapes and sizes. It also allows studying the effect 
of hydrodynamic factors and the scale-up of vessel size by integrating this with 
Computer Fluid Dynamics (CFD). 
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In this study, ibuprofen materials were selected as a model material for measuring 
growth rate of crystal faces and for investigating growth mechanism in terms of being 
non-toxic and reactively amenable to laboratory and molecular scale modelling. It also 
exhibits morphological changes from prisms to needles and plates depending on 
environment or crystallising conditions and hence is representative of the kinds of 
material typically processed by the pharmaceutical industry. 
 
1.2 Research objectives 
 
The research question underlying this PhD study is as follows:  
What is the influence of the crystallisation environment on the crystal growth of 
Ibuprofen as measured at the single crystal level and what are the molecular-scale 
processes that underpinning these interactions? 
This can be delivered through the following core overall objectives: 
 
 Developing a series of novel and effective platforms for the measurement of 
face-specific growth rates in crystalline systems at various crystalliser scale-
sizes such as a 0.5ml cuvette cell, a 0.5ml Peltier crystallisation cell, a medium 
throughput 8-cell crystalliser unit (sample volume ca. 100μl) and a 15 ml small 
jacketed vessel for in-situ crystallisation studies. 
 Studying and characterising solution behaviour in terms of solubilities and 
solution idealities of ibuprofen as a function of solvent and temperature using 
ATR UV/Vis and gravimetric method.  
 Assessment of nucleation kinetics including MSZW and induction time 
determinations using polythermal and isothermal methods to estimate the 
nucleation order and the interfacial energy.  
 Studying the crystal growth kinetics and growth mechanism of individual crystal 
habit faces (hkl) during representative crystallisation processes as a function of 
solvent type, supersaturation and reactor scale-sizes. 
 Correlation and rationalisation of the experimental data through morphological 
prediction, the analysis of crystal surface chemistry and intermolecular bonding 
on these measured growth faces. 
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 Developing a computational methodology based on image analysis to extract 
crystal growth rates of surrounding faces from on-line images.  
 Correlating and comparing the measurements of crystal growth rates in a non-
agitated vessel to the growth rate  in an 7ml agitated batch vessels and to larger 
0.5L scale size using a commercial Perdix ISPV insertion optical camera probe 
to enhance understanding, control & scale-up of crystal growth processes. 
 
1.3 Project management 
This project was jointly funded through research grants from Pfizer, UK Ltd, the UK‟s 
Northern universities N8 Molecular Engineering Translational Research Center 
(METRC) consortium and Malvern Instruments who support project access to their 
Morphologi G3 particle shape analysis system.  
This research work was carried out in the Institute of Particle Science & Engineering 
and Institute of Process Research & Development (iPRD) at University of Leeds under 
the supervision of Professor Kevin J. Roberts and Dr Robert B. Hammond, and Dr. Ivan 
Marziano at Pfizer. The system developed is planned to be integrated into Pfizer‟s 
product development workflow, and is expected to bring about an improvement in 
manufacturing productivity and efficiency. Annual progress reports were submitted to 
Pfizer showing details of the work done and progress made on achieving the outlined 
objectives. There was a technology transfer from Leeds University to Pfizer, UK (Feb 
2012 - Mar 2012) hosted by Dr. Ivan Marziano and to Pfizer, US (Apr 2013) hosted by 
Dr. Kevin Girard as routine equipment to study the effect of crystallising conditions on 
the solid-state material. 
Collaboration with Artificial Intelligence Group of Computing School at University of 
Leeds (Prof. David Hogg and Dr. Ardhendu Behera) was established for developing 
image analysis software for estimation of growth rate of crystal faces in a population of 
crystals. 
The 15ml jacketed vessel cell was built with the advice of Dr Gary Nichols at Pfizer, 
UK. 
1.4 Thesis organisation 
This thesis consists of eight chapters (Figure 1.1) with references and appendices. 
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Chapter 1 presents the introduction, background to the study highlighting the research 
question set with the resulting objectives outlining project management and providing a 
route map to the thesis structure 
Chapter 2 offers a literature review on the fundamental concepts of crystallography and 
theories underpinning crystallisation processes, beginning with solubility, 
supersaturation and moving on to nucleation theory and crystal growth. In addition, the 
design of crystal and particle properties by crystallisation and crystallisation 
charaterisation are also presented. 
Chapter 3 reviews the crystal growth rate and growth mechanism, growth rate 
dispersion and the methodology for the measurement of the crystal growth rate on 
single crystals and on a population of crystals. A detailed review on the crystal growth 
process is then described, mainly focusing on the measurement of crystal growth. 
Chapter 4 describes the materials, instrumentation, and computational and experimental 
methods used in this study. 
Chapter 5 Molecular modelling study including conformational analysis, morphological 
simulation, characterisation of intermolecular interactions and surface chemistry 
analysis of the crystal habit faces are presented and discussed. 
Chapter 6 presents polymorph screening, solubility determination and nucleation 
kinetics of ibuprofen in ethanol 95%, ethyl acetate, toluene and acetonitrile which were 
examined involving MSZW and induction time measurements. 
Chapter 7 begins with the solubility of ibuprofen together with their ideal solution 
behavior, van‟t Hoff analysis and activity coefficient. The mean crystal growth rate of 
the (011) and (001) faces as a function of solvent type and supersaturations are 
examined and discussed at the single crystal level. In addition, the influence of reactor 
scale size and solution agitation is also assessed.    
Chapter 8 Technology Transfer: Growth rate measurements in an industrial R&D 
workstream: Industrial case studies of drug compound A at Pfizer, UK. 
Chapter 9 presents the key outcome of this work and makes some suggestions for the 
future work.  
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Figure 1.1 Schematic illustrative route map presenting the main studies in this thesis.
CHAPTER 1 Introduction 
 Background 
 Aims and Objectives 
 Project management 
 Thesis layout 
CHAPTER 2 Crystal and Crystallisation Science  
 Basic crystallography 
 Crystallisation process: nucleation and crystal growth 
 Design of crystal and particle properties by crystallisation 
 Crystallisation charaterisation 
CHAPTER 3 Crystal Growth Rate Kinetics and Mechanism 
 Expressions of crystal growth rate 
 Growth rate dispersion 
 Techniques for studying crystal growth rate and growth mechanism 
 
CHAPTER 4 Materials, Instrumentation and Methodology 
 Materials used in this study 
 Experimental and computational methods 
CHAPTER 5 Molecular modelling 
 Conformational analysis 
 Morphological prediction 
Intermolecular bonding  and 
surface chemistry analysis on 
the important faces 
 Conformational population  in 
different solvents 
CHAPTER 6 Crystallisation 
Process Characterisation and 
Analysis 
 Polymorph screening  
 Solubility determination  
 Nucleation kinetics of 
ibuprofen as a function of 
solvent was examined  
CHAPTER 7 Growth Rate Kinetics and Mechanism 
 The growth rate on the {001} and {100} faces is measured as a 
function of supersaturation, solvent type and reactor scale-size 
(0.5mL and 15mL) 
  The associated growth mechanism assessed.  
 Compared to the data recorded on the population of crystals 
crystallised in an agitated 7ml reactor 
  
 CHAPTER 8 Technology Transfer: Growth Rate Measurements in an 
Industrial R&D Workstream 
 
CHAPTER 9 Conclusions and Closing Remarks 
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2 Crystal and Crystallisation Science 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
This chapter presents the fundamentals of crystal and crystallisation science including 
crystal nucleation and growth, together with experimental and computational 
methodologies for their characterisation and the influence of crystallisation 
environmental conditions on crystal properties (polymorphism, size and shape). 
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2.1 Introduction 
 
The fundamentals, concepts and theories of crystal science and crystallisation processes 
including crystal nucleation, crystal growth, polymorphism and the effects of shape and 
polymorphism on properties, performance of final products are described in this 
chapter. One of the important aspects in studying crystal science is to comprehend how 
crystal structures and shapes influence the chemical and physical properties of materials 
and how to manipulate and create crystal shapes with desired properties for optimal 
downstream processing. These can be investigated and explained with the aid of 
molecular packing, intermolecular interactions studies in the solid state and also of 
nucleation and crystal growth theory. Sun [28] described the interrelationship among 
the structure, properties, performance and processing in the design and development of 
a new drug and developed a concept of the material science tetrahedron (MST). 
Through some detailed case examples, the MST tool can be applied in pharmaceutical 
research and development of new drug compounds to enable the pharmaceutical product 
development and manufacturing to become more rapidly commercialized in order to 
meet market demands.  
 
This chapter starts with a brief overview of basic crystallography notably crystal 
systems, crystal chemistry, Bravais lattices, Miller indices, followed by an overview of 
the theories of nucleation and crystal growth, which are applied in the later chapters of 
this thesis. The concepts are discussed and analyzed with respect to solid-state and 
crystal surface parameters. 
 
2.2 Basic crystallography 
2.2.1 Crystalline and amorphous solid 
 
Crystals can be divided into crystalline and amorphous state. A solution can transform 
into an amorphous, semi-crystalline or crystalline solid mainly depending on 
supersaturation (cooling rate). For example, if the cooling rate is faster than the rate at 
which molecules can nucleate and rearrange themselves into a thermodynamically 
favorable order, it is likely that an amorphous solid will be produced. In contrast, if 
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molecules have sufficient time to organize into a structure with two- or three-
dimensional order, it is much more likely that a crystalline or semi crystalline solid will 
be obtained. Hence, whilst the crystalline state possesses an ordered and regular 
arrangement of the molecules in a crystal, amorphous materials are converse cases. For 
example, silicon can be formed in both cases; amorphous and crystalline forms (see in 
Figure 2.1), and both states can be used for different applications. 
  
Figure 2.1 (left) Crystalline SiO2 (quartz), in which atomic arrangements are regular; (right) 
amorphous SiO2 (glass) refers to objects having no definite shape and is defined as non-crystal 
material (irregular atomic arrangements) [29]. 
 
In the pharmaceutical industry, amorphous forms of poorly-soluble drugs are generally 
considered to offer substantial improvements in drug dispersability, dissolution 
behaviour and bioavailability compared with the corresponding crystalline forms. 
Nevertheless, amorphous forms are less thermodynamically stable there is thus a risk 
that they may ultimately revert to the crystalline form [29]. 
 
Organic crystalline materials can adopt a number of structural architectures, e.g. 
polymorphs, solvates, hydrates salts etc. Solvates are solvent molecules incorporated in 
the crystal lattice in a stoichiometric and non- stoichiometric way. Hydrates are solvates 
where the solvent is water. If non-volatile molecules incorporated in the crystal lattice, 
the solid forms are called co-crystals [30]. 
 
2.2.2 Lattices, unit cells and crystal systems 
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A crystal is a polyhedral solid state bounded by plane faces and is built by the regular 
repetition of identical units in space.  Its internal structure contains atoms or 
molecules arranged in a three dimensional network. A three dimensional arrangement 
of atoms or molecules can be represented as a „crystal lattice‟. Each lattice point is 
representative of an atom or a group of atoms with the lattice representing the scheme 
of repetition patterns of atoms in the space. A small part of identical units defining 
how the pattern is repeated is referred to as a unit cell. It can be defined by three 
vectors a, b, c (along the crystallographic axes) and the angles α, β, γ between these 
vectors. 
The science of crystallography is developed based on three basic rules [31]: 
 Law of Constancy of the Interfacial Angles: The angles between specified 
surfaces of a crystal remain constant when they grow. 
 Law of Rational Indices: refers to the orderly arrangement of the crystal planes 
in space. These planes represent the various faces of crystals and are referred to 
by the three-coordinate-axes systems. The intercept of planes with axes can be 
represented by a whole integer number. 
 Symmetry: Plane symmetry can be defined by the means of imaginary planes 
which divide the crystal into two exact and completely the same parts. At a 
simple fraction of a complete rotation around an axis of symmetry, the faces, 
edges and corners of crystals will duplicate.  
 
These concepts are reflected in the seven types of unit cell as shown in Table 2.1. 
Table 2.1 The seven crystal systems [5] 
System Angles between axes Length of axes Crystal shapes 
Cubic  α = β = γ = 90 a = b = c 
 
Tetragonal α = β = γ = 90 a=b ≠ c 
 
Orthorhombic α = β = γ = 90 a ≠ b ≠ c 
 
Monoclinic α = β = 90 ≠ γ a ≠ b ≠ c 
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Triclinic α ≠  β ≠  γ ≠ 90 a ≠ b ≠ c 
 
Trigonal α = β = γ ≠90 a= b =c 
 
Hexagonal α = β = 90, γ = 120 a=b ≠ c 
 
 
 
The cubic (regular system) shows the highest degree of the symmetry in the crystal 
system. All the faces of crystals have intercepts with their axis (Figure 2.2). Miller [32] 
suggested that each face of the crystal can be represented by the Miller plane (hkl) with    
OZ
OZ
l
OY
OY
k
OX
OX
h
'','
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Figure 2.2 Miller indices of a plane derived from the intercept of the plane on the 
crystallographic axes. 
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In 1850 Bravais [33] demonstrated that there are 14 possible basic types of lattice 
(Figure 2.3). These can be rationalized with respect to the concept of 7 crystal systems 
through the presence of centering e.g.  through a body centre (with an additional point at 
the centre of the unit cell), face centre (with additional lattice points at the centre at the 
cell faces) etc. 
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X 
X’ 
Y‟ 
Y Z‟ 
Z 
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     Simple Cubic    Body-centered Cubic    Face-centered Cubic 
 
                        
 
 
 
 
 
 
 
Figure 2.3 Bravais lattices classified into three main types: primitive, body center and face 
center [33]. 
 
2.2.3 Crystal defects 
 
In perfect crystals nearly all atoms lie in the position that they should have in three 
dimensional arrangements.  They have exact repetition parameters of a unit cell. e.g. 
single crystals of silicon are produced without any defects with a distance of more than 
ten million unit cells [34]. However, above 0
o
K in reality the atoms are not static and 
can be mobilized in particularly at the elevated temperatures at which crystals are 
produced. Raw materials are not completely pure and the materials can contact with the 
wall of a vessel and with the surrounding environment so defects can be formed within 
the periodic arrangement. There are several kinds of such defects (Table 2.2). 
 
 
Body-centered 
Tetragonal 
Simple 
Orthohombic   
Body-centered 
Orthohombic 
Simple 
Tetragonal 
Based-centered 
orthohombic 
Face-centered 
Orthohombic 
Rhomboheral Hexagonal 
Simple 
Monoclinic 
Base-centered 
Monoclinic 
Triclinic 
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Table 2.2 Summary for types of crystal defects [35] 
Point Line  Two dimensional 
defect (Area or 
plane defect) 
The 
dimensional 
defect 
(Volume) 
Vacancies: Occurrence of 
vacant lattice sites 
Interstitials: Inclusions of 
atoms not on lattice sites 
Impurities: Occurrence of 
foreign particles in the 
lattice 
Dislocations: 
Gliding motions 
with 
combination of 
slip plane and 
Burgers vector 
Stacking faults: 
Additional of odd 
atoms sequence 
(twin) compared 
to original  
 
Inclusions and 
precipitations  
 
 
The vacancies or point defects have a great influence on the properties of solid 
materials; particularly electronic and mechanical properties since they have greater 
internal energy than crystals with close packing atoms. The presence of vacancies in the 
crystal structure plays an important role on the process of the solid-state diffusion. In a 
crystal where the atoms are packed closely together, there is a very low chance of this 
process happening even at high temperature. However, it is possible to happen if there 
are some vacancies in the crystal structure to impede the movement of atoms. Besides, 
there are other point defects such as interstitial atoms and impurities. In interstitials, 
additions of atoms of the same type as those in the crystal structure are sited in the 
interstices so distortion appears.   
 
The dislocations are known as one-dimensional defects (line defects). They can be an 
edge or screw in character or a combination of both of them. These dislocations can be 
defined by both the direction of strain caused by defect (Burgers‟ vector) and a line 
around the distortion occurs. An edge dislocation is a defect where an extra half-plane 
of atoms is inserted into the crystal, leading to compression of inter-atomic distances. 
The Burger‟s vector is perpendicular to the line of distortion. However, in the screw 
dislocation, the Burger‟s vector is parallel to the line of distortion (Figure 2.4) 
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Figure 2.4 (a) Edge dislocation, (b) screw dislocation and (c) the Burgers‟ vector is 
perpendicular to the line of distortion in the case of edge dislocation and in screw dislocation 
the Burger‟s vector is parallel to the line of distortion [36]. 
 
Two dimensional defects (plane defects) will propagate much further into the crystal 
lattice than point or line defects. These can arise on growth sector boundaries or due to 
stacking faults within the crystal. The  plane defect also may happen in many crystal 
structures during the growth process or in crystals grown by the deposition of 
successive close packing layers, the sequence is ABCABCABC…If the sequence has a 
stacking fault in the stacking sequence, e.g. ABCABCBACBA, twinning may occur. 
The two parts of the crystal have the same structure and are mirror images of one 
another. They possess a common plane (C) (a twin plane) which acts as a mirror [34, 
36]. 
 
Three dimensional defects (volume defects) are gross distortions to the crystal lattice. 
These can arise from the incorporation of materials of different chemical composition 
(for instance the solution solvent) or a material of different crystalline structure into the 
crystal lattice. 
 
 
(a) (b) 
(c) 
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2.3 Crystal chemistry and polymorphism 
2.3.1 Crystal chemistry  
 
In a crystal there are many component molecules held together in a 3D periodic 
arrangement by various intermolecular interactions which can be quite weak when 
compared to chemical bonds. Generally interactions can be classified into 5 groups 
(Figure 2.5): (a) co-valance; (b) ionic; (c) non-bonded attractive and repulsive van der 
Waals interactions; (d) metal and (e) hydrogen bonding.  
 
  
 
 
 
 
 
 
 
 
 
 
Figure 2.5  Factors impacting on the crystal structure comprise direction and strength of 
intermolecular forces. 
 
Dipole-dipole interaction: In a covalent diatomic molecule, the electron density will be 
higher in the more electronegative atom. A permanent dipole on one molecule produces 
an electric field that can interact with the permanent dipole on a neighbour molecule. 
The molecules tend to orientate themselves in a position of minimum energy such as 
end to end or side by side position. 
 
Van der Waals force refers to the attractive or repulsive forces between molecules or 
between parts of the same molecule in a non-bonded interaction. Van der Waals forces 
include momentary attractions between molecules or atoms. When the electron 
distribution of a molecule is changed due to the random collision, they become 
Factors driving crystal structure 
Size and shape of molecules Nature of intermolecular forces 
Directed or un-directed Strength  
Covalence: 
Strong and 
directed 
Ionic: 
Strong and 
un-directed 
Metal: 
Mixed and 
un-directed 
van der Waals: 
Weak and un-
directed 
Hydrogen-
bond: weak 
and directed 
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temporary polarization particles. Although they are not stable, many such temporary 
dipoles formed at a given time will interact with neighbour dipoles to produce a net 
attraction between molecules. The van der Waals interaction also usually includes the 
dispersive and repulsive force.  
 
Hydrogen bonding is the electrostatic force between an electronegative atom such as 
nitrogen, oxygen, fluorine etc. and a hydrogen atom. This causes an electric dipole: the 
hydrogen atom with a partial positive charge and the oxygen or nitrogen group with a 
partial negative charge. The hydrogen bonding performs a very strong influence on 
solubility of solute molecules in a solvent.  The strength of a hydrogen bond (between 
10 and 40 kJ/mol) is stronger than a typical van der Waals bond (about 1 kJ/mol); 
however both of them are much weaker than the covalent or ionic bonds (about 5000 
kJ/mol) [37].  
 
Crystal chemistry impacts on physical and chemical properties such as melting point, 
hardness, polymorphism, surface properties etc. 
2.3.2 Polymorphism 
 
According to McCrone, „The polymorphism of any element or compound is its ability 
to crystallise as more than one distinct crystal species‟ [37]. Polymorphs are crystals 
with the same molecule but different crystal structures due to different arrangements 
and/or different conformations of the molecules. It is a significant and complex issue in 
the pharmaceutical industry because there are a few active pharmaceutical ingredients 
that exhibit only one single crystal structure. In addition, the transformation between the 
polymorphic forms during the processing and storing time can also cause significant 
problems to the pharmaceutical industry.  
 
According to Ostwald rules, polymorphs can convert from less stable to more stable 
forms and the most stable form is expected to be the least soluble [38]. The unstable 
form does not always transform directly to the most stable form. The metastable form 
appears first and then transform to the next most stable solid state until the most stable 
form is achieved associated with the minimum energy. In a polymorphic system, 
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thermodynamics favours the formation of the stable form while kinetics can favours the 
formation of the metastable form [38-40].  
 
There are two specific types of polymorphs: 
 Monotropic: There is no reversible transition between polymorphic forms below 
the melting point of both solids. The free energy and solubility curves do not 
cross so only one polymorph is likely to be stable below the melting point 
(Figure 2.6). 
 Enantiotropic: A transition point exists below the melting point and this 
transition is reversible. The free energy and solubility curves cross before the 
melting point (Figure 2.6) 
 
Figure 2.6 Relationship between the Gibbs free energy G and the temperature T for two 
polymorphs for an enantiotropic system (left) and a monotropic system (right) [41]. 
 
The various polymorphs of a substance can exhibit different physical and mechanical 
properties. Since polymorphs are different in the dimensions, shape, symmetry, capacity 
and the void volumes of their unit cells, they have differences in molecular packing, 
causing different physical properties such as refractive index, thermal conductivity, 
electrical conductivity [42]. The differences in the melting point can be explained by 
dissimilarities of the interactions of the molecules in the solid-state as compared with 
the liquid state. In addition, the differences in packing properties and the intermolecular 
interaction energy among polymorph can cause differences in the mechanical 
properties.  
 
Hence, although polymorphs are identical in their chemical compositions, they can 
differ in terms of their solubility, dissolution rate, bioavailability, chemical stability, 
physical stability, melting point, flow behaviour and other properties. In particular, a 
G 
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change of the solubility of different polymorphs can affect the efficacy, bioavailability 
and safety of the drug [37].  Experimental or process conditions are crucial factors to 
determine the production of a particular polymorph. Hence, understanding and 
controlling the transformation process between polymorphs is important in terms of 
obtaining a desired form via the crystallisation process.  
 
2.4 Crystal morphology 
 
Habit and morphology are terms that represent the external shape and appearance of a 
crystal. Even though crystals are in the same crystal system, they may be different in 
terms of their external form or morphology (Figure 2.7) which depends in turn on the 
relative growth rates of the different crystal faces. If a crystal grows in different process 
conditions, the growth rate of a particular face can be accelerated compared to other 
faces, resulting in a different shape. The growth of an individual face is effected by the 
crystal structure, crystallising environment conditions (the degree of supersaturation, 
solvent and impurities) and defects.  
 
                             
Figure 2.7 Various crystal shapes [43]. 
 
The morphology of crystals can have a significant influence on both the solid state and 
the downstream processing including material handling and particle processing, for 
example, filtration, compression, flowability. 
 
In 1978 Gibbs [44] proposed that for the equilibrium shape of a crystal, the total surface 
energy should be a minimum for a constant volume of crystal 
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 ∑             ∑     dAn =0 (2.1) 
where An is the area of the n
th
 face and γn is the surface tension of the n
th
 face. 
 
Gibbs‟ concept was further extended by Wulff [45] who stated that the equilibrium form 
of a crystal should be bounded by faces whose distances from the origin should be 
proportional to the specific surface energies of the faces and similar to the relative rates 
at which the surfaces grow out from the nucleation centre of the crystal; 
γn/hn = constant    (2.2) 
where γn is the surface tension of crystal face n; hn is the distance from a point in the 
crystal known as Wulff‟s point. 
 
The equilibrium shape of a crystal can be constructed by drawing vectors normal to all 
possible crystallographic faces from an arbitrary point and marked on the vectors with 
the distances proportional to γn, and then planes normal to the vectors are built through 
the marks on the vectors creating a closed polyhedron (Figure 2.8), called the 
equilibrium form. 
 
Figure 2.8 Procedure to construct a Wulff plot where O is the nucleation centre. The equilibrium 
shape of a crystal can be constructed by drawing vectors to all possible crystallographic faces 
from O and marked on the vectors with the distances proportional to γn, and then planes normal 
to the vectors are built through the marks on the vectors creating a closed polyhedron [46]. 
 
Morphological crystal shapes of materials have been becoming more and more 
significantly important in the particle science and engineering. Clydesdale et al. [47] has 
developed the HABIT simulation program which calculates attachment energy Eatt as a 
function of the intermolecular interactions where the latter draws down the crystal 
structure for the material examined. These calculations can be carried out in a fairly 
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routine manner and have been used to predict the crystal morphology of a wide range of 
organic crystals revealing good correlation between observed and simulated crystal 
shapes (biphenyl, naphthalene, α-Glycine, L-alanine, benzoic acid, urea, β-succinic 
acid) [47]. The principle of modelling work is that the external morphology of 
crystalline materials can be predicted from the internal crystal structure. Bravais-Friedel 
and Donnay-Harker (BFDH) analysis which is one of the initial methods based on the 
crystallographic geometrical considerations can be used to predict the morphology of a 
crystal. The BFDH rule states that:  
 
“after allowing for the reduction of the growth slice thickness from space group 
symmetry considerations, the most morphologically important forms (hkl), and hence 
those with the lowest growth rates, are those having the greatest interplanar spacings 
dhkl” [48]. 
 
For a given structure, the BFDH method is able to predict the habit or shape of a crystal 
using the corresponding unit cell parameters (a, b, c, α, β and γ) and the symmetry 
operator information. This method uses the crystal lattice and symmetry to generate a 
list of the possible growth faces and their relative growth rates. As a result, the 
theoretical crystal morphology can be generated from these relative growth rates. 
 
Hartman and Perdok [49] extended and developed BFDH theory by calculating the 
intermolecular interactions in the crystallisation process. In this theory, the attachment 
energy is related to the crystal lattice energy or crystallisation energy (Elatt) through the 
slice energy (Esl) which is released upon the formation of a slice of thickness dhkl 
slattlatt EEE      (2.3) 
where Esl is the intermolecular bonding energy within the surface growth slice. 
 
The attachment energy (Eatt) represents for the relative (hkl) surface growth rate as the 
slowest growing face is the one with lowest attachment energy and hence the most 
morphologically important. 
 
The total intermolecular interaction can be considered as the summation of the 
interactions between a central molecule and the surrounding molecules. Each of the 
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intermolecular interactions is calculated by the summation of pairwise atom-atom 
interactions, using the atom-atom approximation through summing the interatomic 
energies between pairs of non- bonded atoms (Figure 2.9).  
 
If there are n atoms in the central molecule and n‟ atoms in each of the N surrounding 
molecules then the lattice energy can be expressed by: 

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where Vkij is the interaction energy between atom  i in the central molecule and the atom 
j in the kth surrounding molecule. The interaction Vkij between any of the non-bonded 
atoms i and j can be described by a number of intermolecular potential functions 
(Momany [50], Lifson [51]). The potential energy of interactions between two atoms 
includes the van der Waals forces having an attractive and repulsive as a function of 
atom-atom separation distance and the Coulomb potential for the calculation of the 
electrostatic interactions. A simple Lennard-Jones potential combined with an 
additional Columbic term to describe the electrostatic interactions: 
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(2.5) 
where A and B are parameters for describing a particular atom-atom interaction, qi and 
qj are the fractional charges on atom i and j separated by distance r, and D is the 
dielectric constant. 
  
Figure 2.9 Basic approach of calculating the intermolecular interactions using the atom-atom 
method: C is the central molecule, P is a molecule outside the slice and S is a molecule inside 
the slice [52]. 
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Since the interactions are between two atoms, the factor of ½ appears in the equation to 
avoid a double count of the atom-atom interactions.  
A computer program HABIT was written and developed to aid in the morphological 
predictions of molecular crystals by calculating such interactions between the 
crystallising molecules in the solid state. The program calculates the lattice, slice and 
attachment energies by a summation of atom-atom interactions in a certain molecule 
and interactions of atoms this molecule has with atoms of all surrounding molecules 
inside a given radius of the sphere. This program requires the fractional atomic 
coordinates of one asymmetric unit of the system; the atomic charges file for this 
asymmetric unit, symmetry operators from the relevant space group, and important 
growth faces. 
 
The specific surface energy (hkl) for the individual faces can be calculated based upon 
the attachment energy [53] using the equation 
 
Acell
hklatt
hkl
NV
dZE
2
     
(2.6) 
where Z is the number of molecules in the unit cell; Eatt is the attachment energy; dhkl is 
the d-spacing of individual face (hkl);  Vcell is the volume of the unit cell and NA is the 
Avogadro number. 
 
Moreover, the HABIT program also enables examination of the intermolecular 
interactions and through this is able to identify the strong bonds and, particularly atom-
atom their constituent or atom type contributions. It can also sort the various 
interactions in terms of either their relative strength or distance [47].  
  
2.5 Crystallisation process 
 
In order to obtain the desired crystal morphology, size and properties suitable for further 
downstream processes, concepts of crystallisation processes including solubility, 
supersaturation, crystal nucleation, crystal growth, polymorphism and the effects of 
shape and polymorphism on properties and performance of a chemical compound need 
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to be understood and controlled. Solution properties, nucleation and crystal growth are 
important components in crystallisation processes.  
 
2.5.1 Solutions, solubility and supersaturation 
2.5.1.1 Solutions and solubility 
 
The solubility of a solid compound in a solvent and mixtures of solvents play a key role 
in crystallisation processes. Why do solids dissolve in solvents e.g. sugar and salt is 
dissolved in water? In order to make it occur, it needs energy to break the bonds 
between the sugar molecules and the hydrogen bond in water to add sugar molecules 
into solution. Generally a solution is a homogeneous mixture of two or more substances 
[26]. A mixture of solvents might be found to be useful in obtaining the desired 
properties of crystal shapes and morphology. Solvents that have been used in industry 
include water, methanol, ethanol, iso-propanol, n-butanol, t-amyl alcohol, acetone, 
methyl ethyl ketone (MEK), methyl isobutyl ketone (MIBK), tetrahydrofuran (THF) 
etc. A saturated solution in a solvent represents the thermodynamic equilibrium between 
solution and the solid phase. Understanding the solubility of a chemical compound in 
solvents is one of the first requirements for the development of a crystallisation process.  
 
Thermodynamics shows a way to calculate the ideal solubility of a solute in any solvent. 
In this calculation, the solubility is independent of the chemical composition of the 
solvent because the ideal solution is formed in this system. The ideal solubility of a 
crystalline material in a solvent was shown by Hilderbrand and Scott [54]: 
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)     
(2.7) 
where X is the mole fraction of the ideal solubility of the solute; ΔHfus is the molar 
enthalpy of fusion of the pure solute; Tm is the melting point (K); T is the solution 
temperature; ΔCp = Cpm - Cps is the heat capacity difference (at constant pressure) 
between the melt and the solid states.  
 
Equation (2.7) can be used to evaluate the ideal solubility of a solute in different 
solvents. However, all solutions are not ideal to some extent as the interaction energy 
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between solvent/solvent, solute/solute and solvent/solute are different particularly for 
complex solvents and solute molecules. If the solubility curve lies below the ideal 
solubility curve, the solution shows a less than ideal behaviour since the intermolecular 
interactions of solute-solute and solvent-solvent are much stronger than those related to 
the interaction between the solute-solvent molecules and the solute has a lower 
solubility in the solvent.  
 
2.5.1.2 Supersaturation 
 
Supersaturation is the driving force of the crystallisation process. The supersaturated 
solution contains more dissolved solid than that required for the equilibrium state. 
Supersaturation can be defined in the different expressions. The most common 
expressions of supersaturation are: 
  
The concentration driving force        
∆c = C – C*              (2.8) 
The supersaturation ratio     
*C
C
S      
(2.9) 
  The relative supersaturation     
1
*


 S
C
C
     
(2.10) 
where C* is the equilibrium saturation of the solution at the given temperature; and C is 
the actual solution concentration at the same temperature 
 
The production of a solid-state through the crystallisation process might appear to be 
simple but despite this it is not completely and clearly understood since the 
crystallisation process includes many complex stages related to the nucleation and 
crystal growth processes.  
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2.5.2 Nucleation 
 
In crystallisation process, nucleation is the first stage of the crystallisation process in 
which the formation and dissolution of small clusters of solute occur with some of these 
clusters continuing to develop to form crystals.  
 
The nucleation concept and mechanism encompass primary nucleation (homogeneous 
nucleation and heterogeneous nucleation) and secondary nucleation (induced by crystal 
seed) (Figure 2.10). Primary nucleation does not involve the presence of any crystal 
matter in the system when there is no induction of foreign particles and crystals in the 
crystallisation solution; this process is called homogeneous nucleation. Heterogeneous 
nucleation is referred to as the nucleation of materials upon a foreign substrate. 
However, secondary nucleation occurs with the presence of seeds which can be served 
as a template for the solute molecule to aggregate and grow within the metastable zone.  
 
 
 
 
 
 
 
 
 
Figure 2.10 Schematic showing the classification of the nucleation stage in a crystallisation 
process. 
 
2.5.2.1 MSZW 
 
The state of supersaturation is the prerequisite for the crystallisation process. Ostwald 
[55] first introduced the terms „labile‟ and „metastable‟ supersaturation to classify a 
supersaturated solution in which spontaneous nucleation occurs or does not occur, 
respectively. Miers and Isaac constructed the solubility–supersolubility diagram based 
on the relationship between the supersaturation and spontaneous crystallisation [56, 57]. 
NUCLEATION 
 
PRIMARY  SECONDARY (induced 
by crystals in the solution) 
HOMOGENEOUS (occurs spontaneously 
by self-molecular assembly) 
 
(Spontaneous) 
HETEROGENEOUS (induced by 
the presence of foreign particles) 
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The solubility-supersolubility diagram showing three regions with different behaviours 
is shown in Figure 2.11. 
 
                    
Figure 2.11 Solubility-supersolubility diagram showing three regions with different behaviours: 
(1) a stable or unsaturated zone; (2) a metastable zone and (3) an unstable zone [56]. 
 
This diagram includes three zones: 
 The stable or unsaturated zone where the crystallisation cannot happen. If 
seeding crystals are added at higher temperature (in stable region), they will be 
dissolved. 
 The metastable zone (supersaturated zone) between the solubility and 
supersolubility curves where the concentration of solution becomes saturated but 
the crystallisation only occurs after a period of time or if crystal seeds are 
introduced in the solution. In this zone, crystallisation is possible and when the 
supersolubility curve is reached, spontaneous crystallisation takes place. Seed 
crystals placed in solutions in this region will grow. 
 The unstable or labile zone where spontaneous crystallisation occurs due to the 
high supersaturation of solution. If seed crystals are added in the labile zone, 
nucleation will occur spontaneously in an uncontrolled manner. 
 
Related to this, two approaches for supersaturation generation can be considered:  
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 Evaporative crystallisation (along the vertical line AB'C'), a solution is 
becoming more concentrated in solute through evaporation of the solvent from 
the solution at constant temperature.  
 Cooling crystallisation (along the line horizontal ABC), a solution is undergoing 
cooling crystallisation. 
 Combined evaporation and cooling crystallisation (along the curved AB‟‟C‟‟), a 
combination of cooling and evaporation are employed in this process. 
 
Whilst the solubility curve reflects the thermodynamic equilibrium of the system, the 
supersolubility curve reflects the kinetics and consequently is less well-defined as it is 
more stochastic and can be expected to change with e.g. cooling rate, solvent type and 
composition, agitation rate and impurity content. Therefore, the metastable zone width, 
a crucial parameter of crystallisation process, which gives a significant insight into the 
nucleation behaviour of a crystallisation system, can also be expected to change with the 
above processing conditions. Hence the nucleation process and its kinetics for a given 
system is usually characterised by changing these factors. 
 
2.5.2.2 Polythermal crystallisation for the determination of nucleation kinetics 
using Nyvlt method 
 
Nyvlt [58] proposed a method for the evaluation of nucleation kinetics. In this method, 
the nucleation rate J is defined as the formation of number of nuclei in the unit volume 
in a period of time dη: 
m
n ck
d
dN
J
max


    
(2.11) 
where ∆cmax is the maximum possible supersaturation, m is the order of nucleation. 
 
The nucleation rate versus the degree of supersaturation showing the nucleation rate 
increases significantly when solutions reach critical supersaturation (Figure 2.12). 
∆cmax can be written as a function of the maximum possible undercooling ∆tmax through 
the equation: 
maxmax t
dt
dc
c      
(2.12) 
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where ∆tmax = tsat - tdis; tsat and tdis are the saturation and dissolution temperatures, 
respectively. 
 
 
 
 
 
 
 
 
 
 
Figure 2.12 Schematic plot of the nucleation rate versus the degree of supersaturation showing 
the nucleation rate increases considerably when approaching critical supersaturation [58].  
 
The nucleation rate may be expressed to be equal to the rate at which supersaturation is 
achieved at the time when first nuclei are detected. 

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d
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bkJ 1     
(2.13) 
where k1 is a constant, ε is a correction factor for the change in concentration in the case 
where species are being hydrated, and b is cooling rate. 
 
Combining the equation (2.11) (2.12) and (2.13), an expression for dependence of the 
MSZW ∆tmax on the cooling rate b can be obtained: 
m
n t
dt
dc
kb
dt
dc












 max     
(2.14) 
This equation can be rewritten after taking logarithms: 
maxloglogloglog)1(log tmk
dt
dc
mb n       
(2.15) 
Plotting logb against log ∆tmax yields a straight line with slope equal to the order of 
nucleation m.  
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Using equation (2.15) for fitting experimental data of more than 25 chemical 
substances, Nyvlt [58] also reported that the nucleation m seemed to be a function of the 
molecular weight of the crystallising substance at certain extent. The data showed the 
mean value of m decreases slightly with increasing molecular weight which confirmed 
the nucleation order m is related to the number of particles forming a nucleus in the 
solution. The measured nucleation order m from the Nyvlt equation will give an 
indication as to the ease at which the crystallising material will nucleate. It is a helpful 
parameter to assess the effect of solvents and/or solvent compositions on the MSZW of 
a crystallising system. 
 
2.5.2.3 Homogeneous nucleation 
 
Nucleation is originated from a sequence of molecular additions into aggregates. Only 
aggregates having a size greater than a critical value will be stable and grow into a 
crystal.  The nucleation process includes two competing processes: coagulation and 
redissolution. The free energy changes associated with these may be considered 
assuming a spherical nucleus. 
 
vvs GrrGGG 
32
3
4
4   
(2.16) 
where ∆GS is the surface free energy; ∆Gv is the volume excess free energy between the 
solid and the liquid phase; r is radius of nucleus; and γ is the interfacial tension between 
the crystal surface and the solution. This is shown schematically in Figure 2.13. 
 
Examination of equation 2.16 reveals ∆G reaches a maximum value, ∆Gcrit, when 
0

dr
Gd
and hence: 
   
  
                
 
(2.17) 
Thus the critical cluster size can be given as: 
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v
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r


2
   
(2.18) 
 
The critical size rc is the minimum size for a stable crystalline cluster to be able to grow 
to macroscopic proportions. Thus, in a supersaturated solution, nuclei can either grow 
into macroscopic crystals or redissolve into the solution depending on their size. When 
particles of a crystallising phase are small, the surface free energy term (positive term) 
dominates over the volume or bulk free energy term (negative term). Hence, the 
particles smaller than rc will dissolve. However as the particles become larger, the 
volume term dominates. Hence, the free energy passes through a maximum point. This 
represents the critical cluster size or minimum size of clusters and the particles larger 
than the critical size will continue to grow. The process will occur with the decrease of 
the free energy (Figure 2.13). The value of rc decreases as supersaturation increases, 
showing the possibility of nucleation will be higher at a higher supersaturation for a 
particular system. When rc approaches molecular dimension an amorphous phase 
results. 
 
 
 
 
 
 
 
 
 
 
Figure 2.13  Free energy associated with a molecule cluster diagram for the nucleation 
explaining the critical nucleus. 
 
Replacing the value of rc into above equation, we get: 
       
     
 (   ) 
 
     
 
 
    
(2.19) 
∆Gs 
∆Gv ∆G 
∆Gcrit=4/3πγrc
2
 
F
ree en
erg
y
, ∆
G
 
Size of nucleus, r 
Chapter 2. Crystal and Crystallisation Science 
 
34 
 
2.5.2.4 Isothermal crystallisation for induction time determination 
 
The rate of nucleation J is defined as the number of nuclei produced per time per 
volume using the Arrhenius relationship. Using the Arrhenius relationship: 





 

KT
G
AJ exp    
(2.20) 
where A is the pre-exponential factor, K is the Boltzmann constant. 
 
Reflecting the small size expected for a critical nucleation cluster, the nucleation rate 
can be difficult to directly measure. In a practical situation, the induction time to the 
initiation of crystallisation is often employed to estimate the nucleation rate J using the 
approximation J~ 1/η for calculation of the interfacial energy. According to the classic 
nucleation theory, spontaneous nucleation will occur when supersaturation is achieved. 
However, in reality there is a period of time between the achievement of supersaturation 
and the appearance of crystals known as the induction time ηind. In cooling 
crystallisation, a supersaturated solution can be obtained by cooling rapidly the solution 
and then the temperature maintained until crystals appear. The induction time can be 
determined when the first crystals appear.  
 
Assuming that the nucleation time is primarily for the formation of the nucleus, the 
induction time η is inversely proportional to the rate of nucleation, J 
 
η =1/J (2.21) 
 
Besides, the Gibbs-Thomson relationship [40, 59] represented the relationship between 
particle size and solubility by the equation: 
rRT
M
S
C
C

2
lnln
*






  
(2.22) 
where C is the solubility of particles; C* is the equilibrium solubility of the substance, R 
is the gas constant, T is the absolute temperature, ρ is the density of the solid, M is the 
molar mass of the solid in the solution, γ is the interfacial tension of the solid with 
solution, υ is the numbers of mole of ions formed from one mole of electrolyte. 
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For non-electrolyte, υ = 1, therefore: 

 SkT
r
Gv
ln2
     
(2.23) 
 Thus from the equation (2.19) 
2
23
)ln(3
16
SkT
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
    
(2.24) 
From equation (2.20), the rate of nucleation can be expressed as: 

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(2.25) 
Combining equation (2.21) and (2.15) and taking natural logarithm for both sides of the 
equation, we can obtain this: 
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
   
(2.26) 
According to the equation (2.26), three variables which have significant effects to the 
rate of nucleation are the temperature, the degree of supersaturation, and the interfacial 
tension. This relationship indicates that the rate of nucleation increases with increasing 
degree of supersaturation. Higher levels of saturation will generate a large number of 
nuclei whilst lower levels of supersaturation produce a smaller amount of nuclei that 
will grow into bigger crystals. 
 
2.5.2.5 Heterogeneous nucleation 
 
According to equation (2.18) both ΔG and rc depend profoundly on the surface free 
energy so any modifications are able to change these values would be most likely to 
have an effect on the possibility of the nucleation process. It has been verified that the 
presence of foreign bodies or a surface in a crystallising solution can reduce the positive 
free energy change (activation energy) therefore this reduces the values of ΔG and r 
associated with the formation of the critical nuclei at constant supersaturation, that is, 
making nucleation more favourable. A decrease in surface free energy would also 
decrease the value of the critical supersaturation, since the nucleation rate is also 
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dependent on the surface energy (equation 2.20). These factors can be expected to make 
heterogeneous nucleation more viable than homogeneous nucleation particularly at low 
supersaturation levels. The reduction of the surface energy will be the highest when the 
best match between the substrate and the crystallising substance is achieved [60]. 
 
The overall free energy change to form critical nuclei associated with heterogeneous 
critical nucleus formation will be less than the free energy change in homogeneous 
nucleation, ∆Gcrit. 
critcrit GG 
'
    (2.27) 
where ∆G’crit is the free energy change when forming a critical nucleus under 
heterogeneous condition; and ∆Gcrit is the free energy change when forming a critical 
nucleus under homogeneous conditions where 0 < Φ < 1 
 
A model for the effect of a solid crystal nucleus forming on a solid foreign body can be 
built by relating the reduction in the free energy of nucleus formation to the contact 
angle θ (Figure 2.14). 
 
Figure 2.14  Interfacial tension at the boundaries between two solids and one liquid [26]. 
 
where θ is the angle of contact between the crystal and the foreign solid surface (angle 
of wetting in liquid-solid systems); γcl is the interfacial tension between the crystalline 
phase and the mother liquor, γsl is the interfacial tension between the solid foreign-body 
surface and the mother liquor, and γcs is the interfacial tension between the solid 
crystalline phase and the foreign body. 
 
The relationship between the surface energies and the contact angle of the nucleus and 
the substrate is given by: 
θ 
γcl 
Crystalline deposit 
or nucleus (c) 
Liquid (l) 
Substrate/Solid surface (s) 
γsl γcs 
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     
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Volmer [61] suggested that: 
  
4
cos1cos2
2
 
  
(2.30) 
For the limiting case when θ = 180° then there is no wetting, (cosθ = -1, Φ= 1) so there 
is no reduction in the energy barrier and the free energy required for the homogeneous 
and heterogeneous nucleation become the same. 
 
When 0° < θ < 180° (partial wetting), there is a reduction in nucleation energy barrier. 
The total free energy required for heterogeneous nucleation is less than for 
homogeneous nucleation and thus the nucleation in this case is easier to achieve. 
 
When the other limiting case where θ = 0°, there is complete wetting and hence no 
energy barrier to nucleation or the free energy of nucleation is zero. 
 
A surface or an interface of different composition than the solute may serve as a 
nucleation substrate in heterogeneous nucleation. It decreases the energy barrier for the 
formation of nuclei which may grow into crystals. The free energy of nuclei formation 
can be expected to be lowered with the presence of a substrate as a result of favourable 
surface interactions between the aggregate and the substrate. Hence, with the presence 
of foreign particles or template surfaces, the nucleation can be induced at lower 
supersaturation or a lower degree of supercooling than homogeneous nucleation. Also, 
nucleation can be promoted by the increase of the surface area of the substrate.  
 
2.5.2.6 Secondary nucleation 
 
When both the substrate and the crystallising substance are the same, it is called 
secondary nucleation. This mechanism will be more favourable than both heterogeneous 
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and homogeneous nucleation and thus crystals can be produced at a lower 
supersaturation [60].  
 
Secondary nucleation is induced by crystals that are present in the supersaturated 
solution. The presence of a crystal (seeding) in the supersaturated solution may cause 
further nucleation at a degree of supersaturation for which spontaneous nucleation can 
not occur due to the lower interfacial tension at the surface. This phenomenon is called 
„breeding of nuclei‟ or „secondary nucleation‟. Breeding can be occurred by several 
mechanisms [62]: 
 Initial (dust) breeding: This occurs when a crystal is first introduced to a solution 
as long as it has not been specially treated before. It is attributed to the existence 
of crystal dust on the surface of the seed. These crystals are washed off and grow 
into new crystals. 
 Needle or polycrystalline breeding: At a high supersaturation, crystals often 
grow imperfectly. In some cases, they develop as needles or dendrites, and in 
others they grow as a conglomerate polycrystalline which is easily broken up 
into further crystals if the solution is agitated. 
 Collision breeding: This occurs in the supersaturated solution when a crystal 
collides with or slides along another one. Collision breeding appears as a main 
cause of secondary nucleation in most of the agitated seeded crystallisation 
systems. 
 
When crystals of solute present in the solution intentionally or unintentionally, the 
supersaturated solution will be easier to nucleate i.e. at a lower supersaturation 
compared to heterogeneous nucleation. The process in which small crystals are 
introduced in the solution has been known as seeding. Seeding is able to control 
polymorphs as well. Kwokal et al [63] used a self-assembled molecular layer of 
Entacapone (SALE) on an Au (100) surface for polymorph-directing seeding of 
Entacapone crystallisation in aqueous/acetone solution. This study reveals the 
possibility of directing nucleation from uncontrolled nucleation sites toward a more 
directed crystallisation process and thus more stable polymorphic form via a selective 
choice of an adsorbed polymorph on a substrate (see Figure 2.15). 
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Figure 2.15  Entacapone crystal (left) Needle-like crystals of form D obtained from with 
absence of SALE; (right) cubic crystal of form A in the presence of SALE [63]. 
 
2.5.3 Crystal growth 
 
Crystal growth is composed of the series of stages by which an atom or a molecule is 
incorporated onto the crystal surfaces. Stages involved in the crystal growth process can 
be summarised as follows: 
(i) Transport of solute molecules toward the boundary layer neighbouring to the 
crystal surface  
(ii) diffusion of solute thorough the boundary layer due to the concentration gradient 
(iii) Adsorption of solute molecule on the crystal surface 
(iv) Diffusion over the crystal surface to choose the energetically favourable binding 
site 
(v) Attachment onto step sites of the crystal surface 
(vi) Diffusion along the surface step 
(vii) Attachment to the kink site of the crystal surface 
 
It is not necessarily that the processes from (i) to (vii) occur in the growth process of 
some materials. Solute particles may omit stage (iv) and (v) and directly incorporate 
onto the kink site or some stages may occur more rapidly comparing to some other 
stages so the slower stage can be neglected. 
The model of the mechanism by which crystals grow is represented in Figure 2.16. 
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Figure 2.16 Kossel model of a crystal surface [60]. 
 
In this model, three sites considered for molecules adsorbed or desorbed from the 
growth layer are steps, terraces and faces.  A growth unit (atom, ion, and molecule) is 
represented by a cube. One cube molecule can have a maximum of six bonds with 
surrounding units. A molecule adsorbing on the step site forms two bonds, on the kink 
forms three bonds and on the terrace forms only one bond. When a cube is incorporated 
onto the layer to form a crystal, it will find a position or a crystal face to attach. There 
are three different types of crystal faces: flat (F) face, stepped (S) face and kink (K) 
face. In this model, if a molecule incorporates onto the kink faces, it will stay there and 
become a part of the crystal. However, there are very few molecules adsorbing directly 
on the kink face. They adsorb on the step face first and then diffuse to the kink site later. 
They may be desorbed many times before incorporating onto the kink faces. Hence, it is 
obvious that the molecules will adsorb on the rough surface; S and K will have a greater 
probability to become a part of this surface than those adsorbing on the F face. This 
results in the rate of crystal growth on the flat face (smooth surface) being much slower 
than that of the rougher step or the kink faces. This will affect the crystal shape due to 
the differences between the growth rates of the different faces. The rapidly growing 
faces get smaller and smaller then tend to disappear. As a result, the surrounding faces 
of crystals are those characterised by the relatively slow growing flat faces.  
 
2.5.3.1 Diffusion reaction theory 
 
There are many factors including the three-dimensional crystal structure, crystal defects, 
temperature, supersaturation, solvents and the presence of impurities which affect 
crystal growth [64].  Noyes and Whitney [65] assumed that the crystallisation process is 
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the reverse process of dissolution. The driving force for crystallisation is the difference 
between the concentration in the bulk of solution and at the solid surface. 
)( *ccAk
dt
dm
m      
(2.31) 
where m is crystal mass deposited in time t; A is surface area of crystal; C is solute 
concentration in the solution; C* is equilibrium concentration; and km is coefficient of 
mass transfer. 
)( *ccA
D
dt
dm


    
(2.32) 
where D is coefficient of diffusion of the solute and δ is the thickness of the stagnant 
film. 
Crystal growth is a combination of two processes: diffusion and surface adsorption. 
Firstly, solute molecules are transported from the bulk of the supersaturated liquid phase 
to the surface of a crystal (diffusion process). Secondly, the solute molecules are 
incorporated into the crystal surface to extend the crystal lattice (adsorption) (Figure 
2.17). Hence, the overall growth rate of a crystal reflects the relative rates of these 
stages. 
 
 
Figure 2.17 Concentration driving forces of two stages (diffusion and adsorption) in crystal 
growth from the solution [26]. 
Diffusion:   
)( id CCAk
dt
dm
     
(2.33) 
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Adsorption:        
)( *CCAk
dt
dm
ir      
(2.34) 
where kd is the rate constant associated with diffusion; kr is the rate constant associated 
with incorporation of growth units into the crystal. 
 
When the diffusion of materials between the bulk solution and the surface of a crystal is 
slow compared to the surface absorption (surface diffusion, integration, and the 
adsorption and desorption of the crystallising units), this is known as mass transport 
(diffusion) controlled. When the surface adsorption is slow compared to the diffusion, 
this is a surface controlled process. However, it is difficult to apply in above 
calculations since the interfacial concentration is not easy to measure. 
 
2.5.3.2 Crystal growth mechanisms 
 
Different crystal faces show different surface chemistry, thus the growth of individual 
faces depends on crystallising conditions such as supersaturation, solvent and impurities 
due to the interactions at the interface. Hence, the growth rate of each face is expected 
to be different resulting in a change of size and morphology of the crystal. The growth 
mechanisms that show the relationship between the crystal growth rate and 
supersaturation level will be described and discussed in the following section. The 
behaviour of growth rate of a crystal face is dependent on its underlying growth 
mechanism [66]. The growth mechanism controls molecular attachment onto the 
growing crystal surface [67]. There are three dominant crystal growth mechanisms 
expected to be active for a particular supersaturation region (Figure 2.21). 
 
 (a) Screw dislocation mechanism (Burton, Cabrera and Frank (1951): This 
mechanism was developed by Burton, Cabrera and Frank to explain experiments which 
observed crystal growth at very low supersaturation where the transport of solute 
molecules from the bulk solution to the crystal surface is unfavourable. According to 
Burton, Cabrera and Frank at low supersaturations, the crystal growth process occurs 
via 2-dimensional diffusion of solute molecules over the crystal surface. The 
incorporation of growth units onto the face of the dislocation protrusion leads to the 
formation of a growth spiral over the crystal surface. Screw dislocations provide a 
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continuous source of kink sites which allow easy attachment of growth units onto the 
surface and facilitate the subsequent growth of the surface (Figure 2.18). 
 
 
Figure 2.18 Crystal grown by the BCF mechanism shows the surface of the crystal with a screw 
dislocation and development of a spiral [60]. 
 
The resulting growth rate expression is given by: 
)tanh(2


B
AR    
(2.35) 
where A and B are complex temperature-dependent constants. 
 
(b) Two-dimensional Birth and Spread mechanism [68, 69]: At higher 
supersaturation, nucleation can occur without the need for edge and kink sites and takes 
place anywhere on the crystal surfaces. These develop through creating a growing 
monolayer. After this initial stage, further growth units integrate into the existing 
monolayer to spread over the surface (Figure 2.19). The relationship between the face 
growth velocity and supersaturation can be expressed by:  
)exp( 26/51


A
AR     
(2.36) 
where A1 and A2 are constants . 
 
 
 
Figure 2.19 Crystal grown by birth and spread mechanism in which nucleation may occur at the 
edges, corners, or on the faces of the crystals [26]. 
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(c) Continuous growth (rough interface) model [70]: At very high supersaturation, 
surface roughening provides abundant sites for surface integration with more kink sites 
resulting in a much higher growth rate.  At this region, the energetics of growth unit 
attachments are the same regardless of the growth direction producing morphologies 
which result in  spherulitic or dendritic crystals (Figure 2.20) . 
     (2.37) 
          
(a)                                                   (b)  
Figure 2.20 (a) Ice (snow) crystal morphology changes by roughening occurring at the corner of 
a crystal;  (b) Dendritic ice crystals [71]. 
 
 
 
Figure 2.21 Schematic showing the crystal growth rate mechanism taking place at the 
crystal/solution interface, involving screw dislocation (a) 2D surface nucleation (b) together 
with the expected crystal growth mechanisms as a function of solution supersaturation (c) and 
the transition between stable growth on a smooth surface to unstable growth at the roughened 
crystal/solution interface ((d) and (e)) [72]. 
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2.5.3.3 The surface entropy factor and its relation to the entropy factor 
 
Jackson (1958) and Bennema and van der Eerden [73] introduced the α factor as a 
surface entropy factor which can be used to predict the growth mechanism of a crystal 
face 
R
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s
t
s
hkl



   
(2.38) 
where L is the molar heat of fusion for the melt growth calculation; in the case of crystal 
growth from solution, L must be replaced by enthalpy of dissolution; ξhkl is the surface 
anisotropy factor: ξ = ns/nt = ESl/Ecr with Esl is the total energy in the slice of the crystal 
face and Ecr is the total crystallisation energy; ∆H and ∆S are the entropy and enthalpy 
of phase transition, respectively. 
 
For solution growth, there are two most used expressions for calculation the surface 
entropy factor αhkl [74]: 
   
   
  
    (2.39) 
   (
   
  
       )  
(2.40) 
where ∆Hs and ∆Hf are respectively the heat of solution and the heat of fusion; Xseq is 
the mole fraction calculated from solubility. 
 
According to Bennema and Gilmer [75] and Davey [76] (Table 2.4), the growth 
mechanism can be predicted by the values of α. 
 
Table 2.3 Predicted growth mechanism according to the value of α 
 Bennema and 
Gilmer [75] 
Davey 
[76]  
Predicted growth mechanism 
α < 3.2 α < 2 The interface is rough so all growth units can 
incorporate onto the growing surface (continuous 
growth). 
3.2 < α < 4.0 2 < α < 5 The interface is smoother and the most probable 
mode of growth is B&S 
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α > 4 α > 5 The surface becomes very smooth and growth 
generally proceeds by screw dislocation (BCF). 
 
When a face is growing at temperatures above TR, the surface is rough and growing 
„continuously with a linear dependence of the growth rate on supersaturation showing 
non-faceted crystal morphology. Whilst a crystal grows below TR, the surface is smooth 
and growing with a layer mechanism (B&S and BCF) and follows a non-linear 
relationship between the growth rate and the supersaturation [77]. Human et al [77] 
calculated the surface anisotropy ξ and the αhkl and     
 for different faces (hkl) in 
various organic solvents and the melt using equation 2.38. For the (001) and (110) face, 
the α factors are above the critical value     
  so the face grows below the roughening 
temperature confirming a proper facetted crystal surface. However, for the growth from 
toluene and the melt, the α factors are slightly above     
  so kinetic roughening may 
happen which is in good agreement with the experimental observations. For the (11-1) 
face, non-faceted growth of this face is expected due to this face is growing above 
roughening temperature. However, the (11-1) face is much smaller or even not present 
so it is impossible to observe if this face growing facetted or not. Similarly, Jetten et al 
[78] calculated the αhkl and     
  of important faces of naphthalene in toluene to 
determine if the (hkl) face is growing above or below the roughening temperature. The 
morphology of crystal growing at below and above the roughening temperature was 
shown from experiments. The experimental results were in good agreement with the 
calculated values of the αhkl and     
 . 
 
The critical values     
  of the αhkl factors of crystal habit faces of biphenyl in methanol, 
toluene, and from the melt were calculated [77] and naphthalene in toluene [78] in 
Table 2.4. 
Table 2.4.The critical values     
  of the αhkl factors of crystal habit faces of biphenyl and 
napthalene 
     
  
Biphenyl 2.6 – 3.4 
Naphthalene  2.5 – 3.4 
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Bourne and Davey [79] [80] considered solvent effects and calculation of the α factor 
for the growth of hexamethylene tetramin (HMT) from vapour and from aqueous and 
ethanolic solutions from the heat of solution, from the entropy of solution and from the 
surface energy. The prediction of the growth mechanism from the α values are linked to 
the observed growth mechanism using data fitting. The α factor calculated from the 
vapour phase correctly predicted a BCF growth mechanism; however, the α value from 
aqueous solution agreed with linear kinetic mechanism; and a BCF mechanism from 
ethanolic solutions. 
 
 
2.6 Design of crystal and particle properties by 
crystallisation 
2.6.1 Background 
 
Variation in the crystallisation process conditions can make a significant effect on the 
physical properties (thermodynamic, kinetic and mechanical properties) (Figure 2.22) of 
the resulting material. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.22 Summary of physical properties of a crystal. 
 
In some cases, minor changes in crystallisation conditions, for example, the 
supersaturation, temperature, cooling or evaporation rate, and the presence of impurities 
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Surface properties:  
 Surface area 
 Surface free energy 
 Interfacial tensions 
 Crystal habit 
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 Hardness 
 Tensile strength 
 Compactibility, 
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 Handling, flow 
and blending 
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 Stability 
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 Rates of solid-state 
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can provoke significant changes in the particle size, shape, purity, and defect structure 
(twinning). Changes of factors in the crystallisation processes can make major 
alterations in the thermodynamic and mechanical properties of a crystal. Hence, the 
supersaturation of solution needs to be controlled to obtain the crystal forms and size to 
meet the drug specifications, e.g. the dissolution rate and bioavailability. In addition, the 
size and morphology of crystals have effects on their downstream processing, e.g 
separation, filtration, flowability, compaction etc. [81]. In the following sections, the 
effects of these crystallisation parameters on the properties of crystals (Figure 2.23) will 
be discussed in more detail. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.23 Diagrammatic route map of the influence of crystallisation conditions on crystal 
properties. 
 
2.6.1.1 Supersaturation  
 
The supersaturation of a solution can be generated by adjusting the solute concentration 
in the solution, i.e. solvent removal, addition of salts with ions which participate in 
precipitation, temperature change, pH change and addition of an antisolvent decreasing 
the solubility of the solute. Supersaturation can have a profound effect on the crystal 
growth, resulting in morphological changes in the crystallising compound over a range 
of supersaturation, e.g. Morphology of snow crystals exhibits various shapes under 
Crystallisation 
Supersaturation (Driving force for crystallisation process) 
Solution nature 
 Solvent 
 pH 
 Concentration of solute 
Impurities 
Nucleation Crystal Growth 
Polymorph Crystallinity Particle size Agglomeratability Purity Shape 
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different crystallising conditions and only shapes grow under specific conditions 
(Figure 2.24). 
Tomozawa [81] studied the modification of octotiamine crystal habit under different 
crystallisation conditions (i.e., supersaturation ratio, pH, temperature, and impeller 
speed). With a pH value from 4.3 to 4.0, a decrease in the supersaturation ratio, and the 
impeller speed, octotiamine crystals for tableting powder showed a similar dissolution 
rate but an excellent flowability (less adhesive) and compressibility comparing to a 
conventional method. Kardum et al [82] studied the influence of cooling profile on an 
unseeded crystallisation process of pentaerythritol. The step and optimal cooling profile 
produced agglomeration and crystals with a wide crystal size distribution. For a linear 
cooling profile, crystals appeared with the wide crystal size distribution and without 
agglomeration. Optimal cooling profiles provide the narrow crystal size distribution 
without agglomeration. Supersaturations can influence the nucleation rate, thus 
changing the mean particle size. The number of nuclei produced was found to increase 
with increasing supersaturation with the size of crystals decreasing. However, large 
crystals are the most frequently produced at low supersaturation [83].  
 
 
Figure 2.24 Morphology diagram of snow crystals showing various shapes under different 
crystallising conditions and only shapes grow under fixed conditions [84]. 
 
2.6.1.2 Solvent 
 
The production of pharmaceutical compounds often involves crystallisation from 
organic solvents or mixtures of solvents. The solvent composition influences the 
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nucleation rate, the relative growth rate of each crystal face, and, thus, affects the shape 
and the size distribution of the product crystals, e.g. a solvent screening study was 
carried out by crystallising different crystal forms of tolbutamide from different solvents 
and studying the dissolution behaviour of its different crystal forms. Crystalline forms 
obtained from methanol and ethanol had the smallest particle size, plate-like shapes, and 
higher dissolution rates whilst crystals produced in acetone, ethyl acetate, and 
tetrahydrofuran had larger size with needle, cubic, and prismatic crystal habits, 
respectively, and had lower dissolution rates [85]. Carbamazepine crystallised from a 
drowning-out method using an anti-solvent has needle-like shape morphology. However 
polyhedral shapes were obtained from alcohol and thin plate-like shapes were found in 
acetone by reducing temperature and using solvent evaporation crystallisation methods 
[86]. Nokhodchi et al. [87] studied the effects of solvents and crystallisation 
temperature on the crystal habit of phenytoin. Variation in the crystallisation 
temperature was observed to change the crystal size. Needle-like crystals were obtained 
from recrystallisation of phenytoin in ethanol whilst rhombic morphologies were found 
in acetone solutions whilst the thin plates produced by the drowning-out method were 
found to have a higher compactibility when comparing to crystals formed using the 
other methods.  
 
However, the understanding of the solvent effect on crystal form at the molecular level 
is still not completely resolved. Lahva and Leiserowitz [88] proposed that favourable 
interactions between solute and solvent on specific faces can lead to a reduction in the 
solid-liquid interfacial tension. Hence, the activation energy for nucleation on the 
crystal surfaces is reduced causing a transition from a smooth to a rough interface and a 
concomitant faster surface growth. Alternatively, it has been postulated that, solvent 
molecules can form strong bonding with the crystallising compounds, with the solute-
solvent dissociation directing the nucleation and growth rates [89].  
 
2.6.1.3 Impurities or additives 
 
Impurities or additives can have a substantial effect on the kinetics of the nucleation and 
growth of a crystal. Some impurities can completely enhance or inhibit the crystal 
growth, whilst others act selectively or with a certain degree on specific crystal faces, 
consequently changing the crystal morphology [26]. Structurally-related substances 
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which are introduced into the crystallisation solution for specific purposes or 
compounds that have resulted from the synthesis or degradation of the desired product, 
represent the common impurities found in organic fine chemicals [90]. Additives are 
frequently used in pharmaceutical technology to modify crystal habits. The mechanisms 
of inducting crystal habit modification and/or the stabilization of polymorphs by 
additives related to the incorporation of additives into the crystal surfaces, thus 
changing the characteristics of the adsorption layer at the interface during the growth 
[26]. In this, additives can dock onto the crystal surface by adsorption, and subsequently 
block the absorption and incorporation of solute molecules on the crystal surface. 
Through this, they disrupt the crystal surface and/or the crystal lattice based on size, 
shape, position, structure and hydrogen bonding capability of their functional groups 
[90]. 
 
Beyond above mentioned examples, there are several other factors such as mixing 
intensity, crystalliser geometry on the crystals properties (shape, size and crystal size 
distribution) [91], pH effects on the impurity of final products [92]. 
 
2.6.2 The interrelationship among the structure, properties, 
performance and processing of crystalline material 
 
Sun [28] analysed an inter-dependent relationship among the structure, properties, 
performance and processing of a drug (Figure 2.25). 
 
                  
Figure 2.25 Inter-dependent relationship among the structure, properties, performance and 
processing of a drug [28]. 
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This requires linking the disciplines and culture of material science-structure and 
property relationships, chemical engineering - processing, and manufacturing - quality 
management. The performance of a drug product including efficacy, safety, 
manufacturability, stability, solubility and bioavailability of a drug depend on its 
structure and properties. For example, solubility and dissolution rate are significant 
factors which rely on the selection of crystal forms (different packing and/or different 
conformations of the molecules) for the formulation of a drug since these properties can 
be expected to influence the absorption of the solid dosage form. Bioavailability is a 
measure of the rate and extent of the absorption of API and hence can be a decisive 
factor in terms of a drug‟s overall efficacy.  
 
Moreover, the corresponding properties of a drug can be mechanical and 
physicochemical properties which are affected by structures at molecular, crystal, 
granular, bulk powder, and finished drug product levels. An example of a structure-
property relationship is provided by acetaminophen (Figure 2.26). For the monoclinic 
form I crystals, molecules are hydrogen-bonded and form zigzag shaped layers which 
interlock and prevent sliding under the influence of a shear stress. For orthorhombic 
form II crystals, molecules are hydrogen-bonded forming flat layers with relative large 
spacing favouring plastic deformation and better tableting performance [93]. 
 
         
Figure 2.26 Molecular packing in crystal structure of acetaminophen (a) form I (monoclinic); 
(b) form II (orthorhombic) [28]. 
 
In addition, crystal structure and packing related to functional groups exposed on the 
surfaces and the elasticity of a crystal impact on the compressibility and powder 
compaction, which is an important aspect of tablet manufacturing. Tablet tensile 
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strength is affected by both bonding area and bonding strength over a unit bonding area 
[94]. Hence, despite identical molecular structure, the bonding strength over a unit 
bonding area may be slightly different due to the different functional groups exposed on 
crystal surfaces which is affect to the powder tabletability of a material [28] (Figure 
2.27). 
 
 
 
 
        
 
 
 
 
 
 
Figure 2.27 Relationship between crystal structures and the powder tabletability [28]. 
 
However, the structure affecting the properties and performance can be modified by 
processing such as chemical synthesis, crystallisation, milling, granulation, and 
compaction. 
In summary, a minute change in crystallisation process or formulation can influence the 
final product quality. An understanding of the inter-dependant relationship among the 
structure, processing, properties and performance not only enables the high quality 
solid-form product to be more easily managed and controlled but also facilitates 
designing and optimizing a formulation and crystallisation process. Hence, a 
development of precision pharmaceuticals demands a detailed understanding of the 
structure, properties, performance and processing inter-relationships. 
 
2.7 Crystallisation characterisation 
 
Polymorphism and the shape of crystalline materials can be identified and characterized 
by a range of analytical methods such as microscopy, scanning electron microscopy, 
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transmission electron microscopy, differential scanning calorimetry (DSC), X-Ray 
diffraction (XRD), powder size distribution analysis (Malvern Instruments) and DVS 
etc. In addition, spectroscopic techniques such as FTIR spectroscopy, Raman 
spectroscopy which have afforded the detailed information on molecular structures and 
interactions in a solution have addressed the importance of solution clusters and 
precursors in determining the outcome of crystal polymorphs and morphology. 
2.7.1 Optical microscopy  
 
The simplest and most important tool used to characterize the crystal shape and crystal 
growth rate is using microscopy. There are two types of microscope that have been used 
widely for the characterisation of polymorphs: optical and electron microscopy. In 
optical microscopy using polarised light provides an excellent technique to improve the 
quality of the images obtained from birefringent crystals which have more than one 
refractive index which are doubly refracting [42]. In polarised microscopy, both a 
polariser positioned in the light path somewhere illuminating the sample together with 
an analyser are needed. When the polarisation direction of the polariser is aligned 90
o
 
with respect to the analyser, a situation known as using crossed polarisers, the empty 
field of view is black. When an anisotropic material is placed on the stage between the 
crossed polarisers, it will show bright contrast if it is not at the extinction position [42]. 
The differential interference contrast (DIC) and phase contrast techniques are 
complementary approaches for producing high contrast images of transparent objects. 
2.7.2 Differential scanning calorimetry (DSC) 
 
 
DSC is a popular technique to study polymorphs for their identification and 
characterization and to determine any phase transformation between forms. Since 
polymorphs have different crystal structures, their phase diagrams and melting points 
differ. DSC monitors the temperature difference between the sample and the reference 
during the heating or cooling cycle. It is based on the principle that the thermal event of 
melting or crystallisation will cause a temperature difference between the sample 
reference when latent heat is either absorbed or released.  The difference in temperature 
between the sample and reference can be converted to the heat flow, which can be used 
to calculate the enthalpy of fusion. DSC data can provide information such as melting 
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point, crystallisation point, solid-solid phase transformation, chemical reactions, 
measurement of heat capacity and changes in heat capacity.  
 
Reference and sample are heated up and cooled down to a temperature at a constant 
rate. DSC measures the difference between the sample and the reference and presents 
the differences in diagrammatic form. The peaks represent the crystalline and melting 
temperature respectively. The integration of the under curve area can give the energy of 
the thermal change.   
2.7.3 Attenuated total reflection ultraviolet visible (ATR UV/Vis) 
spectroscopy 
 
Ultraviolet-visible (UV-Vis) spectroscopy uses light in the ultraviolet and visible 
wavelength range. In this range of the electromagnetic spectrum, the absorption of this 
radiation makes a change in the electronic energy level of molecules which causes 
electronic transitions from the ground electronic state to the excited state. The 
absorbance of the attenuation of the reflected beam can be measured by the logarithm 
between the intensities of the incident light I0 and of the reflect light I: 
I
I
Ab
0log   
(2.41) 
According to the Beer-Lamberts law: 
cb
I
I
Ab 
0log   
(2.42) 
where Ab  is the absorbance; I is the transmitted intensity; I0 is the incident intensity, b is 
the path length, C is the solution concentration (mol/L), and ε is the molar extinction 
coefficient (or molar absorptivity) which depends on the properties of the solute and 
solvent.  
 
An UV-Vis spectrophotometer includes key components such as light sources, 
monochromator, detector and a holder for cuvettes containing samples (Figure 2.28). It 
can be either a single beam or dual beam. In a single beam, all of the light passes 
through the sample cell. Io must be measured by removing the sample. In a double-beam 
instrument, the light is split into two beams before it reaches the sample. One beam is 
used as the reference; the other beam passes through the sample. The reference beam 
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intensity is taken as 100% transmission (or 0 absorbance), and the measurement 
displayed is the ratio of the two beam intensities. 
 
 
 
                                  
   
                           
 
 
Figure 2.28 Schematic diagram of a UV-Vis spectroscopy. 
 
The mechanistic working of ATR (Attenuated Total Reflection) based on light passing 
from a material with high refractive index (ATR crystal at the tip of the probe) to a 
material with lower refractive index (solution). The light enters the solution and can be 
partially absorbed by the solute before being reflected back into the ATR probe. The 
reflected light is therefore attenuated, resulting in a reduction in the output signal due to 
the absorbance of the solution (Figure 2.29). ATR can be practically implemented using 
a fibre optic immersion probe which can be inserted into a saturated or supersaturated 
solution to study solution concentration. 
 
 
Figure 2.29 ATR probe using 3-bounce sapphire ATR crystal.  
 
In this, the fibre-optics is used to transmit light to and from the probe from the UV/Vis 
spectrometer. ATR-UV probes are suitable for the direct measurement of strongly 
absorbing solutions (high solubility solutions) where standard transmission probes 
cannot be used. A combination of PAT tools and solid-state analytical techniques to 
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investigate the polymorphic transformations during the antisolvent crystallisation of 
sodium benzoate from IPA/water mixture to identify the form of the polymorph, 
hydrate, or solvate and investigate which forms exists under the conditions [95]. 
 
ATR-UV probes are suitable for the direct measurement of strongly absorbing solutions 
(high solubility solutions) where standard transmission probes cannot be used. The 
measurement approach has some significant advantages: (a) no sampling; (b) solutions 
need not be diluted; (c) applicable to measure high-solids content slurries on-line; (d) 
easy to set up with a flexible fibre-optics connection to the probe. However, a high 
concentration solution may cause a crystallisation process and the crystals may deposit 
on the ATR probe. Therefore it is necessary to clean the probe properly with solvent. 
For a particular material, a calibration model has to be built from a series of spectra 
recorded at various concentrations and then this calibration model can be used to obtain 
in-situ concentration and supersaturation in a reactor to monitor and control the 
crystallisation process.  
 
2.8 Closing remarks 
 
This chapter reviewed and discussed the fundamental theories of crystallisation 
including the basic crystallography, crystal chemistry, stages of crystallisation process 
explaining nucleation and growth process, particularly in the influence of crystallisation 
environmental conditions on crystal morphology and sizes. These theories are a 
foundation for the study and understanding of crystallisation processing, which will be 
used in chapter 6 and 7 in this thesis. The importance of polymorphism, size, shapes of 
particles, and the effects of crystallizing conditions, e.g. supersaturation, solvents, 
impurity etc. on the quality of final products have been reported and discussed. The 
concepts for the morphological simulation prediction in solid-state materials have been 
described. The chapter reviews some novel and important aspects in crystal science and 
engineering such as the interrelation among the structure, properties, performance and 
processing of materials and the possibility to predict and control final product properties 
from a very early stage of research and development at the molecular scale and the 
significance and potential applications of computational methods in crystal science and 
engineering.  
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3 Crystal growth rate kinetics and 
mechanism 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
This chapter reviews research regarding the on-line measurement of crystal growth 
rates, together with aspects concerning crystal growth rate dispersion and describes the 
expected crystal growth kinetic mechanisms as a function of solution supersaturation. 
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3.1 Introduction 
 
The physical properties of active pharmaceutical ingredients (API), such as particle 
sizes and shapes, can play a significantly important role in the downstream formulation 
of ingredients into the practical drug dosage forms. The growth rate of each 
crystallographically unique crystal face is likely to be different depending on the growth 
environment such as supersaturation, temperature, solvents and impurities etc. mindful 
that its surface chemistry will be different. This, in turn, result in a change of the 
morphology of crystals. There are various methods for the measurement of the growth 
rate of crystals [96] which can be either carried out on the measurement of the linear 
growth rate on specific faces of a single crystal or by estimating an overall linear growth 
rate from the mass deposition rates on the bulk mass of a large number of crystals. The 
single crystal measurement method avoids the impact of other physical phenomena such 
as the collision of crystals with other objects, e.g. the wall of the vessel or other crystals 
that may have an effect on the growth kinetics. 
 
3.2 Expression of crystal growth rates 
 
The crystal growth rate can be expressed as a mass deposition rate, RG, (kgm
-2
s
-1
) and a 
mean linear velocity (ms
-1
) or an overall linear growth rate G (ms
-1
) [26]: 
 
         
  
 
 
  
  
 
  
 
    
  
 
   
  
  
 
  
 
  
  
  
 
  
 
   ̅     (3.1) 
where L is the characteristic size of the crystal; r is the radius corresponding to the 
equivalent sphere; ρc is the crystal density; α and β is the volume and surface factors of 
the crystals; m and A is the mass and area of the crystal. 
 
There is broad agreement in the literature that there are three main methods [96] to 
express the crystal growth rate: 
 
(a)       The face growth rate (Rhkl or vhkl, m/s) is the velocity of movement forward of 
the crystallographic faces in the direction perpendicular to the face (hkl) which can be 
measured on the individual crystal faces over time. These face-specific growth rates can 
Chapter 3. Crystal growth rate kinetics and mechanism 
 
60 
 
be related to their crystal growth mechanisms. Reflecting the fact that different faces of 
a crystal may have different growth rates under the same crystallisation condition. In 
particular, the higher index faces can normally be expected to grow much faster than the 
lower index faces. Therefore, the growth rates of the individual crystal faces cannot be 
considered as an effective measurement of the overall growth rate and the growth rate of 
individual faces (hkl) should be measured to assess the overall growth kinetics.  
 
(b) Overall mass growth rate, RG (kg/m
2
s) is the total mass flux to the 
crystallographic faces  and is used to express the average growth rate of the whole 
crystal: 
 
  
dt
dM
A
R C
C
G *
1
      hklhkl
C
c
G Av
A
R

     (3.2) 
where Mc is the mass of crystal; AC is the surface area of whole crystal; and Ahkl is the 
area of face hkl, vhkl  is the face growth rate and Ahkl is the area of the faces on a crystal.  
 
Measurement of the bulk mass of crystals usually is used for calculation and design 
purposes for batch processes [96], in terms of determining the mass transfer rates under 
controlled conditions e.g. supersaturation, temperature; and for assessing size-dependent 
growth [26]. In this approach the determination of the overall growth rates can be 
conducted by a gravimetric method, i.e. through weighing the crystals mass formed as a 
function of time.   
 
(c) Overall linear growth rate is the rate of change of characteristic dimension: 
 
dt
dL
G      
(3.3) 
G and RG can be related as follows:  
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 It is essential to characterise the shape of the crystal when using overall growth rate, 
where: 
           
  (3.5) 
 
       
     (3.6) 
where α is the volume shape factor and β is the crystal surface shape factor. If crystals 
are spherical or cubic (β/α = 6) then: 
GR CG .
2
1
    
(3.7) 
This expression is commonly applied for the population balance theory. The population 
balance method related to the crystal size distribution (CSD) was firstly applied to 
crystal kinetics by Randolph and Larson [97]: 
 
 (  )
  
 
 (   )
  
       (3.8) 
where n is the population density per unit volume, V is the total suspension volume of 
the crystallizer, G is the linear growth rate, L is the crystal size and t is the time. 
 
3.3 Growth rate dispersion (GRD) 
 
Growth rates of crystals of the same material and size, when exposed to identical 
conditions of supersaturation, temperature and fluid dynamics, do not grow at the same 
rate; this phenomenon is known as growth rate dispersion [21, 25, 98, 99]. Whilst Size 
Dependent Growth (SDG) is the phenomenon by which crystals of different sizes grow 
at different rates, growth rate dispersion (GRD) is a phenomenon where similar sized 
crystals grow at different rates under apparently identical conditions of supersaturation, 
temperature and hydrodynamics.  
 
This phenomena was first reported by White and Wright [99] who found that an initially 
seeded crystal sample which possessed a narrow size distribution of sucrose (size 
500μm) and aluminium trihydroxide crystals (size 55μm) showed a dispersion of 
growth rates when the population of seeded crystals grew. This occurrence has also 
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been observed in many other cases with different crystal materials and sources.  Their 
results revealed that when seed crystals with a narrow size range were grown for a 
period of time, the resulting product crystals showed a very wide size distribution. This 
was demonstrated by Wang and Mersmann [100] and Mitrovic [101] also shown that 
there may be a correlation between the initial crystal sizes and the growth rates. The 
growth rate dispersion was also observed for primary nucleated ADP crystals [20]. With 
individual crystals having their own growth rates and retaining their initial growth rates 
over a long period of time. 
 
Garside and Larson [102] studied the growth rate dispersion of potash alum crystals.  
The number of crystals with an initial size bigger than 10 μm was found to be dependent 
of the supersaturation, while particles with initial sizes smaller than 10 μm was shown 
to be independent of the supersaturation level. Rusli et al. [103] generated potash alum 
crystals in the size range of 2 -25 μm through attrition, e.g. by contacting a large potash 
alum crystal with a steel rod and fracturing small particles off the large crystal.  
Particles below 4 μm grew at a very small rate whilst crystals larger than 25μm 
presented a strong dependence of growth rate on the initial sizes. Sherwood and Ristic 
[104] studied the influence of mechanical stress on the growth rate of materials 
suggesting that there was a competition between stress reduction and dislocation 
enhancement of the growth rate of secondary nuclei causing the growth rate dispersion.   
 
Because the incidence of the variations of growth rate of the uniform sized crystals 
affects the CSD of the product crystals and hence product quality, much research has 
been performed to study the source of GRD. There are three types of factors which are 
able to describe experimental data, the Constant Crystal Growth model (CCG), the 
Random Fluctuation model (RF) [105] and a „fast-growers‟, „slow-growers‟ model 
(FGSG) [106].  
 
The CCG model [20] which proposes the constant relative growth rate of each crystal 
along the growth periods, with different growth rates for the different crystals which 
might differ even for crystals of the same size growing under identical conditions. In 
this mechanism, nuclei are formed with a distribution of growth rates and at constant 
crystallising conditions, with each nucleus showing a constant but different rate.  
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The RF model proposed the growth rate of a crystal fluctuates around an average 
constant growth rate which might be caused by the change of surface structure versus 
time resulting in a growth rate deviation on a particular crystal surface [105]. 
 
Daudey [106] proposed the FGSG model in which proposed two types of growth rate 
that have an influence on the population of secondary nuclei crystals to interpret theses 
growth rate dispersions. The larger crystals produced by a surface breeding mechanism 
by which the surface growth features such as macrosteps are removed by attrition. The 
smaller crystals, produced by a mechanical breeding mechanism, are likely to contain 
more strain, thus growing with low growth rate. Ristic et al [19] studied the growth rate 
of sodium chlorate crystals (size 5-150μm) grown from secondary nuclei showing the 
growth rate of crystals depended on the degree of lattice strain. The most strained 
crystals grow at the slowest rates and the strain focused on or in the surface of very 
small crystals might play a leading role in growth rate dispersion.  
 
3.4 Techniques for studying crystal growth rate 
 
Currently, there have been various techniques studied previously for the characterisation 
of in-line crystallisation processes and for monitoring and measuring of the crystal 
growth rates using optical light microscopy techniques, on-line high speed imaging, 
atomic force microscopy (AFM), interferometry, laser polarization-interference 
techniques, laser confocal microscopy with differential interference contrast etc.  
However, different systems and applications require different methods. For example, 
transmission light microscopy is used for the growth rate determination of crystal faces 
while interference contrast or phase contrast microscopy is applied for measuring step 
velocities where steps are small [96].  
 
These techniques are described in the following sections. 
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Table 3.1 Microscopy techniques for studying crystal growth kinetics and mechanisms 
Technique Applications 
Optical light 
microscopy 
 Characterisation of crystal morphology and size 
as a function of crystallising environment. 
 Measurement of crystal growth rates of 
individual crystal habit faces and identification 
of growth mechanisms 
 Determination of nucleation and crystal growth  
kinetics in-situ 
On-line high speed 
imaging 
 Measurement of crystal growth rate in agitated 
vessel by measuring CSD 
 Monitoring of shape evolution and polymorph 
transformations 
 Investigation of the effect of hydrodynamic, 
agitated speed,  supersaturation, impurities etc. 
on the nucleation and growth kinetics 
AFM  Examination of surface topography to study 
crystal growth mechanism due to its imaging 
capability at high resolution  
 Measurement of grow rates of crystal habit faces 
through observing the growth of steps on the 
surface 
 Study of solvent or additive molecules 
interactions with crystals faces 
Interferometry  In situ examination of  surface steepness, surface  
 Measurement of step velocities and growth rate 
of crystal face, and identification of growth 
mechanisms 
 
3.4.1 Microscopy technique 
 
Optical microscopy employs a series of objective lenses and a visible light to magnify 
the images of a sample. Microscopy techniques equipped with a video camera and 
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commercial image capturing and analysis software has been employed to measure in 
situ the velocity of the moving step and the growth rate of individual faces during 
growth process [5-8, 98, 107, 108]. For example, Davey studied the effect of the 
supersaturation on the growth of the (100) faces of ammonium dihydrogen phosphate 
(ADP) [7] and the effect of ionic species (CrCl3.6H20; FeCl3 and AlCl3) on the growth 
of the (101) and (100) faces of ammonium dihydrogen phosphate (ADP) [7, 8] and the 
growth kinetics of the (001) and (100) face of urea in two cases: pure solution and with 
presence of biuret as an impurity [6].  
 
The use of digital video-microscopy together with computational methods for analysis 
of captured images has also been demonstrated so far, a hot stage adapted to a 
polarizing light digital video-microscope accompanied by a computational method to 
investigate the growth rate [11]. An algorithm method was used to extract growth and 
nucleation data by subtracting grey pixel values corresponding to positions on pictures 
which can relate to the new growth of either nuclei or of growing crystals [16].  
 
From the growth rate data as a function of supersaturation, the mechanism of crystal 
growth was investigated [10, 66, 108].  
 
Furthermore, the estimation of growth rate for different crystal faces through in-process 
imaging and image analysis in multi–dimensional population balance modelling (PBM) 
to study the growth behaviour of crystal sizes in a reactor [14]. The morphological 
population balance model has been used to simulate the dynamic evolution of the shape 
distribution as well as size distribution by incorporating crystal shape information with 
faceted growth kinetics data. This has been demonstrated on L-glutamic acid [109], 
protein [110], [27].  
 
A microscopy system has been employed for the study of kinetics and growth rate of the 
crystallisation process efficiently and conveniently, particularly in the growth rate of 
crystal habit faces. 
 
3.4.2 On-line high speed imaging 
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This technique is able to capture high resolution images of particles in agitated reactors 
and propose the possibility of real-time particle analysis using online high-speed camera 
systems in [14, 17, 18]; Process Vision and Measurement (PVM) of Lasentec and 
Mettler Toledo Ltd [111]; In Situ Particle Viewer (ISPV) of Perdix. Wang et al [17] the 
growth rates of β form needle-shaped L-glutamic acid crystals in 2D using on-line 
imaging and imaging analysis (Figure 3.1). Calderon De Anda et al. [12] characterized 
the crystal morphology, size and shape together with the crystal growth rate of (L)-
glutamic acid which exhibits two polymorphs, alpha and beta using the on-line and 
automated techniques for the real-time shape measurement via analysing the segmented 
images.  
 
 
Figure 3.1 An example of the experiment set-up for measurement of the growth rate of L-
glutamic acid using online imaging system [17]. 
 
The above examples of in-process digital video microscopy for process monitoring and 
measurement of crystal growth rate proved that this technique has been developed and 
improved. However, Wang et al. [17] reported that though on-line imaging has shown 
to be the most promising technique for on-line measurement of crystal shape within 
reactors, however it was limited in 2D imaging. Hence, future research and 
developments should investigate imaging techniques that provide the capability for 
direct 3D information. Li et al. [13] studied a new method for integrating crystal 
morphological modelling with in-situ shape measurement using on-line microscopy.  
The 3-D shape obtained from morphological modelling was rotated to get 2-D images 
and then matching was carried out between these 2-D images and real 2-D images 
acquired from an on-line imaging instrument (Figure 3.2). 
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Figure 3.2 2D projected image of L-glutamic acid generated through predicted 3-D shapes [22]. 
 
The use of in-process digital video microscopy for process monitoring and potentially 
control of product form is highly desirable so far. A recent development in on-line 
crystal morphology measurement and control is using on-line imaging and image 
analysis to measure crystal growth rate for each individual crystal within crystallisation 
reactors, which could open the way for the development of precision in-situ control of 
the growth process and final product quality control.  
 
3.4.3 Focus beam reflectance measurement (FBRM) 
 
FBRM employs a laser light source and a set of lenses to focus the laser light to a small 
spot (a focal spot). Particles will be located in the scanning focused spot and backscatter 
distinct pulses of reflected light. These pulses of backscattered light are detected and 
translated into chord lengths based on the simple calculation of the scan speed 
multiplied by the pulse width (time). The chord length is distant from one edge of the 
particle to another edge. In this technique, a correlation between the numbers of counts 
per second, the cord-length distribution of particles and particle size can be achieved 
(Figure 3.3) [112].  
 
This technique integrated with FTIR/ATR can provide a real time measurement of 
dimension and number of crystals for the nucleation rate and crystal growth rate 
measurements as a function of supersaturation [22, 23] and studying growth kinetics 
and growth mechanisms [24].  Markande [23] used Lasentec focused beam reflectance 
measurement (FBRM) and an in-line process refractometer for monitoring aqueous 
crystallisation of dextrose monohydrate to evaluate the kinetic constants from the 
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growth and nucleation as a function of supersaturation level.  The chord length 
distribution is related to the crystal size but it does not provide information on the 
crystal shape. 
 
 
Figure 3.3 Focused Beam Reflectance Measurement [112]. 
 
3.4.4 AFM 
 
AFM has been a powerful technique in the nanoscale investigation of growth rate and 
growth mechanism. It is able to image material surface  with high resolution in aqueous 
environments, hence facilitating the study of solid-liquid interface [113]. An AFM 
probe mounted at the end of a short, flexible cantilever is impressed on the surface of 
the studied material and then scanned over the sample along a continuous sequence of 
raster lines. As the probe tip translates over the surface, it interacts with the structural 
features on the surface, through collective atomic forces including mechanical contact 
force, van der Waals forces, capillary forces, chemical bonding, electrostatic forces, 
magnetic forces causing the probe to be deflected. These deflections are amplified by 
the deflections of a laser beam and subsequently detected by a position-sensitive split 
photodiode (Figure 3.4). Photoelectric circuitry converts the laser beam deflections into 
height information [113] and AFM has been applied in studying the growth of crystals 
from solution both in-situ and ex-situ and the data can be recorded as a topological 
image and presented in different visual forms [114]. This technique has been 
successfully used to investigate the crystallization of proteins [114-116], barium nitrate 
[117], calcite [118] and viruses [119]. 
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Figure 3.4 Diagram of atomic force microscope (redraw after [120]). 
 
3.4.5 Interferometry 
 
In interferometer system, an illuminating coherent light beam is split into two beams. 
One is reflected by a mirror and another one is reflected by the sample. The reflected 
beams recombine in a detector and interfere with each other. The basic set-up of an 
interferometer is shown in Figure 3.5. The interferometric patterns provide topographic 
information on a growing crystal surface.  Such microtopographic observations can 
reveal the growth kinetics and growth mechanisms of crystal habit faces under various 
crystallising growth conditions. Interferometric studies have been performed on 
paracetamol crystals to investigate the growth kinetics of straining brittle paracetamol 
and plastic sodium nitrate crystals [121], the growth rate and growth mechanism of the 
(101) face of protein at various supersaturation [122], crystal defects [123], and the 
influence of additives [124, 125]. 
 
 
 
 
 
 
 
 
 
Figure 3.5 Schematic diagram of interferometry system (redraw after [121]). 
Detector 
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Laser 
Crystal surface 
Cantilever 
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There are also other techniques such as laser polarization-interference techniques and 
laser confocal microscopy with differential interference contrast microscopy. Liu [126] 
employed laser polarization-interference techniques for the measurement of the growth 
kinetics of (100) KDP crystal faces in the presence of polyphosphate as the function of 
various supersaturation and at different concentration of impurities. Experimental data 
was correlated to a two-dimensional nucleation model for a pure system and Kubota and 
Mullin‟ s model for the case with presence of impurities.  
 
Alexander [127] compared three observation techniques (AFM, Michelson 
interferometry, and laser confocal microscopy with differential interference contrast 
microscopy) through the growth rate measurement of protein crystallisation for the 
investigation of crystal growth kinetics. Growth rate measurements were carried out on 
the same system under identical experimental conditions using the three above different 
techniques showing differences up to 5-fold in growth rate and a different behaviour of 
the growth rate as a function of supersaturation. The explanations for these differences 
are differences in mass transport at the crystal interface during data acquisition and data 
acquisition rate.  
 
In summary, a field of application of these techniques was provided for the choice of the 
optimal measurement technique in crystal growth studies. The growth rate measurement 
of a population of crystal in stirred reactors is usually employed using on-line high 
speed imaging or the FBRM to investigate the size distribution as a function of time. In 
this study, the microscopy technique was suitable and mainly used throughout to 
measure the growth rate of individual crystal faces of spontaneously nucleated single 
crystals at relatively high supersaturation, and the detailed methodology for crystal 
growth rate measurements is described in chapter 4. 
 
3.5 Choice of experiment system for measuring crystal 
growth 
3.5.1 Crystallography structures  
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Ibuprofen (2-(4-isobutyl-phenyl) propionic acid, C13H18O2 M = 206.28g/mol, melting 
point: 76
o
C) is known as a non-steroidal anti-inflammatory drug (NSAID) that has been 
used to relieve pain, cold, fever and inflammation. Ibuprofen has one stereocentre so it 
can exist in two enantiomeric forms S(+)-ibuprofen and R(-)-ibuprofen. The 
commercially available product is usually the racemate since it is difficult to separate 
the two enantiomers. Cheminor Drugs have developed a process for production of the 
pure S-Ibuprofen (the active form of ibuprofen) that could decrease by almost half of 
the regular ibuprofen dosage and associated side effects. The inactive R form is 
unfortunately converted to the biologically active S form within the body so this process 
is unlikely to have commercial development [128]. Racemic ibuprofen contains both 
S(+) and R(-) ibuprofen in equal amounts. The solubility and dissolution rate of S(+)-
ibuprofen and racemic ibuprofen are effected significantly by the temperature and the 
pH value of the solvent [129].  
 
3.5.2 RS-ibuprofen 
 
The racemic (R)-(S) ibuprofen crystals belong to the space group P21/c (four molecules 
in a monoclinic system) and the unit cell with the lattice parameters a = 14.667A˚, b = 
7.886A˚, c = 10.730A˚, β = 99.3628o. The crystal chemistry of RS-ibuprofen molecules 
involves the packing of pairs of hydrogen-bonded (R)-(S) dimers [130] (Figure 3.6).  
 
 
(a)                                  (b) 
Figure 3.6 Molecular diagram showing (a) structure and (b) packing in the crystallographic unit 
cell of the ibuprofen molecule. 
 
The crystal structure of Ibuprofen was first analysed by Shankland et al. [130]. It 
consists of centro-symmetric dimers, in which two molecules are linked by a pair of 
hydrogen bonds between their carboxyl groups (Figure 3.7). The O-H…O hydrogen 
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bonding parameters show a medium strength hydrogen bond with an O-H distance of 
0.963 and a O-H---O angle of 179.5
o
. The hydrogen bonding affects the ibuprofen 
crystal shape by favouring growth in the b direction. The carboxylic acid dimers form 
about inversion centres; in this case the inversion centre is at the body centre of the 
second unit cell up along the b axis. The two molecules shown in Figure 3.7 forming a 
dimer are the asymmetric unit and its inversion object two cells up along the b axis.   
 
                 
(a)                                                          (b) 
  
     (c) 
Figure 3.7 Molecular packing of ibuprofen (a) in the xz plane; (b) in the yz plane and (c) in the 
xy plane. A slightly titled projection close to the yz plane reveals that hydrogen bonds are 
formed across the unit cell and between molecules 1 and 3 in the unit cell of the first row and 
the unit cell in the third row.   
 
The pharmacological mechanism of action of ibuprofen is to reduce the effect of irritant 
chemicals, produced by the body, that cause inflammation and high temperature. 
Ibuprofen was first produced in the UK in 1969 by Boots under the trade name Brufen. 
It has a powdery white appearance and has been sold in the form of capsules, tablets, or 
powder on the market.  
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R-Ibuprofen S-Ibuprofen 
  
  
 
Figure 3.8 Molecule structures of R-ibuprofen and S-ibuprofen. 
 
However, a new polymorphic form of ibuprofen can be obtained by specific re-
crystallisation of the supercooled liquid ibuprofen. The nucleation of this polymorphic 
form is obtained by keeping the temperature at least 60
o
C below that of the glass 
transition temperature Tg of Ibuprofen (Tg = 228
o
C). This new polymorph melts at 290K 
which is below the conventional form [131]. 
 
3.5.3 S-ibuprofen 
 
(S)-Ibuprofen crystals belong to the space group P21 with four molecules in a 
monoclinic, a unit cell with parameters (a = 12.462A˚, b = 8.035A˚, c = 13.539A˚, β = 
112.89
o
) and a needle-like crystal morphology when recrystallised from methanol. S-
(+)-Ibuprofen crystallizes with two independent molecules in the asymmetric unit with 
the molecules packing as cyclic hydrogen-bonded dimers in which each molecule 
adopts an S configuration [132] (Figure 3.9). 
ILLIANLLIAN  
UNY                                  Molecule 1                            Molecule 2 
Figure 3.9 Two molecules of S-(+)-ibuprofen in the asymmetric unit form a cyclic hydrogen-
bonded dimer [132]. 
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3.5.4 Solubility 
 
S-Ibuprofen shows higher solubility, higher dissolution rate and a lower melting 
temperature compared with the racemic form [133, 134]. In the crystal structure of 
ibuprofen, the hydrophilic parts (-COOH) are mutually bonded which results in a 
hydrophobic crystal structure [134]. Hence, Ibuprofen is slightly soluble in water and 
more soluble in organic solvents such as methanol, acetone, ethyl acetate, and hexane. 
The solubility of Ibuprofen in various solvents at the temperature range 10
o
C-40
o
C were 
reported and found that the dissolution enthalpies, ∆H, for these systems (ibuprofen in 
ethanol/ethyl acetate) correspond to 24.7 and 25.4 KJ/mol
-1
 and both systems show a 
nearly ideal solubility behaviour [5].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Solubility of ibuprofen in various solvents [135]. 
 
3.5.5 Crystal morphology 
 
Crystals of racemic ibuprofen exhibit different crystal habits from prisms to needles and 
plates depending upon the different crystallising conditions (Figure 3.11) such as 
solvent type, temperature and the presence of additives. This material mostly has a 
plate-like crystal morphology dominated by a large (100) face with smaller {001} and 
Chapter 3. Crystal growth rate kinetics and mechanism 
 
75 
 
{011} side faces. Changes in crystal habit have been reported many times [5, 136-141]. 
Gordon et al. [135] reported that ibuprofen then crystallised at the commercial scale 
from hexane and heptane solutions was needle-like and had poor processing properties. 
This stimulated pharmaceutical and processing researchers to investigate potential 
process change to obtain equant (cube, sphere, grain) crystals with a higher bulk 
density, lower bulk volume and improved flowability.  
 
It has been demonstrated that in different solvents it is only the crystal morphology that 
changes and the crystal structure remains after recrystallising [137] [141]. While 
crystals produced from methanol and ethanol shows a polyhedral crystal habit, 
crystallisation from hexane results in needle-like crystals at similar conditions. 
However, there are no polymorphic modifications confirming by X-ray powder 
diffraction (XRD) and differential scanning calorimetry (DSC) studies.  
 
Different crystal forms including cubic, needle-shaped, and plate-shaped crystals were 
obtained from the different solvents, leading to differences in the physicochemical [138] 
and mechanical properties [137] impacting on compressibility, flow rate, bulk density 
and dissolution rate. An explanation for these phenomena was that changes in the 
intermolecular packing in the crystal surfaces altered the hydrogen bonding and other 
intermolecular interactions.  
 
The properties of ibuprofen were optimized in the solvent change technique using the 
presence of different water-soluble additives [140]. These additives were only present 
during the crystallisation process and were removed after precipitation by a washing 
process. Ibuprofen molecules can form hydrogen bonds and the additives that are able to 
interact with these hydrogen bonds during the crystallisation process may alter the 
properties of the product crystals. 
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Figure 3.11 Morphologies of ibuprofen in various solutions [136]. 
 
3.5.6 Crystal growth rates 
 
It has been acknowledged that the different morphologies or shapes of ibuprofen 
crystals are formed by different growth rates of certain faces mediated by the effect of 
the growth solvent or additives. Hence, the morphology of ibuprofen can be understood 
through the measurement of growth rate of the individual faces surrounding the 
ibuprofen crystal. Both theoretical and experimental studies of the morphology have 
shown that the important faces are the {002} and {100} faces.  Calculation of the 
relative growth rate using the attachment energy method has shown that attachment at 
the {100} face is the least energetically favourable. Since Eatt is assumed to be directly 
proportional to the relative growth rate, {100} is predicted to be the slowest growing 
face, and therefore dominates the theoretical morphology [130]. The theoretical 
morphology of ibuprofen can be predicted from the intermolecular potential calculations 
and attachment energy calculations. The experimental morphology can be explained by 
the relative growth rates of crystal faces of Ibuprofen through the interaction of solvents 
and growing crystals surfaces obtained from different solvents [5, 136].  
 
So far there have been quite limited studies of this material‟s crystallisation kinetics. 
Rashid et al. [15] studied growth rates of ibuprofen crystals grown from ethanol by 
adding size proportional growth seed crystals to an isothermal non-nucleating batch 
crystallization vessel and sampling the resultant crystals during the batch. They found 
that Ibuprofen crystallising from ethanol exhibits significant growth rate dispersion. 
Cano, et al. [5] measured the growth rates of the {100}, {001} and {011} faces in a 
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single ibuprofen crystal using a crystal-growth flow cell. During these measurements, a 
crystal was secured within the cell with the crystal faces of the seed crystal being 
oriented with respect to the solution flow in order to obtain reproducible growth 
conditions at ζ = 0.013. However, this work did not provide information on the growth 
rates for spontaneously nucleated crystals nor were variation in the crystal growth rate 
between different crystals studied. 
 
3.6 Closing Remarks 
 
There are many methods and techniques for crystal growth rate measurement which can 
be applied for different systems and material models. Despite this, little information has 
been provided regarding the growth rate at high supersaturations of spontaneously 
nucleated crystals nor has the growth rate variations of crystal faces between different 
crystals been studied. There have been several simulation and morphological modelling 
works for ibuprofen crystal and there is no molecular scale understanding on crystal 
morphology and the growth rate of individual faces. This PhD was focused on 
investigating the influence of solvent type (ethanol 95%, ethyl acetate, acetonitrile and 
toluene) at relative supersaturation ζ from 0.55 to 1.3 on the growth rate of the {001} 
and {011} surfaces of nucleated single (RS)-ibuprofen crystals in a stagnant solution at 
two crystallizer volume scale-sizes; 0.5 ml and 15ml using a microscopy technique, and 
the growth mechanisms were assessed through the growth rate data versus 
supersaturations. Furthermore, molecular modelling, intermolecular bonding analysis 
and crystal habit surface chemistry analysis and calculation of solvent-mediated 
attachment energy was examined to enhance the understanding of the observed 
morphology and effect of solvents on the growth rate of crystal habit faces. The 
computational and experimental work is presented in chapter 4. 
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4 Materials, instrumentation and 
methodology  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
 The molecular and crystal structure of ibuprofen, together with a description of the 
instrumentations and the experiment and computation methods are presented in this 
chapter. 
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4.1 Introduction 
 
This chapter describes the material examined in this study and the instrumentation and 
methodologies employed for its examination. Firstly it presents a brief overview of the 
physical properties and structure together with the details of molecular and 
crystallographic modelling and morphological prediction including methodologies for 
conformational analysis, conformer distribution in solvents and morphological 
prediction. Next the experimental set-up and methodology used for polymorph 
screening, solubility measurements, and experimental studies on measuring face growth 
rates at different scale sizes is presented. The latter includes a 0.5 ml cuvette 
crystallisation cell, a 15ml jacketed vessel and a 7ml agitated batch vessel (Avantium 
Crystalline platform).  
 
4.2 Materials 
 
Ibuprofen (melting point 75-77
oC, purity ≥ 98%) was obtained from Sigma Aldrich and 
Tokyo Chemical Industry UK Ltd. 
Table 4.1 Solvents used in studying polymorphism 
Solvents Purity Manufacture  
Acetone  
Acetonitrile  
Ethanol  
Ethyl acetate 
Hexane 
Diethyl ether 
Methanol  
Toluene  
Propanol 
Xylene 
Isopropyl ether 
For residue analysis 
99.9% 
95% 
>99.5% 
> 99% 
>99% 
99.5% 
> 99.8% 
>99% 
> 99% 
> 99% 
Across Organics 
LC-MS 
Sigma Aldrich  
Acros Organics 
Reagent Plus 
Fisher Scientific 
Sigma Aldrich 
Sigma Aldrich 
Sigma Aldrich 
Sigma Aldrich 
Acros Organics 
 
The solvents used for the growth rate determinations were: Ethanol 95% (the azeotropic 
composition of a binary mixture of ethanol and water) from Sigma Aldrich, Ethyl 
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acetate 99.5% Acros Organics, Acetonitrile 99.9% from LC-MS and anhydrous Toluene 
99.8% from Sigma-Aldrich, acetonitrile. 
 
Case study in Pfizer, UK: The material under study was a pharmaceutical compound A. 
The material was recrystallised and provided by Pfizer. Solvents used in this case study 
were 2-Methyltetrahydrofuran (2-MeTHF) (CH3C4H7O) from Sigma-Aldrich. 
 
4.3 Computational methods 
4.3.1 Conformational analysis 
 
The CONFORMER in Material Studio [142] was employed to analyse the 
conformational flexibility of the ibuprofen molecule. The molecular structure for an 
isolated ibuprofen molecule was downloaded from the Cambridge Structure Database 
(refcode: IBPRAC).  Examination of the molecular structure revealed eight significant 
torsion angles which were examined to investigate the flexibility of ibuprofen as in 
Figure 4.1.  
 
Figure 4.1 Structure of an ibuprofen molecule highlighting the potential torsion angles involved 
in double bonds and bonds terminated with hydrogen (not including bonds in benzene rings). 
 
In order to have a good representative selection of torsion angles in the ibuprofen 
structure, an investigation of the extent of flexible torsion angles was carried out using 
systematic grid search of CONFORMER in Material Studio. The extent of change of 
the total energy after optimisation was studied when each of the torsion angles was 
varied from -180 to 180 degrees with step-angle of 20 degrees and the molecular energy 
profiles were calculated using the Dreiding [143] force field. After selecting 
representative torsion angles, two torsion angles were varied from -180 to 180 degrees 
with a step-angle of 10 degrees and the torsion energy was calculated using a molecular 
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mechanics force field in CONFORMER module in Material Studio. The torsion angles 
were kept constrained and the rest of molecule was relaxed and optimized. The contour 
maps (torsion energy maps) for conformational energy of ibuprofen were plotted and 
the conformers of an ibuprofen molecule before and after geometry optimisation were 
marked on this energy map. The simple set-up procedure for this conformational search 
method is shown in Figure 4.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Schematic diagram of conformational analysis using CONFORMER in Material 
Studio. 
 
4.3.2 Conformational propensity as a function of solvents 
 
Ibuprofen conformers were optimised within the COSMO solvent dielectric 
environment for ethanol, ethyl acetate, acetonitrile and toluene and statistical 
thermodynamics COSMO-RS calculations were implemented to calculate the 
population of conformers in the solution. These calculations reveal the preferential 
conformer structure of the early stage clustering of crystallisation of ibuprofen in theses 
solvents and the important building blocks in the formation of these crystal structures. 
   
The calculation of the propensity of conformers is shown in Figure 4.3. In the first step, 
a conformational analysis was performed using the CONFORMER software package in 
T8 
Select flexible and representative torsion angles 
 
Use the systematic search of the conformational space by 
varying specified torsion angles with settings: step-angle, 
optimized geometry, force field (Dreiding)  
Plot the conformational map (energy map) and mark the 
conformer of a crystal downloaded from CSD before and after 
geometry optimization on the map 
Download an isolated ibuprofen molecule 
from Cambridge Structure Database 
 
Use Conformer module in Material Studio to 
find rotatable torsions in the molecule 
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Material Studio in section 4.3.1. After the conformational search was complete, the 10 
lowest energy conformations generated were further optimized using aqueous media 
using GGA/PBE/DNP/COSMO calculations (PBE functional and DNP basis set) in 
Dmol3 [144] which is a unique density functional theory (DFT) quantum mechanical 
code. The gradient-corrected potentials are PBE functional (developed by Perdew, 
Burke and Enzerhof) [145, 146]. The Conductor-like Screening Model (COSMO) [147], 
a continuum solvation model, was used to analyse the stability of the lowest energy 
conformers in solution. In the second step, the *.COSMO files generated from Dmol3 
were used to calculate the propensity of conformers in ethanol, ethyl acetate, acetonitrile 
and toluene at 25
o
C using the COSMOtherm software package [148]. The conformers 
will be weighted internally by COSMOtherm using their COSMO energies and their 
chemical potentials. Normalized weight factor of molecule in compound was shown % 
conformer in mixture of conformer. The equilibrium propensity of conformers was 
calculated according to: 
 ( )   
 ̅( )    ( 
 ( )
  )
∑  ( )    ( 
 ( )
   
 (4.1) 
where ̅̅̅ ( ) is a multiplicity of the conformer (i); R is the gas constant; T is the 
temperature in Kelvin and G(i) is the free energy of conformer (i) in the solution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Schematic diagram of the examination of the conformer distribution in solvents. 
A set of 10 representative conformers for ibuprofen were 
selected from the conformational analysis results  
Input these 10 conformer structures to Dmol3 for geometry 
optimization using the PBE functional and DNP basic set  
 
 
Output files: *COSMO files for each 
conformer 
*.Cosmo files of solvents  
(available from COSMO 
database or generated from 
DMol3) 
COSMOthermX software  
Normalized weight factor of molecule in compound 
(% conformer in mixture of conformers) 
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4.3.3 Intermolecular force calculations 
 
The slice and attachment energies were calculated using the program HABIT98 [52] by 
summing pair-wise the potential energy involved in the intermolecular interactions 
between a central molecule and all molecules within and outside the slice, respectively. 
Habit98 can operate in several modes: LATT, FULL etc. with bonding options (0, -1, -
2, DM (each intermolecular interaction is assigned a particular number known as DM 
number)). The LATT mode is used for calculation of lattice energy and the FULL mode 
is employed for attachment energy calculations associated with morphological 
prediction.  
 
4.3.3.1 Lattice energy and intrinsic synthon classification 
 
Firstly, molecular crystal structures were downloaded from the CSD containing 
essential crystallographic data which are used to calculate the partial atomic charges 
using the semi-empirical quantum mechanics program MOPAC [149].  In order to 
obtain accurate lattice energy, a suitable potential function is chosen to calculate the 
intermolecular interactions involved. The force field was selected according to the 
structure and bonds within the molecule. In this study, the energy of each atom-atom 
bond is calculated using Momany [50] and Lifson [51] force fields. Lifson force field is 
a force field which provides partial charges for the carboxylic group and the alkyl chain 
of the ibuprofen molecule, but there are no parameters and partial charges for the 
aromatic ring, just considering aromatic portion as aliphatic one. Momany force fields 
contain only non-bonded terms switching between the van der Waals and the hydrogen 
bonded terms, depending on the atom-atom distance and the type of the atoms, and a 
separate electrostatic interactions term. The total crystallisation energy (lattice energy) 
per mole is calculated by summing the energy of all atom–atom bonds within a certain 
defined radius and then divided by two. The input file contains crystallography 
information for calculating the lattice energy at a series of limiting radius of 5, 7, 9, 11, 
20, 30, 40 Angstroms. The appropriate potential function chosen is investigated through 
comparison of the calculated lattice energy with the experimental calculated lattice 
energy derived from experimental sublimation enthalpy. 
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Vexp = ∆Hsub – 2RT (4.2) 
The procedure for morphological prediction is shown in Figure 4.4. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Flowchart describing the calculation of lattice energy from crystallographic 
information. 
 
The examination of the intrinsic synthons, referred to as inter-molecular interactions 
which take place within a material, was carried out using the bonding options to identify 
the strong bonds and, particularly constituent atom-atom or atom type contributions. 
Bonding (or Debug) analysis -1 in LATT mode was used for the analysis of the 
intermolecular interactions (its breakdown energy into the attractive, repulsive and 
electrostatic contributions) in the crystal lattice. The energy contribution of each atom in 
the lattice energy (%) and its breakdown in each different type and atom-atom pair were 
also examined by Debug-2. 
The bonding analysis -1 in FULL mode was employed to analyse the assignments of the 
intermolecular bonding (including the direction and strength of these bonds) on each 
crystal surface. The display of the intermolecular interaction of interest, e.g the 
strongest bonds or hydrogen bonds associated with dimer formation of carboxylic 
groups was performed through Debug-DM. 
 
 
Lattice energy calculation  
 
 
Atomic charges calculated 
using MOPAC  
Crystallographic information including 
fractional atomic coordinates, unit cell 
parameters and symmetry 
Selected force field and  
LATT mode calculation 
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4.3.3.2 Morphological prediction and determination of extrinsic synthons 
 
The attachment energies were calculated for all the dominant crystal faces generated 
using the geometrical BFDH principle [48, 150, 151] which states that the larger the 
inter-planar spacing dhkl, the more morphologically important the crystal (hkl) face will 
be. From this, a number of faces which are most likely to be dominant in the crystal 
morphology were chosen. The calculated attachment energies related to the relative 
growth rate of individual faces were used to generate a three-dimensional models of 
predicted morphology of the crystal using the SHAPE software [152]. The procedure 
for morphological prediction is shown in Figure 4.5. 
 
. 
  
 
 
 
 
 
 
 
Figure 4.5  Flowchart describing crystal morphology predictions from calculated attachment 
energies. 
 
Extrinsic synthons referred to as inter-molecular interactions taking place at interfaces 
of the material were also analysed in this study. Accelrys Material Studio [142] was 
used for cleaving a crystal in a specific plane to create crystal surface habits. This 
enabled to examine the molecular arrangement and the properties of the surfaces (e.g. 
hydrophobicity, polar or hydrogen-bonding) on dominant crystal habit surfaces. The 
interfacial molecular interaction of ibuprofen-solvent molecules e.g. the potential of the  
hydrogen bonding formation between solvent molecules and COOH functional groups 
of ibuprofen was utilised to rationalise the growth rate of the individual crystal surface 
habits in various solvents. 
 
Atomic charges calculated MOPAC or INTERCHEM 
Calculating attachment energy 
of individual faces  
Plot crystal morphology using SHAPE 
Relative face growth  
Crystallographic information including fractional 
atomic coordinates, unit cell parameters and symmetry 
Select force field, FULL 
mode calculations and 
provide a list of (hkl) 
crystal faces 
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4.4 Experimental method  
4.4.1 Polymorph and solvent screening  
 
Experiments of (RS)-ibuprofen polymorph screening were carried out in a shaker MaxQ 
2000 Barnstead/Lab-line with a temperature controlled Julabo F25. A set of slurry 
solutions of (RS)-ibuprofen in various solvents including polar protic, polar aprotic and 
non-polar (ethanol, methanol, propanol, ethyl acetate, acetonitrile, acetone, diethyl 
ether, isopropyl ether, toluene, hexane and xylene) were prepared in vials. These vials 
were agitated in a shaker for a period of about 2 days. The solutions were heated up to 
70
o
C then cooled down and kept constant at 0
o
C to recrystallise. The final solutions 
were dried carefully in a vacuum oven to collect crystals and observe their shape under 
a light microscope. The DSC data were determined using a differential scanning 
calorimeter (DSC 820, Mettler) (Figure 4.6). Each sample was heated from 25 to 85°C 
at 5
o
C/min in aluminium pans under nitrogen atmosphere. The onsets of the melting 
points and enthalpies of fusion were determined using STAR
e
 software. 
 
 
 
Figure 4.6 DSC 820 Mettler used to determine melting points of ibuprofen recrystallised from 
series of solvents. 
4.4.2 Solubility measurements 
4.4.2.1 Equipment 
 
An ATR UV/Vis spectroscopy system comprising a Cary 50 from Varian 
spectrophotometer and an ATR probe from Hellma Analytics (Figure 4.7) was 
Chapter 4. Materials, instrumentation and methodology 
 
87 
 
employed for solubility determinations of solutions of ibuprofen in all solvents except 
toluene where gravimetric methods were used. The material of construction of the ATR 
probe tip is sapphire and the barrel material is made from titanium with an outer 
diameter of 6.35 mm. This operates at over the wavelength range from 240 - 1100nm 
and is optimal for the direct measurement of strongly absorbing solutions where 
standard transmission probes cannot be used. This measurement approach had the 
advantage: in that it involved no sampling; the solutions need not be diluted; it was 
applicable for the measurement of high-solids content slurries on-line; and it was easy 
to set up with a flexible fibre-optics connection to the probe. 
 
Unfortunately the depth of penetration for toluene at the critical angle increases 
indefinitely at 319 nm so a limiting value of the refractive index is reached at 319 nm 
[153] and hence this technique could not be used for measurements in toluene and in 
this case this solubility was determined by gravimetric methods.  
 
 
 
Figure 4.7 ATR UV-Vis spectroscopy Cary 50 from Variant employed to measure solubility of 
ibuprofen. The inset shows the probe. 
 
4.4.2.2 Procedure 
 
A set of saturated solutions with excess, suspended solids of (RS)-ibuprofen in various 
solvents was prepared in vials and put in a shaker MaxQ 2000 Barnstead/Lab-line with 
a temperature controlled Julabo F25. The vials were agitated for 24 hours then allowed 
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to settle for 6 hours to ensure all solids were separated from the saturated solvent. The 
saturated solutions were separated from solid phase for solubility measurement. 
 
ATR UV-Vis spectroscopy method: Calibration curves were obtained by scanning a 
series of known concentrations of Ibuprofen in solvents over the wavelength range from 
300 to 250nm (the characteristic ibuprofen absorbance peak is at 264nm). Saturated 
solutions at different temperatures were also scanned to obtain absorbances and hence 
the solubility of ibuprofen at various temperatures was determined from the calibration 
curve.  
 
Gravimetric method: One gram of saturated solution at different temperatures 15
o
C, 
20
o
C, 25
o
C, 30
o
C, 35
o
C was withdrawn and transferred to vials, the solvents were then 
allowed to evaporate at room temperature for approximately one week until the 
remaining mass of solid-material was constant with time and then the solubility, 
expressed in gram of solutes/gram of solvent, was calculated by the equation (g/gsolvent). 
  
      
        
 (4.3) 
 
4.4.2.3 Data analysis 
 
The ideal solubility of crystalline materials can be calculated by: 
     
   
 
(
 
  
 
 
 
) 
 
(4.4) 
where ΔHm is the enthalpy of fusion and Tm is the melting temperature, obtained from 
DSC. 
 
For real solutions equation (4.4) is not valid and the van‟t Hoff equation provides the 
enthalpy and entropy of dissolution through the plots of lnX versus 1/T: 
      
     
  
 
     
 
  
 
(4.5) 
where X is the mole fraction of solute in solution; ∆Hdis and ∆Sdis are the enthalpy and 
entropy of dissolution, respectively; T is the temperature of solution; Tm is the melting 
point of the solute; and R is the gas constant. 
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According to Raoult‟s law, the activity coefficient of the solute in the saturated solution, 
  
   , is defined as: 
   
      
     
   
 (4.6) 
where   
   is the activity of the solute i in the saturated solution and is given by: 
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)+ (4.7) 
where   
   denotes the mole fraction experimental solubility; Tfus and ΔHfus obtained 
from DSC in section 4.4.1. 
 
Activity coefficients are calculated from the ratio of ideal solubility at a given 
temperature and the experimentally measured solubility at that temperature. The 
logarithm of activity coefficient γ in ethanol 95%, ethyl acetate, acetonitrile and toluene 
versus saturation temperature T can be fitted as: 
               (4.8) 
                             
4.4.3 Polythermal and isothermal crystallisation 
4.4.3.1 Equipment 
 
The Avantium Crystalline platform consists of a multi-reactor crystallisation platform 
which can fit 7ml crystallisers equipped with three-blade marine impeller (34 x 10 mm) 
and overhead and bottom magnetic stirring (8 independent temperature blocks from -
15
o
C up to 150
o
C controlled by a microprocessor controlling a heat and peltier element. 
Crystalline provides an inlet for a dry purge gas (typically nitrogen) to prevent 
condensation on the reactor blocks and electronics (Figure 4.8). The high quality digital 
visualisation probes are independent of each other, and can be synchronised with the 
turbidity measurements and temperature profile of each independent rector.  
 
In this equipment, there are 2 blocks equipped with a 2.0 x magnification lens and 1 
block equipped with a 1.0x magnification lens. There are two operation modes: standard 
Chapter 4. Materials, instrumentation and methodology 
 
90 
 
mode (only temperature and turbidity probe) and particle viewer (temperature, turbidity 
and camera for on-line particle viewing). 
 
For these experiments to measure MSZW, the blocks were only operated in standard 
mode to record the temperature and turbidity of solutions. 
 
                                         (a)                              (b) 
Figure 4.8 (a) A 7ml crystalliser with overhead and bottom magnetic stirring which can be fitted 
in blocks of Avantium Crystalline platforms ; (b) Multi-reactor Avantium Crystalline platforms 
with parallel 7ml crystallizers with overhead and bottom stirring [154] 
 
4.4.3.2 Procedure 
 
The MSWZ studies were carried out for solutions in ethanol 95% (1.4g/ml and 
0.98g/ml), ethyl acetate (0.72 g/ml) and acetonitrile (0.28g/ml) and toluene (0.65g/ml). 
Solutions were heated to 50
o
C at various heating/cooling rates ranging from 0.1- 0.5 
°C/min. The system was held at 50
o
C for 30 mins and cooled to -15°C at the specific 
heating/cooling rate with a stirring speed of 500 rpm overhead and 100rpm bottom 
stirred throughout the experiment. These runs were repeated from 3-4 times for each 
cooling rate. 
 
The induction time determinations were carried out for solutions in ethanol 95% 
(1.4g/ml), ethyl acetate (0.98 g/ml) and acetonitrile (0.40 g/ml) and toluene (0.87 g/ml). 
The vials were stirred at a stirring speed of 500 rpm overhead and 100 rpm bottom 
stirred throughout the experiment and were heated at 55
o
C and held for 30 mins to make 
sure that the crystals were dissolved. The solution was drastically cooled to the desired 
Overhead stirrer 
Bottom magnetic stirrer 
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temperature at a rate of 20
o
C/min and kept constant at that temperature until the onset of 
nucleation. The time at which the solution reached the saturated temperature was set as 
time zero.  The percentage of the light transmission decreased at the onset of nucleation 
and the difference between the time at which the transmittance started to decrease and 
time zero was recorded as the induction time, η   . Several runs were repeated from 4-8 
times for consistency and reproducibility of the results. 
 
4.4.3.3 Data analysis 
 
The dissolution and crystallisation temperatures were obtained at the different 
heating/cooling rates. Figure 4.9 shows an example of a turbidimetric profile for 
polythermal studies: (a) transmittance and temperature as a function of time and (b) a 
plot of transmittance as a fuction of temperature. The temperature of crystallisation is 
determined at the point at which the transmittance starts to drop significantly.  
 
(a)                                                                       (b) 
Figure 4.9 A sample turbidimetric profile for polythermal studies of 0.72g/ml of ibuprofen in 
ethyl acetate at the heating/cooling rate 0.1C/min: the transmittance and temperature as a 
function of time (a); plot of the transmittance as a function of temperature (b). From these plots, 
temperature of dissolution and temperature of crystallisation at different heating/cooling rates 
were investigated. 
 
The equilibrium MSZW is the difference between the dissolution and crystallisation 
temperature and it was obtained at infinitely slow cooling rate. The dissolution 
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temperature (Tdis) and crystallisation temperature (Tcrys) versus heating/cooling rate was 
plotted and Tdis and Tcrys extrapolated at 0
o
C/min to estimate the MSZW. 
                      (4.9) 
 
The order of the nucleation (m), reflecting the cooling rate dependence of the process 
was determined using Nyvlt‟s equation 
     (   )   
  
  
                      
(4.10) 
where b is cooling rate, m is the order of nucleation; c is the equilibrium concentration; 
kn is the nucleation rate constant, ε is associated with the molecular weight and ΔTmax is 
the MSZW. 
 
Plotting logb against log ∆tmax yields a straight line with slope equal to the order of 
nucleation m. The nucleation rate constant can be obtained from the intercept value. 
 
Induction time is a parameter measuring the metastability of the crystallisation system 
like the MSZW of slow cooling. The induction time is considered as the time elapsed 
between the achievement of saturation and the appearance of the first crystals (see 
Figure 4.10).  
 
Figure 4.10 An example of isothermal crystallisation for ibuprofen crystallising from 
acetonitrile: Induction time is the period of time between the solution being saturated at a given 
temperature and the appearance of first nuclei of ibuprofen (the transmittance drops indicating 
the onset of crystallisation). 
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The interfacial energy was calculated using classical nucleation theory 
    *
       
     (   ) 
+      (4.11) 
 
The slope of the straight line plot of ln() vs. 1/T3(ln)2 was used to determine the 
interfacial energy/tension. 
 
The radius of a critical nucleus can be derived by the equation 
   
     
           
 (4.12) 
where the shape factors are kA = 4π and kv = 4π/3 for the spherical nuclei.  
 
4.4.4 Single crystal growth rate measurements 
4.4.4.1 Equipment 
 
 
The diagram of instrumentation employed in this study is shown in Figure 4.11.  
 
Figure 4.11 Diagram of scale-up crystallisation instrumentation for measurement of crystal 
growth rate at single particle level (pink block); for measurement of crystal growth rate in a 
population of crystals (blue block). 
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The growth rates of faces habit planes {001} and {011} for individual single crystals as 
a function of the growth solvent used and the solution supersaturation were measured at 
two scale sizes: a 0.5ml crystallisation cuvette cell (Figure 4.12) and a 15ml jacketed-
vessel (Figure 4.13). The crystallisation setup employed for this comprises an inverted 
optical polarizing microscope (Olympus Optical IMT-2 or Leica/ Leitz DM IL 090-131-
002) integrated with a CCD Lumenera Infinity 3.3 megapixel camera, a PC with Image 
Capture and Image Analyze Software to capture pictures during crystal growth. The 
crystallisation vessels comprised of: 
 A UV cuvette cell 0.5ml (54 x 10 x 1 mm) submerged in a shallow tank of water 
whose temperature was controlled by a Haake F3 recirculation bath. 
 A 15ml jacketed vessel (34 (mm) ID diameter x 17(mm) height), with flat 
optical glass dics at the top and the bottom connected to a Huber ministat chiller. 
The jacketed vessel was equipped with an ATR UV/Vis spectrometer immersion 
probe to monitor the solution concentration and hence the level of 
supersaturation during crystallisation. 
 
              
 
Figure 4.12 Prototype cell for measurement growth rate of individual faces of ibuprofen. 
 
 
 
Objective lens 
Illumination 
Water in  
Thermocouple  
Water out 
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Figure 4.13 Crystallisation system set up for measurement of crystal growth rate in a 15ml 
jacketed vessel. 
 
4.4.4.2 Procedure 
RS-ibuprofen solutions were prepared by dissolving solute in ethanol 95% (1.4g/ml), 
ethyl acetate (1g/ml), acetonitrile (0.4g/ml) and toluene (0.87g/ml). 
 
For the 0.5ml scale, a pipette was used to transfer the prepared solution into the cuvette 
cell which was sealed and fixed to the bottom of the water tank.  
For the 15ml scale, the prepared solution was transferred into the vessel. 
 
The ibuprofen/solvent solutions were heated to 50
o
C to completely dissolve all 
ibuprofen crystals, then the solutions were cooled down to a constant temperature such 
as 20, 23, 25 and 27
o
C to maintain a specific supersaturation as monitoring using ATR 
UV/Vis spectroscopy and the system was monitored until crystals were found to appear. 
The Image Analyze Software was used to capture a temporal sequence of images of the 
crystals as they developed. 
 
Water out 
Water in 
Flat optical lid  
Flat optical base 
Temperature probe ATR probe 
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Procedure for growth rate measurement for a case study in Pfizer: The cuvette cell 
was employed to study the morphology of this compound in pure 2-MeTHF and a 
mixture of 99% of 2-MeTHF and 1% of water. Compound A solutions were prepared 
by dissolving compound A in 2-MeTHF (30mg/ml) and in a mixture of 99% 2-MeTHF 
1% and water (18mg/ml). The prepared solution was transferred into the 0.5ml glass 
cuvette crystallisation cell immersed in a tank of water. This cuvette was sealed and 
secured at the bottom of the glass surface of the water tank, whose temperature was 
controlled using a Huber recirculation bath.  
 
The solutions were heated to 40
o
C to completely dissolve the solid material, and then 
the solutions were cooled down to a set temperature corresponding to a specific 
supersaturation level and held the temperature constant. The experiments were carried 
out in 2 conditions: (a) in a stagnant condition (the cuvette cell was placed at a fixed 
position in the water tank, without tilting or shaking) or (b) in a turbulent condition (the 
cuvette cell was placed at a fixed position in the water tank, with random tilting or 
shaking to accelerate the nucleation). When crystals are nucleated and grown, an 
inverted, polarizing video microscope Carl Zeiss together with the Image Capture and 
Image Analyze Software was used to capture a sequence of images of the crystals in 
order to observe morphology and determine the growth rate of crystals along the length 
(longer direction) and the width (shorter direction).  
 
4.4.4.3 Image analysis 
 
The dominant faces of ibuprofen crystals can be indexed by comparing the predicted 
morphology and experimental morphology. A titled predicted morphology for ibuprofen 
showing the {011} and {111} are oriented in the similar direction. The crystal is lying 
flat on one of its {100} faces therefore it is impossible to state whether the {111} face is 
present in the experimental morphology or not. However, the {011} face is much more 
dominant compared to the {111} face so it is reasonable to assume the growth rate in b 
direction was measured for the {011} face. 
 
The growth rates of faces {001} and {011} were measured using two different methods 
as shown schematically in Figure 4.14. 
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 Either the length of a line from the centre of the crystal and perpendicular to the 
projection of the crystal edges for (001) or (00-1) and (011) or (0-11) or (01-1) 
or (0-1-1) faces (assuming crystals are symmetric was measured). 
 Or the separation distance between two opposite parallel faces of crystals was 
measured and then divided by two. 
 
                   
Figure 4.14 Image of crystal with overlaid annotations highlighting the methodology for the 
measurement of growth rate of the individual faces.  
 
Assuming the crystal is lying flat on one of its {100} faces, the in-plane measurements 
were geometrically corrected with the aid of MORANG [155] to allow for the tilt of the 
{001} and {011} planes (80.64
o
 and 84.42
o
 respectively) with respect to the sample‟s 
dominant {100} habit plane to be taken into account. Because the face is slightly tilted, 
it is seen as an area rather than a single line. Therefore, the edge of the face needs to be 
chosen consistently for a series of crystals.  Growth rates of crystal faces were 
determined by capturing images at user-defined time-intervals (typically ranging 1-10 
minutes, depending on the growth rate) and then by plotting the distance from the centre 
of the crystals to the faces as a function of time. The slope of the line corresponds to the 
measured growth rate of the face. Mean growth rates, together with standard deviations, 
were obtained from between five to eight growth rate measurements on individual 
single crystals under equivalent conditions. The coefficient of variation for the growth 
rate of each crystal face in each solvent and two scale-sizes was calculated by the 
standard deviation divided by the growth rate of the crystal faces. 
 
(100) 
(001) 
 
(011) 
(0-11) (0-1-1) 
(01-1) 
(00-1) 
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4.4.4.4 Growth mechanism investigation  
 
The growth mechanism was assessed through user-defined fitting functions using the 
appropriate growth kinetic models. Birth and Spread (equation 3.6) and BCF (equation 
3.7) to plots of mean growth rate versus range of supersaturation to evaluate which 
model gives the better fit. Data fitting was carried out using nonlinear curve-fitting in 
Origin [156]. The quality of regression was measured by the coefficient of 
determination R
2
. In this, if the value of adjusted R
2
 (adj. R
2
) is found to be close to 1, 
the plot calculation can be regarded as being very strong, i.e. showing a high degree of 
confidence in the regression model. The adj. R
2 
can be negative when the fit is poor 
[156]. 
 
4.4.5 Comparison of the growth rate in non-agitated vessel and in 
agitated-vessel 
 
There were two techniques used to measure the growth rate of ibuprofen crystal in 
ethanol in this section. In the first technique, the growth rate of number of crystals in 
agitated reactors as a function of supersaturation. Crystal size was analysed by Image 
analysis software.  The diameter of the particle was then calculated as a diameter of a 
sphere with equivalent area. In the second technique, the growth rate of individual 
crystals was estimated by direct observation from an inverted microscope. 
 
4.4.5.1 Growth rate measurement in agitated vessel using Avantium platforms 
 
These growth rate measurements in agitated reactors were carried out in The Avantium 
Crystalline platform (see Figure 4.8). For these particle size measurements, the 2 blocks 
quipped with a camera (2x magnification lens) were employed and the system was 
operated in particle viewer mode (temperature, turbidity and camera for on-line particle 
viewing). 
 
The growth rate of ibuprofen was determined from seeded batch saturated solutions. 
0.98g/ml (Tsat ≈ 30
o
C) of ibuprofen in ethanol 95% was prepared. The prepared vials 
were placed in the CRYSTALLINE and were heated 10
o
C above the saturation 
temperature for an hour. The temperature was then brought down to 27
o
C and 28
o
C with 
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10
o
C/min cooling rate and after 20 minutes the ibuprofen seed crystals were added to 
the vials and the system was left at constant temperatures. The images were obtained at 
every 5-15 seconds and analysed using Process Image Analysis Expert [157] software 
in order to obtain particle size distribution and hence the overall crystal growth rates. 
 
A fundamental limitation of image analysis reflects the difficulty in terms of 
segmenting crystal images from the diffuse background presented from within a 
concentrated solution. The image analysis software calculates the diameter of a circle 
that has the same number of pixels detected for the particle, and is referred to as an area 
equivalent diameter. The supersaturation ratios used were 0.157 and 0.105. 
 
This was done by calculating the area of the crystal and converting into area equivalent 
diameter of a circle. 
 
4.4.5.2 Growth rate measurement in non-agitated vessel using microscopy 
 
The growth rates of faces and of single crystals as a function of solvents and 
supersaturation were measured using a 15 mL jacketed-vessel which was connected to a 
Huber Ministat circulation water bath to control the temperature of the solution (Figure 
4.13). 
 
The growth rate of ibuprofen in ethanol was determined from seeded batch under-
saturated solutions. 7ml of ibuprofen in ethanol at concentration 0.98g/ml was prepared 
and transferred into the vessel. Solutions were kept at a constant temperature 27
o
C and 
28
o
C in 30 minutes to ensure the temperature of solution was homogenous. Seed 
crystals were introduced to a stagnant solution in a 7mL jacketed vessel. When seed 
crystals were grown, an inverted, polarizing video microscope together with the Image 
Capture and Image Analyze Software was used to capture a sequence of images of the 
crystals in order to analyse the overall growth rate. At each supersaturation, each 
experiment was repeated twice to check the reproducibility of the data.  
 
In order to obtain crystal growth rate, further analysis described below must be followed 
on each captured image. Firstly, the centre of a crystal is defined by drawing two 
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diagonal lines from two adjacent corners to the opposite end. Then the distance from the 
centre of the crystal to the specific faces were measured by drawing lines perpendicular 
to each face (Figure 4.15). 
 
Figure 4.15 Sketch for the calculation of an area of a crystal; from this the equivalent diameter 
can be calculated. 
 
The area of a crystal can be calculated by 
A = ½*a1*h1 + ½ *a2*h2+ [½ (a1+a2) ]*[½ (b1+b2)]   (4.13) 
From the calculated area of crystals during the period of time, the overall growth rate 
(equivalent diameter) can be estimated. 
 
4.5 Conclusions  
 
This chapter shows materials used in this study together with a general description of its 
crystal and molecular structures, the instrumentation and methods for computational and 
experimental works were presented in this chapter. 
 
The basic computational method for crystal morphological prediction using the 
attachment energy method together with intermolecular bonding analysis of the 
important faces; conformational population in different solvents and solvent-mediated 
effect on crystal morphology are summarized in this chapter. 
 
The experimental crystallisation study involved polymorph screening, solubility 
measurements, MSZW determination, and a study of the growth rate of individual faces 
of ibuprofen as a function of solvent type, supersaturation and scale-sizes. The methods 
for the nucleation kinetics of ibuprofen in ethanol, ethyl acetate, toluene and acetonitrile 
were examined MSZW and induction time measurements were presented. The 
measurement of crystal growth rate for the {001} and {011} face were performed in a 
 
(100) 
{001} 
h1 h2 a2 a1 
b1 
b2 
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0.5ml cuvette crystallisation cell and a 15mL jacketed vessel. In addition, the 
methodology for measuring the overall growth rate of single crystals in stagnant 
solution compared to the data recorded on the population of crystals crystallised in an 
agitated 7ml reactor are presented.  
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5 Modelling the molecular and 
crystallography structure and its 
mediation by its solution state 
environment 
 
 
 
 
 
 
 
 
Summary: 
This chapter presents the outcomes of molecular modelling including conformational 
analysis for an isolated ibuprofen molecule, morphological prediction with both 
monomer and dimers as the growth unit and intermolecular bonding analysis on the 
dominant  faces {100}, {001} and {011}. 
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5.1 Introduction 
 
Computer modelling based on crystal structures offers a powerful technique for 
assessing the correlation between crystal structures, conformational energy space of a 
molecule, crystallising conditions and crystal morphology and shape. The purpose of 
the work in this chapter, therefore, is to link the subsequent chapters involving 
polymorphism screening crystal morphology observations and crystal growth rate of 
individual faces in various solvents (in chapter 7). This involves the analysis of 
conformational flexibility as related to polymorphism, the prediction of the theoretical 
morphology using BFDH and attachment energy models using HABIT simulations, and 
to compare these observations with experimentally derived morphologies aided by a 
detail analysis of the including intermolecular interactions both within the bulk structure 
and on the crystal habit faces. This is complemented by molecular-scale visualization of 
the bulk and surface chemistry. The morphological predictions of solvent-mediated 
morphologies are compared with the in-situ observations of ibuprofen crystal 
morphology in various solvents. The theory behind these calculations is given in chapter 
2 and methodology is given in chapter 4. 
 
5.2 Conformational analysis for a free ibuprofen molecule 
 
Conformer analysis of the torsions using Materials Studio revealed eight potential 
torsion angles including double bonds and bonds with terminal hydrogen atoms 
(disregarding bonds in the benzene rings) in a free ibuprofen molecule. To investigate 
and select the most flexible torsion angles associated with significant energy changes, 
the energy of the molecule when rotating each torsion angle are shown in Table 5.1. 
. 
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Table 5.1 Total energy changed when rotating each torsion angle using the Conformer module 
in Material Studio 
Torsion  
angles 
Atoms involved 
in torsion angle 
Emin and Emax (kcal/mol) 
T1 
T2 
T3 
T4 
T5 
T6 
T7 
T8 
C2-C3-C4-H7 
C2-C3-C5-H10 
C11-C2-C3-C4 
C10-C11-C2-C3 
C9-C8-C6-C1 
C1-C6-C7-H14 
C7-C6-C1-O1 
C6-C1-O1-H1 
27.06 
27.06 - 31.12 
27.07 - 33.23 
27.24 - 33.03 
27.35 - 32.27 
27.06 - 31.17 
27.04 - 28.8 
27.06 - 52.24 
 
 
This initial analysis revealed that four of these torsion angle rotations, T3, T4, T5 and 
T8 resulted in the greatest change of energy.  These were selected to characterise the 
conformational flexibility of ibuprofen. An example of the molecular structure reveals: 
T3 affects the twist of the carbon chain, T4 and T5 involve a twist of the carbon chain 
with respect to the benzene ring and T8 is associated with the orientation of the 
carboxylic group with respect to the carbon chain (Figure 5.1). Based on this, torsion 
energy maps were built and are shown in Figure 5.3. Ibuprofen molecules with 
measured torsion angles T3, T4, T5 and T8 before and after geometry optimisation are 
shown in Table 5.2. 
 
Table 5.2 Measured torsion angles T3, T4, T5 and T8 from the structure of an ibuprofen 
molecule before and after geometry optimisation, which were used to mark on the energy map 
 Torsion angles T3 T4 T5 T8 
RS-ibuprofen Before Optimization -168.7 78.0 96.5 176.6 
After optimization -173.6 68.1 114.6 -179.7 
S-ibuprofen Molecule 1 -170.3 86.0 92.5 175.5 
Molecule 2 171.5 -79.1 -95.0 -172.5 
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(a)
(b) 
(c) 
 
Figure 5.1  RS-ibuprofen molecules with measured torsion angles T3, T4, T5 and T8 (a) before 
geometry optimization; (b) after geometry optimization and (c) S-ibuprofen molecules. 
 
T3 
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T5 T8 
T3 
T4 
T5 
T8 
T8 
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The study reveals the not so surprising result that ibuprofen is not a very flexible 
molecule.  This is shown by the fact that the torsion angles, before and after geometry 
optimization, do not change significantly, for example, the torsion angle T3 changed 
from -168.7
o
 to -173.6
o
, T4 from 78
o
 to 68
o
 etc. in which the total energy of the 
molecule decrease to its lowest value (Figure 5.2). 
 
Figure 5.2 Energy minimisation using the Geometry Optimization in Material Studio. 
 
The effect of conformational change on the molecular energy of ibuprofen is 
summarized in table 5.1. The range of energy change (kcal/mol) when rotating these 
torsion angles (T3-T4), (T3-T5), (T3-T8), (T4-T5), (T4-T8) and (T5-T8) from -180 to 
180 degree is shown in Table 5.3 and Figure 5.3 (a, b,c, d, e, f). 
 
Table 5.3 Energy change when rotating two torsion angles (T3-T4), (T3-T5), (T3-T8), (T4-T5), 
(T4-T8) and (T5-T8) from -180 to 180 degree (kcal/mol) 
 
 
 
 
 
 
 
 
 
 
Torsion angle Emin and Emax (kcal/mol) 
T3-T4 
T3-T5 
T3-T8 
T4-T5 
T4-T8 
T5-T8 
21 - 48 
29.8 - 41 
30- 60 
29.8 - 4.2 
30 – 60 
29.8 - 35.0 
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x: Racemic-ibuprofen molecule (1 molecule in asymmetric unit) before optimisation  
*: Racemic-ibuprofen molecule after optimisation 
x: S-ibuprofen molecules (2 molecules in asymmetric unit) 
 
(a) The torsion angle T3 (C11-C2-C3-C4) and T4 (C10-C11-C2-C3) reflects the 
conformation of the carbon chain.  
 
 
(b) The torsion angle (T3) and (T5) reflects the twist of the carbon chain which is involved 
in C4-C3-C2-C11 and C9-C8-C6-C1.  
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(c) T3 (C11-C2-C3-C4) reflects the conformation of the carbon chain and T8 (C6-C1-O1-
H1) is a torsion angle associated with the position of the carboxylic group with respect 
to the carbon chain.  
 
 
(d) T4 (C10-C11-C2-C3) and T5 (C9-C8-C6-C1) reflect the twist of the carbon chain with 
the benzene ring.  
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(e) T4 (C10-C11-C2-C3) reflects the twist of the carbon chain with the benzene ring and 
T8 (C6-C1-O1-H1) is a torsion angle associated with the position of the carboxylic 
group with respect to the carbon chain.  
 
(f) T5 (C10-C11-C2-C3) reflects the twist of the carbon chain with the benzene ring and 
T8 (C6-C1-O1-H1) is a torsion angle associated with the position of the carboxylic 
group with respect to the carbon chain.  
Figure 5.3 Energy map of a free ibuprofen molecule together with marked torsion angles for an 
isolated racemate-ibuprofen molecule before and after geometry optimization and S-ibuprofen 
molecules. 
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The torsion energy map shows that the crystal structure downloaded from the database 
before and after geometry optimisation was marked in the torsion energy minimum of a 
free molecule. The success of this method in mapping out the favoured conformational 
space of the molecule which was studied and assessed by comparing CONFORMER 
search output with the minimum conformational energy on an isolated ibuprofen 
molecule. The values of the two torsion angles of the ibuprofen molecule were marked 
on this map indicating the torsion angles for molecules in the crystal structure (observed 
structure) which is close to the calculated torsion energy minimum. This is consistent 
with there being little recorded evidence for polymorphism in this material when 
recrystallised at non-extreme conditions. It is in good agreement to published literature.  
 
In this study, the BFDH and attachment energy model were employed for the prediction 
of ibuprofen morphology. The simulation calculations were performed to obtain 
attachment energies for a growth unit based on a monomer and dimer, as ibuprofen 
molecules pack in the crystal lattice as dimers by forming hydrogen bonds between the 
carboxylic groups so it is likely that the dimer growth unit is present in the crystal 
lattice. 
 
5.3 Predicted morphology compared to experimental 
morphology 
 
 
In this study, the BFDH and attachment energy model were employed for the prediction 
of ibuprofen morphology. The simulation calculations were performed to obtain 
attachment energies for a growth unit based on a monomer and dimer, as ibuprofen 
molecules pack in the crystal lattice as dimers by forming hydrogen bonds between the 
carboxylic groups so it is likely that the dimer growth unit is present in the crystal 
lattice. 
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5.3.1 Attachment energy morphological simulation for a growth unit 
based on a monomer 
 
5.3.1.1 Force field and charges 
 
The tested force fields used in this work were Momany and Lifson force fields for 
carboxylic acid. The atomic co-ordinates of the resultant crystal structure of ibuprofen 
together with the atomic partial charges as calculated using MOPAC or INTERCHEM 
are tabulated in Table 5.4.  
 
Figure 5.4 Numbering of the atoms in an ibuprofen molecule structure. 
 
Table 5.4 Atomic charges of all atoms in the ibuprofen crystal structure 
Atomic 
number 
Atomic 
type 
X 
coordinate 
Y 
coordinate 
Z 
coordinate 
Charges 
1 C1 0.4166 0.34642 0.3982 0.2983 
2 C2 0.17355 -0.13553 0.7004 -0.1033 
3 C3 0.09846 -0.26027 0.6429 -0.1223 
4 C4 0.04237 -0.40949 0.7423 -0.1866 
5 C5 0.13806 -0.31984 0.5818 -0.191 
6 C6 0.35072 0.22129 0.3253 -0.0539 
7 C7 0.40131 0.10904 0.2436 -0.1657 
8 C8 0.3042 0.1251 0.4211 -0.0923 
9 C9 0.2185 0.1740 0.4460 -0.0989 
10 C10 0.1770   0.0901 0.535 1 -0.1137 
11 C11  0.2197 -0.0405   0.6035 -0.0606 
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12 C12 0.3059  -0.092  0.5798  -0.1237 
13 C13 0.3475 -0.0085   0.4900 -0.0933 
14 H1 0.4309  0.5642 0.4715  0.2582 
15 H2  0.2182 -0.2042   0.7642 0.0829 
16 H3  0.1449 -0.0572  0.7495 0.0796 
17    H4  0.0548  -0.2010 0.5755 0.0811 
18 H5 0.0864 -0.3885  0.8066 0.0639 
19 H6  0.0182 -0.2258  0.7821 0.0739 
20 H7  -0.0045 -0.3992  0.7029  0.0715 
21 H8  0.1797 -0.3746  0.5198 0.08 
22 H9  0.0850 -0.4811  0.5417  0.0727 
23 H10  0.1768 -0.4706  0.6520  0.0628 
24 H11 0.3060  0.2896   0.2733 0.101 
25 H12  0.4503 0.0429  0.2974 0.0926 
26 H13 0.4223   0.1811  0.1808 0.0723 
27 H14 0.3609  0.0314  0.1946  0.0708 
28 H15  0.1895 0.2663  0.3970  0.1204 
29 H16  0.1169 0.1266  0.5524  0.1207 
30 H17  0.3403 -0.1892  0.6333  0.1281 
31 H18  0.4075 -0.0473  0.4762  0.1258 
32 O1  0.3801  0.4935  0.4163 -0.2821 
33 O2  0.4969 0.3118 0.4402  -0.3692 
 
 
5.3.1.2 Lattice energy 
 
With the chosen force field and calculated charges for each atom, the lattice energy was 
calculated and the contribution of van der Waals and coulombic intermolecular 
interactions into the lattice energy are shown in Figure 5.5. 
Chapter 5. Modelling the molecular and crystallography structure and its mediation by its 
solution state environment 
 
113 
 
 
Figure 5.5 Lattice energy which is a sum of the van der Waals and electrostatics interactions 
which converges at 20 Å. The van der Waals and electrostatic contributions also converge with 
distance. 
 
The calculated value of lattice energy was found to be -28.93 (kcal/mol) with the lattice 
convergence taking place at ca 20Å as shown Figure 5.5. This provides a reasonable 
agreement with the experimental lattice energy calculated from the heat of sublimation 
for ibuprofen; 30.10 kcal/mol [136]. It suggested that these force fields; Momany and 
Lifson chosen, are appropriate for this calculation. It was shown that the van der Waals 
and Coulombic intermolecular energies increase rapidly and converge as the limiting 
radius increases because only molecules within a fixed distance from the central 
molecule contribute to the lattice energy. This occurs at a distance of 20Å from the 
central molecule. The van der Waals interactions 25.1 kcal/mol contributing to the 
overall lattice energy were found to be much higher than the Coulumbic interactions, 
which was around 3.8 (kcal/mol). 
 
5.3.1.3 Analysis of strong intermolecular interactions (synthons) on the crystal 
lattice 
 
The bonding analysis features were used for the analysis of the intermolecular 
interactions in the crystal lattice (see Table 5.5). Analysis of interatomic interactions: 
Further calculations (Table 5.6) showed the most important atom-atom interactions 
within all the intermolecular interactions.  
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Table 5.5 Five strongest intermolecular interactions on the crystal lattice corresponding to the 
different molecular distance 
Bond  
type 
Multi
plicity  
Dist. 
(Å)  
Attractive 
energy  
Repulsive 
energy  
Coulombic 
Total 
(kcal/mol)  
a 4 9.81 -47.4 42.15 -2.22 -7.47 
b 8 6.28 -3.72 1.24 -0.11 -2.58 
c 4 6.69 -3.14 1.31 -0.43 -2.26 
d 8 7.08 -3.00 0.76 -0.02 -2.25 
e 4 8.04 -1.67 0.33 0.01 -1.33 
 
Table 5.6 Contributions of different type of atoms in the asymmetric unit to the lattice energy 
(%) 
Atom Attractive 
energy  
Repulsive 
energy  
Coulombic 
Total Percentage 
C1 -2.41 1.06 -0.36 -1.71 7.8 
C2 -1.02 0.29 0.26 -0.46 2.1 
C3 -0.76 0.14 0.15 -0.48 2.17 
C4 -0.87 0.30 0.24 -0.34 1.53 
C5 -1.13 0.42 0.29 -0.42 1.93 
C6 -1.15 0.43 0.17 -0.56 2.54 
C7 -1.36 0.60 0.59 -0.17 0.87 
C8 -1.01 0.23 0.14 -0.64 2.93 
C9 -1.25 0.44 0.05 -0.76 3.45 
C10 -1.20 0.49 0.00 -0.71 3.24 
C11 -1.10 0.48 0.09 -0.54 2.46 
C12 -1.39 0.58 0.44 -0.38 1.71 
C13 -1.30 0.51 0.28 -0.52 2.39 
H1 0.00 0.00 -3.33 -3.33 15.23 
H2 -0.43 0.08 -0.45 -0.79 3.62 
H3 -0.35 0.06 -0.12 -0.4 1.82 
H4 -0.30 0.07 0.04 -0.19 0.88 
H5 -0.45 0.21 -0.25 -0.49 2.26 
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H6 -0.26 0.04 -0.06 -0.29 1.31 
H7 -0.20 0.02 0.02 -0.15 0.70 
H8 -0.44 0.09 -0.14 -0.48 2.20 
H9 -0.30 0.05 0.02 -0.23 1.07 
H10 -0.47 0.13 -0.22 -0.56 2.57 
H11 -0.61 0.39 -0.53 -0.75 3.43 
H12 -0.34 0.05 -0.27 -0.56 2.56 
H13 -0.63 0.28 -0.42 -0.77 3.50 
H14 -0.54 0.15 -0.18 -0.56 2.57 
H15 -0.48 0.11 -0.06 -0.43 1.98 
H16 -0.37 0.07 0.04  -0.26 1.20 
H17 -0.58 0.17 -0.79 -1.2 5.49 
H18 -0.61 0.32 -0.64 -0.93 4.27 
O1 -2.66 1.97 1.43 0.74 -3.38 
O2 -2.79 2.43 -2.20 -2.56 11.69 
                             
Table 5.6 shows the constituent intermolecular interactions partitioned with respect to 
their contributing atomic sites in the molecule. This reveals that atom carbonyl oxygen 
O2 in (C=O) and hydroxyl oxygen H1 in (O-H) contribute the most to the lattice energy 
and that the strongest intermolecular interactions are those related to hydrogen bond O--
-H interactions.  
 
5.3.1.4 BFDH selection of slices and the attachment energy 
 
From the BFDH rule based on the cell dimensions, molecular positions, and with an 
assumption that the slowest faces possess the highest density of material and largest dhkl, 
the miler indices and morphology of the ibuprofen crystal was obtained. The calculated 
surface attachment energies for the individual faces are given in Table 5.7 with the 
predicted morphology, based on these values, given in Figure 5.6 and the experimental 
morphology shown in Figure 5.7. 
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Table 5.7 Interplanar spacing (in Å) and attachment energies (in kcal/mol) for a growth unit 
based on a monomer 
Face Multi
plicity 
dhkl  Eatt  
(Momany) 
Eatt  
(Lifson)  
Eatt  
(Bunyan, 1991) 
100 
110 
011 
11-1 
111 
210 
002 
10-2 
21-1 
102 
20-2 
211 
0 1 2 
1 1 -2 
3 1 0 
1 1 2 
2 
4 
4 
4 
4 
4 
2 
2 
4 
2 
2 
4 
4 
4 
4 
4 
14.47 
6.92 
6.32 
6.01 
5.60 
5.33 
5.29 
5.25 
5.00 
4.73 
4.65 
4.54 
4.39 
4.37 
4.11 
4.06 
-4.27 
-15.84 
-18.30 
-17.14 
-16.46 
-18.25 
-14.79 
-16.59 
-19.46 
-15.26 
-25.91 
-18.16 
-21.93 
-20.63 
-19.67 
-19.34 
-4.75 
-15.46 
-16.13 
-16.93 
-16.19 
-18.26 
-16.22 
-18.18 
-19.67 
-16.74 
-24.76 
-18.26 
-20.09 
-20.73 
-19.97 
-19.30 
-4.76 
-17.85  
-18.04 
-17.40 
-16.70  
-18.76  
-8.29 
-17.20 
 
-15.86 
Elatt (kcal/mol) -28.93 -28.04 -28.94 
 
     
(a) (b)                  
 (c) 
Figure 5.6 Morphology of ibuprofen calculated using  (a)  Lifson force field; (b) Momany force 
field;  and (c) ibuprofen crystal grown from vapour phase [136]. 
Chapter 5. Modelling the molecular and crystallography structure and its mediation by its 
solution state environment 
 
117 
 
 
                                      
                                (a)                    (b)               (c)              (d)             
 
Figure 5.7 Morphology of ibuprofen recrystallised in ethanol (a), ethyl acetate (b); acetonitrile 
(c); toluene (d). 
 
 
 
Figure 5.8 Thin crystal morphology of ibuprofen recrystallised in ethanol solutions 
 
The crystal morphology obtained from the morphological simulation from both force 
fields was found to be in good agreement with published literature [5, 136, 158] and 
with the optical micrographs taken of the crystals grown from various solvents in this 
study, apart from the aspect ratios of the crystals (Figure 5.7). The {100} face has 
smallest attachment energy so it is the slowest growing face of ibuprofen which is in 
good agreement with the observed morphology (thin crystals) (Figure 5.8).  Ibuprofen 
crystals are quite thin and the {100} face is the dominant face. Larger {110} and {111} 
faces and smaller {011} faces present in the morphology calculated from Momany force 
field whilst larger {011} face and a smaller {110} face present in the theoretical 
morphology calculated from Lifson.  However, the morphology calculated from the 
Momany force field is slightly thinner than that calculated from the Lifson force field. 
(001) 
(100) 
(01-1) (011) 
(00-1) 
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The simulated morphology for ibuprofen crystals revealed that the {100}; {001} and 
{011} are the dominant faces which is also in relatively good agreement with 
experimental results and previous observations from the literature [136, 159]. However, 
the {110} face is not present in the experimental crystals and the aspect ratio of 
ibuprofen crystals vary with crystallising environments. 
 
5.3.1.5 Analysis of the strongest bonds on the {001}, {011} {100} and {110} face 
 
Intermolecular bonding for ibuprofen in terms of the most important bond types, 
multiplicity, distance and strength of bonds (Table 5.8) and the display of theses 
intermolecular interactions (Figure 5.9) were discovered and analysed to give details on 
the strongest bonds on dominant crystal surfaces {011}, {001} and {100}. For example, 
to examine the strength and direction of hydrogen-bonds and contributions of these 
strongest bonds on the slice and attachment energy and surface chemistry to rationalise 
the growth rate of these faces. 
 
Table 5.8 Bonding analysis for the {011}, {001} and {100} faces with for a growth unit based 
on a monomer 
 
Bond  
type 
Multip
licity  
Dist. 
(Å)  
ATT  REP  COU  Total  
Face 
{011} 
Face 
{001} 
Face 
{100} 
Face 
{110} 
a 4 9.81 -47.4 42.15 -2.22 -7.47 (+/-) (SL) (SL) (+/-/SL) 
b 8 6.28 -3.72 1.24 -0.11 -2.58 (SL/+/-) (+/-) (SL) (SL) 
c 4 6.69 -3.14 1.31 -0.43 -2.26 (SL) (SL) (SL) (+/-/SL) 
d 8 7.08 -3.00 0.76 -0.02 -2.25 (+/-/SL) (+/-) (SL) (+/-) 
e 4 8.04 -1.67 0.33 0.01 -1.33 (SL) (SL) (+/-) (+/-/SL) 
 
(SL): slice energy bond 
(+): attachment energy bond: molecule lies above the slice centre and contributes to 
Eatt(+) 
(–): attachment energy bond: molecule lies below the slice centre and contributes to 
Eatt(-) 
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(a)                                                            (b) 
 
          (c)                                             (d) 
 
(e) 
Figure 5.9 Molecular interaction of the 5 strongest bonds (a) The strongest bond type a (-7.47 
kcal/mol) is a hydrogen-bond between carboxylic acid -COOH groups of ibuprofen 
(homosynthon); (b) Second strongest bond type b (-2.58 kcal/mol); (c) Third strongest bond 
type c (-2.26 kcal/mol); (d) Fourth strongest bond type d (-2.25 kcal/mol); (e) Fifth strongest 
bond type e (-1.33 kcal/mol). 
 
The intermolecular bonding results on dominant faces for ibuprofen are dominated by 
strong bonds of -7.47 kcal/mol (van der Waals contribution of -5.25 kcal/mol is much 
higher than columbic contribution). These are hydrogen-bonded molecules between 
molecule number 1 and molecule number 3 which continue along the [010] direction so 
crystals are expected to grow more significantly in the b direction more so than in the a 
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and c direction which is in good agreement with the observed morphology. In addition, 
it was also shown that most of the strong bonds (hydrogen bonds) for the {100} face are 
inside the slice, thus Eslice for this face is high making this face one of the most 
morphologically important. The strongest bonds (type a: -7.47 kcal/mol) contributes to 
the attachment energy on the {011} face both above and below the slice centre and 
contributes to slice energy on the {001} face, which envisage the growth rate of the 
{011} face being greater than the growth rate of the {001} face. 
5.3.2 Attachment energy morphological simulation for a growth unit 
based on a dimer 
 
5.3.2.1 Force field and charges 
 
The force fields used in this work were Momany and Lifson force fields for carboxylic 
acid. The atomic co-ordinates of the resultant crystal structure of ibuprofen together 
with a set of atomic partial charges for the dimer using MOPAC with the AM1 method 
are tabulated in Table 5.9.  
 
Table 5.9 Atomic charges of two molecules for the dimer calculation  
 
Atom X Y Z Charges 
 
Atom X Y Z Charges 
1 C1 0.417 0.347 0.398 0.329 34 C1 0.583 0.653 0.602 0.329 
2 C2 0.174 -0.136 0.700 -0.103 35 C2 0.826 1.136 0.300 -0.103 
3 C3 0.099 -0.260 0.643 -0.122 36 C3 0.902 1.260 0.357 -0.122 
4 C4 0.042 -0.320 0.742 -0.187 37 C4 0.958 1.320 0.258 -0.187 
5 C5 0.138 -0.410 0.582 -0.191 38 C5 0.862 1.410 0.418 -0.191 
6 C6 0.351 0.221 0.325 -0.056 39 C6 0.649 0.779 0.675 -0.056 
7 C7 0.401 0.109 0.244 -0.168 40 C7 0.599 0.891 0.756 -0.168 
8 C8 0.304 0.125 0.421 -0.093 41 C8 0.696 0.875 0.579 -0.093 
9 C9 0.219 0.174 0.446 -0.095 42 C9 0.781 0.826 0.554 -0.095 
10 C10 0.177 0.090 0.535 -0.113 43 C10 0.823 0.910 0.465 -0.113 
11 C11 0.220 -0.045 0.604 -0.060 44 C11 0.780 1.045 0.397 -0.060 
12 C12 0.306 -0.092 0.580 -0.124 45 C12 0.694 1.092 0.420 -0.124 
13 C13 0.348 -0.009 0.490 -0.095 46 C13 0.652 1.009 0.510 -0.095 
14 H1 0.431 0.565 0.472 0.301 47 H1 0.569 0.436 0.529 0.301 
15 H2 0.218 -0.204 0.764 0.083 48 H2 0.782 1.204 0.236 0.083 
16 H3 0.145 -0.057 0.750 0.080 49 H3 0.855 1.057 0.251 0.080 
17 H4 0.055 -0.201 0.576 0.081 50 H4 0.945 1.201 0.425 0.081 
18 H5 0.087 -0.389 0.807 0.064 51 H5 0.914 1.389 0.193 0.064 
19 H6 0.018 -0.226 0.782 0.074 52 H6 0.982 1.226 0.218 0.074 
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20 H7 -0.005 -0.399 0.703 0.072 53 H7 1.005 1.399 0.297 0.072 
21 H8 0.180 -0.375 0.520 0.080 54 H8 0.820 1.375 0.480 0.080 
22 H9 0.085 -0.481 0.542 0.073 55 H9 0.915 1.481 0.458 0.073 
23 H10 0.177 -0.471 0.652 0.063 56 H10 0.823 1.471 0.348 0.063 
24 H11 0.306 0.290 0.273 0.105 57 H11 0.694 0.710 0.727 0.105 
25 H12 0.450 0.043 0.297 0.092 58 H12 0.550 0.957 0.703 0.092 
26 H13 0.422 0.181 0.181 0.073 59 H13 0.578 0.819 0.819 0.073 
27 H14 0.361 0.031 0.195 0.071 60 H14 0.639 0.969 0.805 0.071 
28 H15 0.190 0.267 0.397 0.122 61 H15 0.810 0.734 0.603 0.122 
29 H16 0.117 0.127 0.552 0.121 62 H16 0.883 0.873 0.448 0.121 
30 H17 0.340 -0.189 0.633 0.128 63 H17 0.660 1.189 0.367 0.128 
31 H18 0.408 -0.047 0.476 0.125 64 H18 0.592 1.047 0.524 0.125 
32 O1 0.380 0.494 0.416 -0.306 65 O1 0.620 0.506 0.584 -0.306 
33 O2 0.497 0.312 0.440 -0.420 66 O2 0.503 0.688 0.560 -0.420 
 
5.3.2.2 Lattice energy  
 
The calculated energy for ibuprofen for a growth unit based on a dimer is 42.95 kcal 
/mol which contribute from electrostatic and van der Waals forces (Figure 5.10). 
 
Figure 5.10 Lattice energy which is a sum of the van der Waals interaction and electrostatics 
which converges at 20 Å in the dimer calculation.  
 
It was shown that the van der Waals and coulombic intermolecular energies increase 
rapidly and converge as the limiting radius increases. This occurs at a distance of 20Å 
from the central molecule. The van der Waals interactions - 41.38 kcal/mol (≈ 96% of 
the lattice energy) contributing to the overall lattice energy were found to be much 
higher than the coulombic interactions, which was around - 1.68 kcal/mol. 
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5.3.2.3 Attachment energy and predicted morphology 
 
The calculated surface attachment energies for the individual faces are given in with the 
Table 5.10 predicted morphology, based on these values, given in Figure 5.11. 
 
Table 5.10 Attachment energies (kcal/mol) calculated for a growth unit based on a dimer  
Face Multi
plicity 
dhkl 
(A
o
) 
Eatt  
(using Momany) 
Eatt  
(using Lifson)  
Eatt (Win and Doherty) 
[159] 
100 
110 
011 
11-1 
111 
210 
002 
10-2 
21-1 
102 
20-2 
211 
012 
11-2 
310 
112 
2 
4 
4 
4 
4 
4 
2 
2 
4 
2 
2 
4 
4 
4 
4 
4 
14.47 
6.92 
6.32 
6.01 
5.60 
5.33 
5.29 
5.25 
5.00 
4.73 
4.65 
4.54 
4.39 
4.37 
4.11 
4.06 
- 8.53 
- 32.55 
- 32.21 
- 33.55 
- 32.27 
- 34.21 
- 29.59 
- 33.19 
- 34.58 
- 30.53 
- 33.68 
- 34.55 
-35.72 
-31.38 
-35.00 
-33.89 
- 9.50 
- 35.87 
- 36.59 
- 37.00 
- 35.63 
- 37.67 
- 32.45 
- 36.38 
- 38.11 
- 33.50 
- 36.97 
- 38.09 
-39.50 
-34.73 
-38.56 
37.56 
-9.59 
 
-35.20 
-35.61 
-34.23 
 
-31.45 
-35.35 
Elatt (kcal/mol) - 42.95 - 47.43  
 
   
(a)                                                                         (b) 
Figure 5.11 Predicted crystal shapes of (RS)- ibuprofen in a dimer using Momany (a); Lifson 
force field (b). 
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Both of the monomer and dimer models gave the predicted shape similar to the 
sublimation crystal with plate-like morphology, dominated by the {100} face.  
However, it showed that the dimer calculation seems to give a better prediction of 
ibuprofen morphology with the {011} face present as the dominant form to grow in the 
b axis direction which agrees with the literature published by Winn and Doherty [159]. 
Particularly, the dimer model using Momany force field provides a thinner crystal and 
more elongated in the b direction compared to the monomer model. Also, the smaller 
{110} faces appear in the dimer model. However, there were less numbers of crystal 
faces considered from the dimer calculation compared to that in this study.  
 
5.3.2.4 Analysis of the strongest bonds on the {011}, {001}, {100} and {110} faces 
 
Intermolecular bonding and the display of theses intermolecular interactions on crystal 
surfaces {011}, {001} and {100} are shown in Table 5.11 and Figure 5.12. 
 
Table 5.11 Full calculation mode analysis for the {011}, {001}, {100} and {110} faces with for 
a growth unit based on a dimer  
Bond  
type 
Multip
licity  
Dist. 
(Å)  
ATT  REP  COU  Total  
Face 
{011} 
Face 
{001} 
Face 
{100} 
Face 
{110} 
a 4 7.89 -5.96 1.82 -0.35 -4.49 (+/-) (SL) (SL) (+/-) 
b 8 6.66 -4.98 1.248 -0.21 -3.71 (SL/+/-) (+/-) (SL) (+/-/SL) 
c 8 12.99 -3.03 0.76 -0.02 -2.29 (+/-) (+/-) (SL) (SL) 
d 4 16.65 -1.69 0.33 0.00 -1.36 (+/-) (SL) (+/-) (+/-) 
e 8 16.88 -1.26 0.46 0.01 -0.79 (SL/+/-)  (+/-) (+/-) (+/-/SL) 
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(a)                                          (b) 
 
                                     (c)                                                 (d) 
(e) 
Figure 5.12 Molecular interaction of the 5 strongest bonds in (a) The strongest bond type a (-
4.49 kcal/mol); (b) Second strongest bond type b (-3.71 kcal/mol); (c) Third strongest bond type 
c (- 2.29 kcal/mol); (d) Fourth strongest bond type d (- 1.36 kcal/mol); (e) Fifth strongest bond 
type e (- 0.79 kcal/mol). 
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For growth units based on a dimer, it showed the similar trend of intermolecular 
interactions for the calculations with the growth unit based on a monomer. The 
strongest bond type (-4.49 kcal/mol) contributes to attachment energy on the {011} and 
{110} face both above and below the slice centre and contributes to slice energy on the 
{001} face and the first three strongest bonds contribute to slice energy on the {100} 
face. This indicates that the {011} face is the fast growing face and the {100} is the 
slow growing faces. 
 
The ratio of calculated attachment energy of the {011} and {001} face for the growth 
unit as a monomer and as a dimer is quite similar which is around 1.1 to 1.3 
respectively. However, the ratio of attachment energy of the {011} and {001} of 
observed crystals grown in ethanol, ethyl acetate, acetonitrile and toluene simulated 
from SHAPE software [152] are 3, 10.5; 15.2; and 16.5  respectively. It showed 
discrepancies between the attachment energy values in the vacuum morphology and the 
experimental morphology. The attachment energy of the {011} is much greater than that 
of the {001} face in these solvents, which was linked to the relative growth rate and the 
crystal habit surface chemistry analysis and to the dominant synthons on the {001} and 
{011} face and the surface synthon analysis provided in the previous section.. 
 
Interfacial angles of dominant faces of grown ibuprofen crystals and of predicted 
morphology was measured from optical micrographs to allow indexing of the faces on 
the experimental morphology (Figure 5.7) for the measurements of the crystal growth 
rate of the individual faces. It showed the interfacial angles on the dominant faces of 
grown ibuprofen matched those calculated from morphological prediction. The {011} 
faces were obviously present in growth solution morphology. However, the crystals 
were lying flat on the {001} face and the crystals were too thin for identification of the 
{011} and {-111} face.  
 
5.4 Detailed surface chemistry analysis of the {001}, {011}, 
{100} and {110} face 
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The chemistry analysis for the crystal habit faces {001}, {011}, {100} and {110} was 
performed to examine the crystal surface chemistry of these important faces. Molecular 
packing on the {001} face shows a non-polar property with -CH3 groups projecting out 
of the surface. The –COOH groups are quite restricted in position and the hydrogen 
bonds formed between -COOH groups are only in one direction (Figure 5.13). The 
cleaved surface revealed the hydrogen bonds formed contribute to construct a crystal 
lattice which agrees with the analysis of the strongest bonds on the ibuprofen crystal 
surface of the {001} face where bond a (the hydrogen bonds) and bond c contribute to 
lattice energy whilst bond b and d contribute to attachment energy.  
 
  
(a)                                                   (b)  
Figure 5.13 Molecular packing diagrams based upon the crystallographic structures of the {001} 
face viewed along the y axis (a) and along the x axis (b) showing its hydrophobic nature with –
CH3 groups exposed at the surface with the –COOH groups exposed in one direction and in a 
quite restricted position. 
 
The {011} face is more polar and –COOH groups on the {011} face are more exposed 
and more easily accessible than –COOH groups on face {001}. The intermolecular 
hydrogen bonds appear in two different directions (see Figure 5.14) contributing to slice 
energy and attachment energy resulting in much faster growth compared to the {001} 
crystal face. This fact can be used to envisage or rationalise the relative growth rate of 
the {011} and {001} face. As the {011} face exhibits great hydrophilicity on which 
carboxylic acid groups provide good binding sites for polar solvent molecules which are 
more easily accessible to form hydrogen bonds. 
 
 
x 
z z 
y 
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Figure 5.14 Molecular packing diagrams based upon the crystallographic structures of the {011} 
face viewed along the x axis (a) and along the y axis (b) showing a more polar surface with 
exposed –COOH groups at the surface with two different directions. 
 
Figure 5.15 shows the molecular model of the {100} crystal surface of ibuprofen which 
has layers of dimers formed by hydrogen-bond between carboxylic groups.  The surface 
possesses two different natures as the molecular arrangements have two distinct 
molecular structure terminations, which can be either polar (with –COOH groups) or 
non-polar (with alkyl-groups). The approach associated with two modes of termination 
of the {100} face for ibuprofen crystals. Carboxylic acid groups projecting out from the 
surface are free to interact with solvent molecules in surrounding environment so the 
adsorption of solvent on the crystal surface may inhibit the growth rate of face {100}. 
Interactions of the alkyl portions of neighbouring layers result in weak attachment 
energy. Hence, this face is predicted to be a slow growing face. 
 
  
Figure 5.15 Molecular packing diagrams based upon the crystallographic structures of the {100} 
face viewed along the x axis (a); viewed along the y axis (b). 
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The {110} face exposed with -COOH groups and alkyl groups shows intermolecular 
hydrogen bonds appearing in different directions. COOH groups on the {100} face are 
more exposed and more accessible. Hydrogen bonds are involved both in the formation 
of a crystal lattice and in the attachment of the crystal lattice on the crystal habit surface 
(Figure 5.16). This agrees with the analysis of the strongest bonds on the ibuprofen 
crystal surface of the {110} face. 
 
  
Figure 5.16 Molecular packing diagrams based upon the crystallographic structures of the {110} 
face viewed along the x axis (a) and viewed along the y axis (b). 
 
The surface chemistry analysis for the dominant crystal habit faces was carried out to 
relate to the bonding analysis on these faces and envisage and/or to rationalise the 
growth rate of face {001} and {011} in chapter 7. Surface chemistry analysis, where the 
properties of the surfaces (e.g. hydrophobicity, polar or hydrogen-bonded) was 
examined and from this, relative qualitative binding interactions between solvents and 
solute and the associated inter-molecular interaction on specific growing faces can be 
analysed to interpret the growth rate . For example, polar solvents are found to inhibit 
the growth rate of faces which contain available binding sites for hydrogen bond 
formation. Hence, ibuprofen morphology grown from solvents can be explained by 
molecular arrangement at the {011} and {001} surface and hydrogen bonds can be 
formed between solvents and COOH functional groups of ibuprofen. It can be predicted 
that the {100} is a very slow growing face, and the {011} face grows faster than the 
z 
y 
z 
x (a) (b) 
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{001} faces; however the relative growth rate between {011} and {001} depend on the 
growth environments. 
 
5.5 Conformer population in solutions 
The 10 optimized ibuprofen conformations using GGA/PBE/DNP/COSMO calculations 
(PBE functional and DNP basis set) in Dmol3 are shown in Figure 5.17. 
 
                 Conformer 1                                                    Conformer 2 
 
                 Conformer 3                                                   Conformer 4 
 
                 Conformer 5                                                    Conformer 6 
 
                 Conformer 7                                                    Conformer 8 
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                     Conformer 9                                                    Conformer 10 
 
Figure 5.17 10 lowest energy and optimised conformers were chosen for the conformational 
distribution study. 
 
The conformation distribution of the 10 conformer in ethanol, ethyl acetate, acetonitrile 
and toluene at 25
o
C are shown in Table 5.12. 
 
Table 5.12 Percentage of ibuprofen conformer in solvents (%) calculated from COSMOtherm 
software package  
Conformer Ethanol Ethyl acetate Acetonitrile Toluene 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
4.27 
19.77 
5.55 
19.69 
4.87 
2.1 
17.77 
1.63 
6.65 
17.69 
4.27 
21.12 
4.52 
21.5 
3.93 
2.62 
18.2 
1.71 
5.49 
16.63     
4.29 
20.60 
4.98 
20.32 
4.31 
2.50 
17.70 
1.84 
5.82 
17.64 
4.30 
20.87 
4.46 
21.47 
3.90 
2.73 
18.26 
1.74 
5.46 
16.80 
 
 
There was no significant solvent effect on the conformer distribution in different 
solvents. The population of four conformers (conformer 2, 4, 7 and 10) has a highest 
percentage in the range of 17-21% in all four solvents compared to other conformations 
in the population. There were only a very slightly change in the percentage of the 
conformer 2, 4, 7 and 10 in different solvents (Figure 5.18).  The torsion angles of 
favoured conformations of ibuprofen in all solvents are shown in Table 5.13. This 
indicates there is no conformational polymorphism in different solvents for ibuprofen.  
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Figure 5.18 Population of four conformers (2, 4, 7 and 10) in solvents. 
 
Table 5.13 Torsion angles of preferred conformations in solutions 
Conformer T3 T4 T5 T8 
2 
4 
7 
10 
-168.83 
-168.83 
-168.83 
-168.83 
-101.75 
78.25 
-101.74 
78.25 
-83.24 
-83.24 
96.75 
96.75 
146.16 
146.16 
146.16 
146.16 
 
This methodology has also been used for calculation of conformation populations of 
form A and B of famotidine, tatireline, ritanovir and S-ibuprofen [160] showing relative 
conformation distribution can be used to predict conformational polymorphs based on 
the trend of conformation distribution in different solvents. For example, form B of 
famotidine was found in water solution with high initial concentration independence of 
cooling rate whilst form A of famotidine was recrystallised from methanol and 
acetonitrile. The calculated population of conformer A and B in these solvents revealed 
that conformer A presents the highest population in methanol and acetonitrile and 
conformer B has the highest population in water. Furthermore, this method can be used 
for solvent screening and selection based on the relative population of conformers in 
solvents. 
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5.6 Conclusions 
 
This chapter reported a modelling study applied to examine the conformation of an 
isolated molecule, the morphology, intermolecular interactions and crystal habit surface 
chemistry for ibuprofen. CONFORMER in Material Studio was successful in analysing 
the flexibility of the ibuprofen molecule. The energy of a free molecule before and after 
geometry optimisation does not change much indicating ibuprofen is a rigid molecule. 
The molecule is located within a minimum energy space or is close to the minimum 
energy in the energy map which is a validation for the known crystal structures of a 
given molecule in the CSD.  
 
The calculated values of lattice energy based on a monomer growth unit of -28.9 
(kcal/mol) revealed a reasonable agreement with the experimental lattice energy 
calculated from the heat of sublimation for ibuprofen of 30.10 kcal/mol [136]. The 
simulated crystal habit for ibuprofen revealed a prismatic plat-like crystal shape, shown 
to be in good agreement with expected shapes from experimental observations and 
previous studies [5, 136]. The habit prediction for racemate-ibuprofen revealed a flat 
crystal morphology with predominance of the {001} crystal habit face.  Both of the 
Momany and Lifson force fields gave a good prediction for the ibuprofen morphology 
in vacuum.  
 
Both of the monomer and dimer models gave the predicted shape similar to the 
sublimation crystal with plate-like morphology, dominated by the {100} face.  
However, the dimer model using Momany force field provides the better predicted 
morphology, a thinner crystal and more elongated in the b direction compared to the 
monomer model. The smaller {110} faces appear in the dimer model. 
 
From atom-atom bond analysis, carbonyl oxygen (C=O) and hydroxyl hydrogen (O-H) 
atoms were found to account for the highest energy per atomic site in the lattice energy.  
The strongest intermolecular interactions are hydrogen bond chain O---H. Intermo-
lecular bonding analysis revealed the strength and direction of the strongest bonds on 
each of the {011}, {001} and {100} surface which was used to rationalise and validate 
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the growth rates of the {011}, {001} and {100} faces (reported in chapter 7). The 
strongest bonds are the hydrogen bonds which contribute to the attachment energy on 
the {011} face and to the slice energy on the {001} face, which verifies the growth rate 
of the {011} face is greater than the growth rate of the {001} face. Most of the strongest 
bonds located on the {100} face are inside the slice thus this face is one of the most 
morphologically important. The strength and direction of hydrogen-bonds was also 
viewed through Material Studio. Moreover, cleaving the surfaces of these faces were 
also shown as validation, by analysing the properties of the surfaces e.g. 
hydrophobicity, polarity or hydrogen-bonded and relative binding interactions between 
solvents and solute and the associated inter-molecular interactions involved on specific 
growing faces. 
 
The attachment energy model used in this chapter takes into account the effect of crystal 
internal structure on the morphology; however these predictions can be improved by 
taking into account the crystallising environment (such as solvents, supersaturation 
etc.). Both of the models (monomer and dimer) did not predict accurately the solvent-
grown shapes. Hence, prediction of ibuprofen morphology in growth solutions using 
systematic grid search should be performed to compare with the experimental crystals. 
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6 Crystallisation process 
characterisation and analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
Polymorph screening, solubility determination, and the nucleation kinetics of ibuprofen 
in ethanol 95%, ethyl acetate, toluene and acetonitrile were examined involving MSZW 
and induction time measurements. 
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6.1 Introduction 
 
Polymorphism screening, solubility determination and assessment of nucleation kinetics 
are all important components for characterising crystallisation behaviour. To study the 
crystal growth kinetics of ibuprofen, it is essential to measure the solubility together 
with nucleation kinetics associated with the crystallisation behaviour of ibuprofen. From 
solubility data, supersaturation, a concentration driving force for the crystallisation 
process, a fundamental and key parameter in designing and controlling the 
crystallization process in terms of product yield and the nucleation and crystal growth 
rates can be calculated. In addition, solubility is a very important parameter to the 
understanding and study of nucleation manners.  
 
Hence, this chapter presents the results of the polymorph screening, and then the 
solubility measurement for ibuprofen in ethanol 95%, ethyl acetate, acetonitrile and 
toluene measured by ATR UV/Vis spectroscopy, which will be used to calculate the 
supersaturation of solutions. Solubility data are also discussed from the perspective of 
molecular aspects of solute-solvent interactions and van‟t Hoff plots to assess if it is 
ideal or non-ideal solubility in these solvents, activity coefficients were also calculated 
for each solvent to reveal the affinity of the ibuprofen molecule to solvent molecules. 
The basic kinetics parameter, the MSZW and induction time were also obtained through 
polythermal (slow cooling) and isothermal (crash cooling) methods, respectively. The 
polythermal experimental results were associated with the empirical relationship 
between the undercooling temperature and the cooling rate derived by Nyvlt [58] to 
determine nucleation parameters such as the nucleation order and the nucleation 
constant. Another crucial parameter in nucleation theory is the interfacial energy 
between the nucleus and liquor surrounding environment within the concept of classical 
homogeneous nucleation theory which can be estimated from the isothermal 
experimental results showing the relationship of induction time and supersaturation.  
 
6.2 Polymorphism screening 
 
Polymorphism screening was performed to verify whether different polymorphic forms 
appear in different solvents following recrystallisation at room temperature.  The 
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melting points and enthalpy of melting of ibuprofen crystals recrystallised from various 
solvents are reported in Table 6.1 and Figure 6.1. 
 
Figure 6.1 DSC data of ibuprofen raw material together with ibuprofen recrystallised from 
solvents showing similar melting points and melting peak shapes. 
 
Table 6.1 DSC data: onset of melting point, melting point peak and enthalpy of fusion 
Solvents Polarity Onset of 
melting point 
(°C) 
Melting 
peak 
(°C) 
ΔHfus 
(kJ/mol) 
Methanol 
Ethanol 
Propanol 
Acetonitrile 
Ethyl acetate 
Acetone 
Diethyl ether 
Hexane 
Isopropyl ether 
Toluene 
Xylene 
Ibuprofen  
Polar protic 
Polar protic 
Polar protic 
Polar aprotic  
Polar aprotic 
Polar aprotic 
Non-polar 
Non-polar 
Non-polar 
Non-polar 
Non-polar 
74.51 ± 0.5 
74.51 ± 0.3 
74.52 ± 0.5 
75.62 ± 0.4 
74.93 ± 0.3 
75.43 ± 0.5 
75.30 ± 0.7 
75.34 ± 0.7 
75.46 ± 0.6 
75.02 ± 0.4 
74.56 ± 0.5 
75.25 ± 0.5 
76.13 ± 0.4 
76.13 ± 0.5 
75.72 ± 0.3 
77.05 ± 0.4 
77.41 ± 0.5 
76.68 ± 0.4 
76.46 ± 0.4 
76.29 ± 0.3 
77.12 ± 0.4 
77.81 ± 0.5 
76.59 ± 0.4 
77.30 ± 0.4 
24.01 ±  0.5 
23.87 ± 0.4 
25.97 ± 0.4 
24.45 ± 0.5 
25.43 ± 0.3 
25.84 ± 0.4 
23.73 ± 0.5 
23.58 ± 0.5 
26.21 ± 0.5 
24.21 ± 0.4 
25.39 ± 0.5 
25.28 ± 0.3 
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Based on the onset of melting points and melting peaks given by DSC, it is can be 
concluded that there is no polymorphism in ibuprofen recrystallised from various 
solvents which agrees with previous studies [137]. There were single melting peaks and 
no other endotherms or transitions were observed as illustrated in Figure 6.1.  The 
onsets of melting points are around 74.5
o
C - 75.6
o
C, melting peaks are in the range 
75.7
o
C - 77.8
o
C and the value of enthalpy of fusion 23.8 - 26.2 kcal/mol. From the data 
published, the molar enthalpy were to be 26.65 kJ mol
-1
 obtained by adiabatic 
calorimetry [161] and 25.5 kJmol
-1
 from DSC [162, 163]. There was a small difference 
in the melting point and heat of fusion between ibuprofen crystals recrystallised from 
different solvents. This may be due to a difference in the degree of structural order 
within the samples, the variance of degree of structural perfection when recrystallised 
from different solvents and/or samples were not completely free from solvents. 
 
It is likely that only the external shape of the ibuprofen crystal exhibits morphological 
changes from prisms to needle-like and plate-like [135, 136] which is affected by the 
different growth rates of the individual faces, without changing the internal structure. 
The only known crystal structure for ibuprofen has been published [130] with the 
exception of an evidence for a new crystalline phase of (RS)-ibuprofen [131], however 
the crystal structure has still not been revealed yet.   
 
6.3 Solubility measurements 
 
In this study the solubility of (RS)-ibuprofen in ethanol 95%, ethyl acetate, acetonitrile 
and toluene measured by ATR/UV-Vis spectroscopy at the range temperature range of 
10, 15, 20, 30, and 35°C are reported. Spectra of ibuprofen in solvents at various 
concentrations are shown in Figure 6.2. Calibration curves for ibuprofen in three 
solvents were obtained using the specific absorbance peak of ibuprofen at 264 nm 
(Figure 6.3). 
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Figure 6.2 Spectra of ibuprofen in ethanol 95%, ethyl acetate and acetonitrile showing 
absorbance at 264 nm increase with increasing concentration of solutions. 
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Figure 6.3 Calibration curves were obtained from the absorbances at 264 nm of the known 
concentration solutions. 
 
 
The Beer-Lambert law states that the absorbance of a solution is directly proportional to 
the concentration of the absorbing species in the solution and the path length. Hence, 
ATR UV/Vis spectroscopy was employed to determine the concentration of ibuprofen 
in a solution for a fixed path length. The calibration curve of ibuprofen was determined 
by measuring the specific absorbance peak of ibuprofen at 264nm versus a range of 
concentrations with the fitting parameters summarised in Table 6.2. 
 
Table 6.2 Calibration line of ibuprofen in ethanol 95%, ethyl acetate and acetonitrile at 
temperature from 15-35
o
C  
Solvents Calibration line 
Ethanol 95% 
Ethyl acetate 
Acetonitrile 
y = 0.0823x – 0.013 
y = 0.0786x – 0.0034 
y = 0.0503x + 0.0017 
 
 
Using these calibration curves, the solubility of ibuprofen in solvents over the 
temperature range 15-35
o
C was calculated from the measured ATR UV/Vis curves. 
These ibuprofen solubility values (g/ml) in ethanol, ethyl acetate and acetonitrile were 
then fitted by polynomial functions which obey the above equations for the temperature 
range 15-35
o
C.  
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Figure 6.4 Spectra of ibuprofen in ethyl acetate showing solubility increase with increasing 
temperature and λmax does not shift with temperature. The λmax was not found to shift even in 
different solvents and concentration nor even as a function of temperature.  
 
From the absorbance of saturated solutions and the obtained calibration curves, the 
solubility of ibuprofen in ethanol, ethyl acetate, acetonitrile (using ATR UV/Vis 
spectroscopy) and toluene (from gravimetric method) was calculated and shown in 
Table 6.3. 
           
Table 6.3 Solubility of ibuprofen in ethanol, ethyl acetate, acetonitrile and toluene (g/ml) 
T (
o
C) Ethanol 95% Ethyl Acetate Acetonitrile Toluene 
15 
20 
25 
30 
35 
0.54 ± 0.011 
0.65 ± 0.007 
0.78 ± 0.011 
0.98 ± 0.029 
1.26 ± 0.009 
0.38 ± 0.009 
0.45 ± 0.005 
0.59 ± 0.005 
0.72 ± 0.007 
0.94 ± 0.053 
0.09 ± 0.001 
0.12 ± 0.001 
0.19 ± 0.006 
0.28 ± 0.009 
0.40 ± 0.005 
0.31 ± 0.001 
0.40 ± 0.000 
0.51 ± 0.002                          
0.65 ± 0.001 
0.82 ± 0.015 
 
 
The theoretical solubility of ibuprofen in ethanol 95%, ethyl acetate, acetonitrile and 
toluene were calculated based on the Hilderbrand equation assuming ideal solution 
behaviour and compared to the data collected from experiments. The onset of melting 
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point temperature was obtained by DSC in section 6.2. The enthalpy and entropy of 
dissolution of Ibuprofen in various solvents were calculated; summarised in Table 6.5. 
The solubility of ibuprofen is high in ethanol, ethyl acetate and toluene and low in 
acetonitrile which can be rationalized on the basis of solvent polarity and the like- 
dissolves-like rule of thumb. e.g. a non-polar compound will be dissolved by non-polar 
solvents and vice versa. The polarity can be based on the dipole moment parameter. 
Ibuprofen is an organic compound with medium polarity due to the presence of both 
polar (-COOH group) and non-polar portions (benzene ring and substituted group -C2H6 
attached to benzene ring). The dipole moment of ethanol, ethyl acetate and toluene is 
lower than that of acetonitrile (shown in Table 6.5) thus ibuprofen has a higher 
solubility in ethanol, ethyl acetate and toluene than in acetonitrile (Table 6.3).  
 
 
The theoretical solubility of ibuprofen in ethanol 95%, ethyl acetate, acetonitrile and 
toluene were calculated based on the van‟t Hoff equation assuming ideal solution 
behaviour and compared with the data collected from experiments. The solubility of 
ibuprofen in ethyl acetate, ethanol 95%, acetonitrile and toluene have a discrepancy 
from the ideal behaviour with the experimental solubility. In the ideal case, the 
solubility is independent of the chemical composition of the solvent since the solute-
solute, solvent-solvent and solute-solvent interaction are equal so there is no favour of 
any particular interaction and enthalpy of mixing is zero. However, in the less than ideal 
case of acetonitrile, it is shown that the intermolecular interaction energy between two 
solute molecules is stronger than between solvent and solute molecules. The enthalpies 
of solutions are all positive so they are endothermic in all cases. The solubility of a 
solute is determined by the properties in equilibrium with the solvents and the 
conditions for the solute in solution.  
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             : ideal solubility                    : Ethanol 95%                         : Ethyl Acetate        
            : Acetonitrile                     : Toluene 
Figure 6.5 Polynomial regression lines of the solubility of ibuprofen in ethanol, ethyl acetate, 
acetonitrile and toluene at temperatures from 15-35°C (left); and plot of 1/T versus lnX of the 
ideal solubility and the real solubility (right). 
 
The activity coefficient γ as a function of temperature is shown in Table 6.4. The values 
of γ in acetonitrile are from 3.57-7.69 which is higher than that in ethanol, ethyl acetate 
and toluene. When examining the solubility of a solute in different solvents, the activity 
coefficient completely accounts for the effect of solvent [162]. Ibuprofen is found to 
behave differently in various solvents according to the values of γ. In acetonitrile, where 
γ values are much greater than 1.0, the solution behaviour becomes more nearly ideal as 
the temperature increases. The high values of γ in acetonitrile are due to a consequence 
of weaker interactions between ibuprofen molecules and acetonitrile, whereas the 
almost ideal values of γ in ethyl acetate, ethanol and toluene are due to stronger 
interactions between ibuprofen and these solvent molecules. This indicates that 
ibuprofen molecules generally do not exhibit much affinity for acetonitrile or maybe 
rather that acetonitrile does not have affinity for ibuprofen molecule. Therefore, the 
results presented here, as well as those presented previously [164], support the fact that 
ibuprofen is principally a lipophilic compound. 
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Table 6.4 Calculated activity coefficients of ibuprofen in various solvents as a function of 
temperature 
Activity Coefficients γ 15 20 25 30 35 
Ethanol 95% 
Ethyl Acetate 
Acetonitrile 
Toluene 
1.41 
1.05 
7.60 
1.24 
1.42 
1.09 
6.84 
1.22 
1.44 
1.05 
4.95 
1.18 
1.40 
1.07 
4.24 
1.15 
1.35 
1.04 
3.57 
1.14 
   
The solubility data were validated either from the gravimetric method or from the 
literature. Possible uncertainties in the solubility measurements in this study could be 
due to the errors in the weighing materials, evaporation of solvents when dissolving the 
materials, variations in water bath temperature when preparing the saturation solution 
and any incomplete settling of the excess ibuprofen solids in the gravimetric method. 
However, the solubility and activity coefficient of ibuprofen measured in this study is 
quite similar with literature data [162, 165]. 
 
 
Figure 6.6 Comparison of the solubility (a) in ethanol; (b) in ethyl acetate; (c) in toluene; (d) in 
acetonitrile in this study with published data. 
 
There are a few solubility data of ibuprofen in the solvents studied are available in the 
literature but they are obtained from the gravimetric method which consumes more time 
and labour compared to using the ATR UV/Vis spectroscopy. Solubility data for 
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ibuprofen in absolute ethanol [5, 158, 162, 166] and a mixture of ethanol and water 
[158, 166] are available in the literature.  
 
Table 6.5 Enthalpy of dissolution, ∆H, and entropy of dissolution, ∆S, derived from solubility 
data, together with calculated activity coefficient and temperature dependence fitting parameter. 
Logarithm of activity coefficients of as a function of saturation temperature (Lnγ = aT + b) 
 
Solvents Ethanol 95% Ethyl Acetate            Acetonitrile Toluene 
Dipole moment 
Solubility (g/ml) 20
o
C 
∆H (KJ/mol)       
∆S (KJ/K-1mol-1)   
 γ (T = 15-35oC)   
        a             
        b 
1.69 
0.65 
25.23 
0.07 
1.35-1.44 
-0.002 
0.3897 
1.78 
0.45 
26.16 
0.075 
1.04-1.09 
-0.0008 
0.077 
3.92 
0.12 
53.76 
0.154 
3.57-7.60 
-0.0398 
2.6482 
0.36 
0.4 
27.6 
0.08 
1.14-1.24 
-0.0045 
0.2837 
 
6.4 Polythermal crystallisation as a function of solvent 
 
The polythermal crystallisation of ibuprofen in ethanol (1.4g/ml and 0.98g/ml), ethyl 
acetate (0.72g/ml), acetonitrile (0.28g/ml), and toluene (0.65g/ml) as a function of 
solution cooling/heating rate were carried out to investigate the MSZW. The raw data of 
MSZW measurements for ibuprofen in ethyl acetate, acetonitrile and toluene are shown 
in Appendix A1.  
 
The crystallisation temperature for ibuprofen in ethanol 95% at the different 
concentrations 1.4 (g/ml) (Tsat ≈ 38
o
C) and 0.98 (g/ml) (Tsat ≈ 30
o
C) was not obtained 
since the solutions barely crystallised at the cooling rates 0.1; 0.2; 0.3; 0.4 and 
0.5°C/min (see Figure 6.7).  
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(a) 
 
 
(b) 
                            : Temperature;                     : transmittance 
Figure 6.7 Experimental polythermal data for ibuprofen in ethanol 95% solution illustrating that 
(a) ibuprofen (1.4g/ml) does not crystallise under polythermal crystallisation at a 
heating/cooling rate of 0.1
 o
C/min when cooling from 55
o
C to -15
o
C; (b) ibuprofen (0.98g/ml) 
does not crystallise under polythermal crystallisation at heating/cooling rate 0.5
o
C/min when 
cooling down from 50
o
C to -15
o
C.  Crystallisation only occurs during the hold segment of the 
program i.e after the cooling stage is complete. 
 
It was also shown that the less concentrated solution (0.98g/ml) was likely to have 
higher probability to nucleate than the more concentrated solution (1.4g/ml). This 
perhaps reflects the fact that the solutions in ethanol require longer induction time for 
cluster aggregation and to form the nuclei which can grow into crystals. 
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Figure 6.8 Plots of the dissolution and nucleation on-set temperatures for ibuprofen in ethyl 
acetate (0.72g/ml), acetonitrile (0.28g/ml), and toluene (0.65g/ml) as a function of solution 
cooling/ heating rate. The dissolution and crystallisation temperature are determined from the 
intercepts. 
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The plots of temperature versus the cooling rates are presented in Figure 6.8 showing 
the dissolution/crystallisation temperature dependency on the heating and cooling rates. 
The undercooling temperature decreases with decreasing heating/cooling rate. The 
MSZW is a parameter to indicate how deep the solution has to be undercooled before 
the nucleation process starts to occur. It is quite obvious with slow cooling rate, the size 
of clusters in solution can follow the change in the solution state so that the MSWZ is 
narrower; whilst the structure changes in solution are slower than the change of the 
temperature with the rapid cooling (high cooling rate) so the MSZW becomes wider 
[96]. Table 6.6 summarises the MSZW of ibuprofen in ethyl acetate, acetonitrile and 
toluene and the relationship between Log(b) vs Log (ΔT). 
 
Table 6.6 MSZW of ibuprofen in ethyl acetate, acetonitrile and toluene solutions and the 
relationship between Log(b) vs Log (ΔT) 
Solvents Tdis (
o
C) Tcrys (
o
C) MSZW (
o
C) Log(b) vs log (ΔT) 
Ethyl acetate 
Acetonitrile 
Toluene 
31.2 
30.9 
31.8 
18.2 
17.2 
21.8 
13.0 
13.7 
10.0 
y = 1.549x – 2.54 
y = 3.268x – 4.563 
y = 0.939x – 1.700 
 
The MSZW is not very big compared to many pharmaceutical compounds. It was also 
shown that the slopes of dissolution and crystallisation temperature lines are rather flat 
suggesting the intrinsic barrier but it does not really depend on cooling/heating rates. 
 
It was seen that the dissolution temperature does not fluctuate much while 
crystallisation temperature is quite susceptible to the cooling or heating rate. The 
crystallisation temperature generally decreases with increasing cooling rate. It can be 
elucidated by the assumption that the higher the cooling rate is, the formation of nuclei 
and clusters are expected to occur faster due to high supersaturation being reached 
quickly. A large number of smaller and unstable nuclei are generated which are likely to 
dissolve or rearrange themselves to achieve the stable crystals. On the contrary, the slow 
cooling with lower cooling rate is associated with the lower rate of supersaturation 
production. Hence, it is possible that there are a small amount of nuclei which possess 
excess the critical size and these nuclei grow directly into mature crystals, which results 
in nucleation occurring at a higher temperature.  
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In this study the crystallisation temperature of ibuprofen in these solvents was found to 
be quite scattered due to the high solubility of ibuprofen in organic solvents. Solutions 
were very viscous, in particular in ethanol, resulting in higher interfacial tensions and 
potentially unstable nucleation. Any foreign material or the molecular ordering or 
embryo still present somewhere in the reactor such as the cap of crystallisers or the wall 
of the reactor, or the stirrer can cause heterogeneous nucleation. Thus it is difficult to 
state which solvent produces the widest MSZW. In summary it can be concluded that 
the MSZW of ibuprofen is from 10
o
C to 13.7
o
C. Ibuprofen in toluene has a smallest 
MSZW and in ethanol scarcely crystallises even though experiments were implemented 
at two different concentrations (1.4g/ml and 0.98g/ml). 
 
The polythermal (slow cooling) crystallisation experiments were performed on 
Ibuprofen systems to find the kinetics of the nucleation process including nucleation 
order and nucleation constant from the Nyvlt equation and MSZW. The nucleation 
order determined by the slope of these straight lines is 1.55, 3.27 and 0.94 in ethyl 
acetate, acetonitrile and toluene respectively which indicated that ibuprofen nucleated 
easier in toluene and ethyl acetate solutions than in acetonitrile solutions. 
 
6.5 Isothermal crystallisation as a function of solvent 
 
The raw data of induction times of ibuprofen in acetonitrile, toluene, ethanol 95% and 
acetonitrile are shown in Appendix A2. An example of induction of ibuprofen in 
acetonitrile is shown in Figure 6.9. 
 
Figure 6.9 An example of the measured induction time of ibuprofen in acetonitrile (0.4g/ml) at 
S = 6.86. 
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The induction time experiments were repeated in many isothermal crystallisation runs 
and summarized in Table 6.7 and Figure 6.10.  
 
Table 6.7 Induction times of acetonitrile, toluene, ethanol 95% and ethyl acetate 
Acetonitrile 
T S Induction time (mins) Average 
-5
o
C 24.9 25; 26; 76 42.3 ± 29.2 
0
o
C 15.9 52; 83; 85, 98; 109 and 107 89 ± 21.1 
5
o
C 10.4 76; 101; 102; 112; 142; 197 121.7 ± 42.6 
10
o
C 6.86 99; 113; 134; 160; 173; 263; 295 176.7 ± 74.9 
Toluene 
T S Induction time (mins) Average 
0
 o
C 5.52 20; 31; 35; 38 31± 7.9 
5
o
C 4.84 34; 87; 92; 115; 135; 136; 161 108.6 ± 41.9 
10
o
C 3.84 38; 41; 45; 46; 56; 142; 48; 55 55.9 ± 34.2 
15
o
C 2.91 91; 98; 110; 112; 135; 141; 168; 173 128.5 ± 30.9 
 
Ethanol 95% 
T(
o
C) S  Induction time (mins) Average 
0
o
C 5.02 42; 117; 208; 222; 27; 324 156.7 ± 115.3 
5
o
C 4.04 94; 49; 289; 489; 580 300.2 ± 234.3 
10
o
C 3.26 424; 608; 140; 205; 834; 967; 101; 679 494.8 ± 328.4 
Ethyl acetate  
T(
o
C) S Induction time (mins) Average 
15
o
C 2.68 12; 18; 48; 107; 34; 38; 82; 96 54.4 ± 36.4 
20
o
C 2.14 70; 99; 82; 19 67.5 ± 34.5 
25
o
C 1.71 73; 124; 262; 104 140.8 ± 83.5 
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Figure 6.10 Induction time of acetonitrile, toluene, ethanol 95% and ethyl acetate at different 
supersaturation ratios. 
 
The isothermal (crash cooling) crystallisation experiments for the ibuprofen system was 
attempted to investigate the induction time. From the data it is apparent that the 
induction times increase, as expected, with higher temperatures (lower supersaturations) 
and vice versa. Comparing the MSZW and induction time data, it is likely that 
ibuprofen in toluene and ethyl acetate solvents would have a smaller MSZW and 
induction time when compared to acetonitrile and ethanol. However, the data has high 
variation in all systems, very large for the ethyl acetate and ethanol 95% systems so 
many repetitions should be carried out to obtain probability distributions of induction 
times in the cases of ethanol 95% and ethyl acetate. Similarly, the induction period of 
aqueous solution of KCl scattered rather large [167] which is often found and arise from 
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the stochastic character of nucleation. This is anticipated as nucleation is considered to 
be a random stochastic process [26]. Jiang and ter Horst [168] have developed a method 
for determination of nucleation rates from an examination of the cumulative probability 
distributions of induction times in agitated solutions due to the stochastic nature of 
nucleation process; this reflects the variation of the nucleation time. The appearance of a 
nucleus can be considered as a random process at a constant supersaturation level. The 
effective nucleation rate varies so widely from one sample to another, defining a typical 
nucleation rate or time is not trivial. Hence, a measure of the average nucleation time or  
the distribution of induction time might be required [169].  
 
Ibuprofen in ethanol 95% is a viscous solution. High viscosity has a tendency to prevent 
nucleation [96]. Therefore, high viscosity results in less freedom and space for solute 
molecules to diffuse and aggregate together to form molecular clusters and then nuclei 
in supersaturated solutions according to classical nucleation theory. Myerson et al. [170, 
171] measured the diffusion coefficients in a number of systems in aqueous 
supersaturated solution. The diffusion coefficient was shown to decrease rapidly with 
increasing concentration in the supersaturated region.  
 
Hence, in this study the viscosity of supersaturated solution was examined as a function 
of solvents and temperatures at the temperature range 20
o
C-50
o
C using the Bohlin 
Gemini rheometer and viscosity calculated using the Newtonian model fit is presented 
in Figure 6.11. 
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Ethanol 95% 1.4g/ml : Tsat = 38°C 
Ethanol 95% 0.98g/ml, ethyl acetate 0.72 g/ml, acetonitrile 0.28g/ml and toluene 0.65g/ml: Tsat 
≈ 30°C 
Figure 6.11 Viscosity of ibuprofen solution examined as a function of solvents and temperature. 
 
It is clearly shown that the saturated solutions at T = 30
o
C of ibuprofen in ethanol 95% 
(0.98g/ml) has much higher viscosity compared to ibuprofen in ethyl acetate (0.72g/ml), 
acetonitrile (0.28g/ml) and toluene (0.65g/ml) solutions. The higher concentration of 
ibuprofen in ethanol shows a much higher viscosity. The system has demonstrated 
whilst viscosity of ibuprofen in ethanol showed a strong dependence on temperature, 
viscosity in ethyl acetate, acetonitrile and toluene are quite similar and showed less 
dependence on temperature. The viscosity of ibuprofen in ethanol increased 
significantly when the solution was cooled down to 30-20
o
C (see Figure 6.11) which 
might result in increasing difficulty of the solutions to crystallise at low temperature at 
any cooling rate 0.1-0.5
o
C/min and the less concentrated solutions in ethanol associated 
with the lower viscosity have a higher probability to nucleate than the more 
concentrated solutions. 
 
The interfacial energy, a parameter involving the growing crystal and the surrounding 
mother liquor, can be estimated from a plot of lnηind versus T
-3
(lnS)
-2
. This uses equation 
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2.26 in chapter 2 with the molecular volume of ibuprofen taken as 306Å
3 ≈ 3.06*10-28 
m
3
 (the volume of a unit cell V = 1224.54
 
Å
3 
and the number of molecules in a unit cell 
Z = 4; assuming 4 molecules occupied the whole volume of the unit cell and from this 
the volume of an ibuprofen molecule was calculated); the Boltzmann constant K = 
1.3805*10
-23
J/K. The calculated interfacial energy from the slopes of the straight lines 
is shown in the Figure 6.12 and results in the value shown in Table 6.8 and the plots of 
the dependence of the size of the critical nucleus as a function of temperature and 
supersaturation are shown in Figure 6.13. 
 
Figure 6.12 Plot of lnηind versus T
-3
(lnS)
-2 
of ibuprofen in 4 solvents. Interfacial tension can be 
calculated from the slope of the line. 
 
 
Table 6.8 The interfacial energy calculated from the slopes of the straight lines Lnηind versus T
-
3
(lnS)
-2
 
 Lnηind versus T
-3
(lnS)
-2
 Interfacial energy (J/m
2
) 
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y = 1E+08x +3.436 
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(a)                                                                 (b) 
    
(c)                                                              (d)     
Figure 6.13 The size of the critical nucleus as a function of temperature and supersaturation (a) 
in acetonitrile; (b) in toluene; (c) in ethanol 95% and (d) in ethyl acetate. 
 
It is clearly shown that, as expected, the radius of the critical nuclei increases with 
decreasing the degree of supersaturation and increasing temperature. This is consistent 
with homogeneous nucleation theory as discussed in chapter 2. If the solutions are 
maintained at higher temperature associated with the lower supersaturation, the size of 
the critical nuclei will increase. At each concentration and temperature of solution a 
particular size of cluster for the nucleation process is expected. If the state of solution 
varies, the size of critical cluster also changes resulting in a wider or smaller MSZW; 
hence, MSWZ depends on many parameters such as supersaturation, temperature, 
cooling rate, agitation speed etc. 
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6.6 Conclusions 
 
This chapter presented the DSC data including melting points and enthalpy of 
dissolution of ibuprofen, solubility data, MSWZs and induction times for ibuprofen of 
RS-ibuprofen in a range of solvents. The solubility, enthalpy and entropy of dissolution 
and activity coefficient of ibuprofen at different temperatures were compared to the 
published data showing quite similar values. The experimentally measured solubility of 
ibuprofen is lower than calculated by the van‟t Hoff equation showing discrepancy from 
the ideal behaviour with the real solubility, consistent with strong solute-solute 
interactions, particularly in the case of acetonitrile. ATR UV/Vis spectroscopy was 
found to be a rapid and efficient technique for the measurement of solubility for strong 
absorbing materials but was found to have some limits in terms of the refractive index 
of some solvents. 
 
It was also found that the MSZW of ibuprofen is relatively small. This is not typical for 
many organic crystallising systems where the induction of the nucleation process can be 
slow and limited. Though the MSZWs and the induction times for ibuprofen scatter 
quite widely in all solvent systems, it was shown that ibuprofen has the smallest MSZW 
in toluene. Ibuprofen in ethanol is not a good system for studying MSZW due to the 
high viscosity of solution. The viscosity increases more rapidly with increasing of 
concentration in the supersaturated region. This retards the cluster diffusion in solutions 
and the formation of nuclei. In this system, higher concentration and holding solutions 
at lower temperatures make even solution harder to crystallise. The induction times 
increase with decreasing supersaturation, which are in quite good agreement with 
classic nucleation theory. The critical nucleus diameter and thus size decreases as the 
supersaturation increases. The nucleation order and the calculated interfacial energy is 
summarised in Table 6.9. 
 
Table 6.9 The nucleation order and calculated interfacial energy calculated from MSZW 
 Ethanol  Ethyl acetate Acetonitrile Toluene 
Nucleation order 
Interfacial energy (J/m
2
) 
- 
5.33*10
-3
 
1.55 
2.56*10
-3
 
3.27 
5.52*10
-3
 
0.94 
4.38*10
-3
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The solubility and MSZW results are essential and useful for the design of a 
crystallisation process for the measurement of crystal growth rate. The solubility and 
MSZW indicates that the measurement of the growth rate of spontaneously nucleated 
single crystals should be performed in the range of ΔT > 13oC in this research and the 
seeding experiments can be carried out within the MSZW (≈ 13oC).  
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7 Growth kinetic and mechanism  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
The growth rate on the {001} and {100} faces versus supersaturation for spontaneously 
nucleated single crystals in stagnant solutions is measured as a function of solvent type 
and reactor scale-size (0.5mL and 15mL) and the interface growth mechanism  
assessed. This is compared to the data recorded on the population of crystals 
crystallised in an agitated 7mL reactor. 
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7.1 Introduction 
 
Crystals of racemic ibuprofen exhibit different crystal habits as a result of varying 
crystallisation conditions [5, 135-139, 141]. This material primarily exhibits a plate-like 
crystal morphology dominated by a large {100} face with smaller {001} and {011} side 
faces. So far there have been limited studies of this material concerning the 
crystallisation kinetics [5, 15]. Despite this, little information has been provided 
regarding the growth rate of spontaneously nucleated crystals nor has crystal growth 
rate variation of the individual faces been studied. This chapter reflects upon the growth 
kinetic and growth mechanism of the {001} and {011} surfaces of spontaneously 
nucleated single (RS)-ibuprofen crystals under diffusion limited conditions (stagnant 
solutions) at two scale sizes; 0.5mL and 15mL, as a function of solvent (ethanol 95%, 
ethyl acetate, acetonitrile and toluene) and relative supersaturation, ζ, from 0.55 to 1.30 
is presented.  
 
The growth mechanism of these faces was investigated by fitting growth rate data to 
growth kinetic models notably B&S and BCF. The growth rate of single crystals in non-
agitated vessel is compared to the measurements made on a population of crystals 
crystallising in a 7 mL agitated vessel. 
 
7.2 Mean growth rate of the {001} and {011} faces as a 
function of growth environment 
 
A full set of the experimental growth rate data provided in this thesis is given in the 
Appendix B. The data comprises a total of 125 single ibuprofen crystals, spontaneously 
nucleated in 120-130 growth runs measured in ethanol 95%, ethyl acetate, acetonitrile 
and toluene over a supersaturation range from 0.54 to 1.31 at 2 scale sizes 0.5 and 15 
mL. 
A sequence of images of crystals grown in a 0.5mL cuvette crystallisation cell in 
different solvents is shown in Figure 7.1. An example of the plot the distance from the 
centre of the crystals along the growth normal as measured for 5 crystals in the 15ml 
growth cell to the faces as a function of time are shown in Figure 7.2. Simultaneously, 
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the ATR UV/Vis spectra and calculated solute concentration and relative 
supersaturation of ibuprofen in ethanol collected during crystallisation experiments to 
monitor the supersaturation of solution are shown in Figure 7.3 The mean growth rates 
of the {001} and {011} faces of single ibuprofen crystals spontaneously nucleated in 
ethanol, ethyl acetate, acetonitrile and toluene in 0.5 mL and 15 mL are shown in Table 
7.1 and Figure 7.4.  
 
 
 
Chapter 7. Growth kinetic and mechanism 
 
160 
 
 
 
Figure 7.1 Series of optical micrographs of ibuprofen crystals grown in ethanol 95% between ζ 
= 1.17 and ζ = 0.66 (a), in ethyl acetate between ζ = 1.20 and ζ = 0.69 (b), in acetonitrile 
between ζ = 1.12 and ζ = 0.79 (c) and in toluene between ζ = 1.17 and ζ = 0.70 (d) at the 0.5ml 
scale size showing the growth of the crystals and their morphology as a function of solvent, 
elapsed time and solvent supersaturation. 
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Figure 7.2 The distance from the centre of the crystals to the faces was plotted as a function of 
time. The slope of the line gives the measured growth rate of the face measurement for the 
estimation of the growth rate for the {011} and {001} face. 
 
 
  
Figure 7.3 ATR UV/Vis spectra of ibuprofen in ethanol during crystallisation obtained every 
minute in 50 mins (left); Solute concentration and relative supersaturation calculated from the 
UV/Vis absorbance calibration model  in 15mL jacketed vessel (right). 
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Table 7.1 Mean growth rate of face {011} and {001} of ibuprofen in ethanol 95%, ethyl 
acetate, acetonitrile and toluene in prototype cell 0.5 mL and jacketed-vessel 15 mL 
 
Choice 
of     
solvents 
 ζ Number 
of 
crystals 
Mean Growth Rate R(μm/min) 
R{001} R{011} 
0.5mL 
scale 
15mL 
scale 
0.5mL  
scale 
15mL scale 
Ethanol 
95% 
0.66 
0.79 
0.89 
0.97 
1.17 
5 
8 
5 
5 
5 
3.6 ± 0.7 
4.6 ± 0.4 
6.2 ± 0.8 
8.0 ± 0.9 
13.2 ± 1.6 
3.8 ± 0.5 
5.6 ± 1.0 
7.2 ± 0.8 
8.9 ± 0.4 
13.2 ± 0.7 
8.5 ± 2.1 
11.8 ± 1.1 
14.3 ± 1.5 
16.6 ± 1.7 
21.6 ± 1.3 
11.1 ± 0.8 
14.9 ± 1.4 
16.9 ± 0.9 
18.4 ± 1.1 
24.6 ± 4.1 
Ethyl 
acetate  
0.54 
0.69 
0.76 
0.85 
0.97 
1.06 
1.20 
6 
5 
6 
7 
7 
7 
7 
1.8 ± 0.3 
3.4 ± 0.4 
4.4 ± 0.6 
6.3 ± 0.4 
8.3 ± 0.8 
9.7 ± 0.8 
12.2 ± 2.6 
1.9 ± 0.3 
3.9 ± 0.9 
5.8 ± 0.4 
6.6 ± 0.7 
10.1 ± 0.8 
12.6 ± 0.5 
13.8 ± 1.2 
17.7 ± 2.0 
31.6 ± 1.8 
37.5 ± 3.1 
42.5 ± 3.2 
48.9 ± 3.7 
52.1 ± 6.6 
61.3 ± 7.7 
19.1 ± 3.7 
36.5 ± 3.0 
41.7 ± 4.1 
47.1 ± 2.1 
53.0 ± 2.2 
58.6 ± 3.3 
65.4 ± 3.7 
Acetonitr
ile  
0.79 
0.93 
1.03 
1.12 
1.31 
6 
5 
6 
6 
6 
3.6 ± 0.7 
5.0 ± 0.3 
7.4 ± 2.0 
10.7 ± 2.0 
14.6 ± 2.6 
4.8 ± 1.0 
5.8 ± 0.3 
9.3 ± 0.6 
12.7 ± 1.4 
16.9 ± 1.4 
51.5 ± 5.2 
60.0 ± 6.7 
79.9 ±11.5 
90.0 ± 11.7 
112 ± 12.5 
56.3 ± 5.0 
72.9 ± 3.5 
85.4 ± 7.9 
104.9 ± 8.8 
121.4 ± 12.6 
Toluene 
0.7 
0.78 
0.86 
1.17 
6 
5 
6 
6 
1.8 ± 0.2 
2.1 ± 0.2 
3.2 ± 0.6 
4.4 ± 1.7 
   2.4 ± 0.5 
2.8 ± 0.5 
3.5 ± 0.8 
5.0 ± 0.4 
27.8 ± 1.8 
30.5 ± 2.6 
34.1 ± 4.2 
40.2 ± 5.1 
   32.0 ± 2.3 
33.6 ± 4.4 
38.7 ± 3.1 
43.8 ± 2.4 
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        Ethanol          ethyl acetate          acetonitrile          Toluene            
Figure 7.4 Mean growth rate of the {011} and {001} face versus supersaturation of crystals 
grown in ethanol 95%, ethyl acetate, acetonitrile and toluene.  
 
The growth rates of ibuprofen crystals grown in absolute ethanol at different 
temperatures using stirred seeded batch crystallization were reported in [15] showing 
the growth rate in ethanol followed a first order dependence on supersaturation. i.e. G = 
kG ζ
n  
where G is the linear growth rate of crystals (in μm/min), n is the kinetics order (n 
= 1), kG is the growth rate coefficient (kG = 15)  and ζ is the supersaturation. 
 
Table 7.2 Comparison of the mean growth rates of face {011} and {001} of ibuprofen in 
ethanol with the growth rate calculated from G = kG ζ
n  
(with kG = 15, n =1) [15]) 
Supersaturation 
σ 
This study Data after Rashid [15] 
Face {001} 
 
Face {011} 
0.66 3.6 - 3.8 8.5 - 11.1 9.9 
 
0.79 
 
4.6 – 5.6  11.8-11.9 11.85 
 
0.89 
 
6.2 – 7.2  14.3 – 16.9 13.35 
 
0.97 8.9 - 8.9 16.6 - 18.4 14.55 
 
1.17 13.2  21.6  - 24.6  17.55 
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The mean growth rates (R) of the {001} and {011} faces increase quite significantly 
with increasing relative supersaturation. R{001} and R{011} are responsible for 
defining the shape of crystals. For the solvents studied, R{011} is greater than R{001}, 
in particular for crystals grown in ethyl acetate, acetonitrile and toluene. This results in 
shapes with a higher aspect ratio in these solvents (elongated crystals), e.g. in ethanol 
the ratio of R{011} and R{001} ranges from 1.6 to 2.6 whilst that in ethyl acetate 
ranges from 5.0 to 9.8 with even higher values in acetonitrile and toluene.  
 
Considering the four solvents, for solutions at the same supersaturation level, R{011} in 
acetonitrile is the highest and R{011} in ethanol is the lowest. R{001} of ibuprofen 
crystals in ethanol and ethyl acetate are nearly similar and R{001} in acetonitrile is 
lower than R{001} in ethanol and ethyl acetate. R{011} in acetonitrile increases much 
more with increasing supersaturation compared to the other solvents (Figure 7.4). The 
rate of change of growth rate with changing supersaturation, dR/dζ, for the {001} and 
{011} faces in four solvents was not found to follow a linear relationship, for example, 
in ethyl acetate the gradients of R{011} with supersaturation (dR{011} /dζ) at ζ > 0.76 
were found to be lower than those measured for ζ ≤ 0.76. At ζ < 0.76 dR{011} /dζ is 
90.4 and dR{001} /dζ is 11.6 but at  ζ > 0.76 dR{011} /dζ is 50.7 and dR{001} /dζ is 
17.4.  
 
At the 15 mL scale, the measured R{001} and R{011} are slightly greater than that 
found for the measurements at 0.5 mL scale. According to Noyes and Whitney [65], the 
driving force for crystal growth is the difference between the concentration in the bulk 
of solution and at the solid surface. As crystals start to grow in a supersaturated 
solution, the concentration drops across the stagnant film of liquid adjacent to the 
growing crystal faces and thus the diffusion process, in which solute molecules move 
from the bulk of the liquid phase to the thin stagnant film, occurs. It was reported that 
film thickness measured on stationary crystals in stagnant aqueous solutions is up to 150 
μm whilst this rapidly drops to zero in vigorously agitated systems [26]. It is postulated 
that probably the mass transfer is greater for the larger scale size where the solution 
volume is greater hence suggesting that the diffusion rate is greater at the 15 mL 
solution compared to that at the 0.5 mL cuvette, thus the driving force for the crystal 
growth should be less in the 0.5 mL cuvette. With the same small amount of material 
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crystallized out, the local supersaturation levels should decrease faster in the 0.5 mL 
solution when compared to that in the 15 mL cell. However, examination of the ATR 
UV/Vis data measured in-situ shows the supersaturation level to be comparatively 
constant during crystallisation process. This probably due to the small numbers of 
nucleated single crystals in the unagitated vessel resulting in a modest un-measurable 
supersaturation change. When the crystals are growing, the supersaturation levels are 
likely to decrease locally within the solution adjacent to the growing crystal faces, and 
this change in concentration is not likely to be detectable by the ATR UV-Vis probe 
given its location some distance away (~8 mm). In addition, the temperature in the 15 
mL vessel may not be completely homogeneous, while crystals which settle on the flat 
optical disc at the 15 mL vessel base may be at a slightly lower temperature when 
compared to that of the bulk solution due to a lack of coolant circulation around the 
disc. In contrast, the thin 0.5 mL cuvette is totally immersed in a water tank and thus the 
temperature should be controlled within ±0.1
o
C.  
 
7.3 Crystal morphology as a function of growth 
environment 
 
The {001}, {011} and {100} faces are the dominant external morphological forms for 
ibuprofen crystals. The morphology of ibuprofen crystals grown from ethanol, ethyl 
acetate, acetonitrile and toluene at both scale sizes (cuvette 0.5mL and jacketed vessel 
15mL) were found to be quite consistent from crystals to crystals and between two scale 
sizes in good agreement with previous studies [5, 136]. Plate-like hexagonal shaped 
crystals are obtained from ethanol whilst more elongated forms are found in ethyl 
acetate, acetonitrile and toluene. Crystal prepared from toluene and acetonitrile 
solutions were found to grow with the most needle-like morphology. The former 
exhibited some curvature on the {001} faces which might be with kinetics roughening.   
Changes of relative growth rate of the {001} and {011} faces with solvent type and 
supersaturation result in a variation of the crystal aspect ratios (the ratio of the length 
and the width of a crystal) reflecting the fact that the crystals tended to be more 
elongated in the less polar and non-polar solvents and with decreasing supersaturation, 
as shown in Figure 7.5 and Figure 7.6. 
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Figure 7.5 Photographs of aspect ratios (the ratios of the length and the width of crystals) of 
ibuprofen crystal grown from ethanol, ethyl acetate, acetonitrile and toluene versus relative 
supersaturation together with the vacuum morphology figure from Bunyan [136]. Note that the 
aspect ratios mostly tend to increase with decreasing supersaturation. 
 
Ethyl acetate 
Toluene Acetonitrile 
Ethanol 
Vacuum morphology
ζ  = 1.15 
ζ  = 0.66 
ζ  = 1.17 ζ  = 0.70 ζ  = 1.12 ζ = 0.66
ζ  = 1.20
 
 ζ  = 1.17 
ζ  = 0.54
 
 ζ  = 1.17 
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Figure 7.6 Aspect ratios of ibuprofen crystals grown from ethanol, ethyl acetate, acetonitrile and 
toluene versus relative supersaturation at two scale-sizes: 0.5ml and 15ml. 
 
Similar effects were reported by Ristic, et al. [9] who observed that the growth 
morphology of monoclinic paracetamol from pure aqueous solution at different 
supersaturations exhibited a strong supersaturation-dependence associated with a 
change from a columnar to a plate-like habit with increasing supersaturation.  
 
 
7.4 Variation in growth rates crystal by crystal 
 
Each crystal growth rate data point reported here represents a mean value between five 
and eight individual crystals for which the growth rate was measured. Figure 7.2 
illustrates the growth of the {001} and {011} face over time for five individual crystals. 
The face specific growth rates were found to display a good linear fit for each crystal 
surface indicating that these surfaces follow the constant crystal growth model. This 
model proposes the constant growth rate of each crystal along the growth periods. 
However, different crystals have different growth rates. The growth rate variations of 
ibuprofen in various solvents are summarised in Table 7.3. 
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Table 7.3  The coefficient of variation for the growth rate of the crystal faces 
Solvent type   The {001} face The {011} face 
0.5mL 15mL 0.5mL 15mL 
Ethanol  0.12 0.103 0.12 0.09 
Ethyl acetate 0.123 0.10 0.095 0.07 
Acetonitrile 0.177 0.103 0.12 0.083 
Toluene 0.193 0.173 0.092 0.084 
 
The average standard deviation of these particular crystal measurements was found to 
be about 12%.  Caution should be exercised in interpreting this data as errors e.g. due to 
the blurring of the crystal boundaries, minor errors from manual measurements etc. 
could be introduced. Nonetheless, the standard deviations of the measured growth rates 
are broadly representative of the variation in growth rates of crystal habit faces in 
individual crystals. According to observations of sequence of single crystals grown 
during a period of time, there were different growth rate between four similar faces 
(011), (0-11), (01-1) and (0-1-1) faces and each crystal grows at slightly different rate in 
the same conditions. Given that the initial size of crystal studied is very similar, these 
observations are more consistent with the growth rate dispersion (GRD) effect than one 
of size dependant growth (SDG).  
 
In this study, the growth rate data shows a lower growth rate variation for the growth of 
spontaneously nucleated crystals in stagnant, supersaturated solutions compared to the 
GRD observed in a stirred batch crystallizer which was measured from size distribution 
of crystals from seeding [15]. The latter study showed ibuprofen growth in absolute 
ethanol and water-ethanol mixtures at the 1L stirred seeded batch crystallisation vessel 
size exhibits GRD with a log normal distribution of growth rates having a spread of the 
coefficient of variation CVv which is calculated by the standard deviation/mean size of 
volume based distribution of the growth rate on a volume basis. The distribution spread 
CVv versus experimental growth time at 25
o
C in absolute ethanol) had the value of 0.5 
(Figure 7.7).  
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Figure 7.7 Distribution spread CVv versus experimental growth time at 25
o
C in absolute 
ethanol) (reproduced with permission from Rashid et al [15]). 
 
Similarly, studies of the growth rate behaviour of anhydrous sodium sulphate crystals 
revealed that the GRD of single crystals grown in a flow cell was less than that found 
among a population of crystals prepared in a batch crystallizer [172]. This was 
rationalised in terms of crystal collisions occurring in the agitated crystalliser producing 
greater numbers of faster growing nuclei. 
 
Whilst a significant number of studies have been carried out, the mechanism of GRD is 
still a matter of some debate. The GRDs of ibuprofen was compared with some other 
organic and inorganic materials in Table 7.4.  
 
Table 7.4  Growth Rate Dispersion of some other organic and inorganic materials 
Materials The coefficient 
of variation 
References 
Lysozyme (face {110})  
Lysozyme (face {101})  
Paracetamol (face {110}) 
Sucrose 
Citric acid monohydrate   
ADP  
Ibuprofen 
0.05 - 0.2 
0.05 - 0.33 
0.061 - 0.141 
0.28 
0.35  
0.37 
0.07- 0.19 
Judge et al. [21] 
Judge et al. [21] 
Finnie et al. [173] 
Berglund and Murphy [174] 
Berglund and Larson [175] 
Garside and Ristic [20] 
This study 
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The GRD for the growth rate of the {001} and {011} of ibuprofen is quite similar to 
that of the {110} direction of paracetamol and slightly lower than other materials.  
 
The GRDs of both faces in this study was found to increase with increases in the mean 
growth rate when crystals grow at the high supersaturation. The growth rate of the 
{001} and {011} faces showed a trend of higher GRD at the higher supersaturations and 
the GRD in the 15 mL vessel is less than the GRD in the 0.5 mL cuvette.  It is similar to 
the case of citric acid monohydrate [175], sucrose [174], and fructose and protein [21]. 
At the higher supersaturations, the nucleation rate was found to be greater, which means 
more crystals are generated in the in-situ cell which grow at the same time in solution 
resulting in a more rapid desupersaturation of the growth solution at the smaller scale 
size (0.5 mL). The GRD do not vary greatly between the solvents except the GRD for 
toluene. This is might due to the very needle-like crystals with curvy {001} faces which 
were found in toluene.  
 
7.5 Rationalisation the growth rates with intermolecular 
bonding and surface chemistry 
 
In these four solvents, the growth rate of face {011} was found to be greater than the 
growth rate of face {001} in particularly crystals grown in ethyl acetate, acetonitrile and 
toluene. This resulted in a higher aspect ratio for the crystals formed in these solvents. 
The morphology, the growth rate of face {011} and {001} and aspect ratio of crystals 
can be rationalised and understood at the molecular scale through morphological 
prediction, analysis of the intermolecular bonds on the ibuprofen crystal surface of the 
{011}, {001} and {001} faces and the chemistry of the crystal habit surfaces.  
 
The analysis of the strongest bonds on the ibuprofen crystal surface of the {011}, {001} 
and {100} faces showed that the strongest bond type (-7.47 kcal/mol) are hydrogen-
bonded molecules between molecule number 1 and molecule number 3 which continue 
along the b direction so crystals are expected to grow more in this direction. The 
hydrogen bonds contribute to attachment energy on the {011} face and contributes to 
the slice energy on the {001} face, which can be used to verify the growth rate of the 
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{011} face being greater than the growth rate of the {001} face. This is in good 
agreement with the growth rate data of the measured {011} and {001} face in studied 
solvents. On the contrary, most of the strongest bonds on the {100} face are inside the 
slice thus this face is expected to grow slowly and become the most morphologically 
important. This agrees with the predicted and experimental morphology of ibuprofen, 
apart from the aspect ratio of crystals. It is likely due to the fact that the growth 
conditions effect the relative growth rate of the {011} and {001} faces resulting in 
changes of aspect ratio of crystals. The more detailed analysis of solution-crystal 
surface interactions, in this case solvent type, is considered. 
 
The morphology of a crystal in different growth environments depends, collectively, on 
the relative growth rates associated with its constituent crystal habit faces. 
Mechanistically, these rates reflect the balance between the rate of desolvation of 
solvent molecules and the rate of solute adsorption at the different crystal growth 
interfaces. Ultimately these rates are linked to the respective interaction energies 
associated with the solute and solvents molecules on these surfaces. Hence, the growth 
rate of an individual habit face can be rationalised as being determined by interactions 
between solute and solvents on specific faces through either a reduction or an increase 
in interfacial tension and concomitant growth rate. Hence, the ibuprofen morphology 
grown from solvents can be explained by molecular arrangement at the {011} and 
{001} surface and hydrogen bond can be formed between solvents and the COOH 
functional group of ibuprofen.  
 
Figure 5.13 and Figure 5.14 showed molecular packing diagrams which highlight the 
basic surface chemistry of the {001} and {011} growth surfaces. On the {011} face the 
molecules are arranged alternatively nearly parallel and perpendicular to the surface and 
intermolecular hydrogen bonds appear in different directions contributing to slice 
energy and attachment energy. Moreover, if considering the effect of solvent (polar, less 
polar and non-polar) on the growth rate of the {001} and {001} face, in particular the 
growth rate of the {011} face significantly varies among ethanol, ethyl acetate, 
acetonitrile and toluene. The {011} face exhibits great hydrophilicity because the 
carboxylic acid groups are more easily accessible so the use of polar solvents (ethanol 
which can act either as a hydrogen bond donors or acceptors) would inhibit the growth 
of {011} resulting in shortened crystals (plate-like crystals). On the contrary, a more 
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apolar solvent (ethyl acetate or acetonitrile) or non-polar (toluene) which interact to a 
lesser extent to the {011} face thus obtaining more elongated crystals. Moreover, 
interactions of less polar solvents with alkyl groups on the {001} face hinders the 
growth of this face. 
 
In summary, the molecular modelling was quite successful in qualitative interpretation 
and supporting for the experimental data, particularly the growth rate of {011} and 
{001} in various solvents. The different shapes are formed by the differences in the 
relative growth rates of specific faces of ibuprofen crystals due to the interaction of 
solvent molecules and the structures of specific growing faces. Hence, the 
computational calculations using attachment energy and the BFDH approaches 
accurately predict the shapes of crystals grown in vacuum; they are not very accurate for 
crystal grown in the solution. 
 
7.6 Growth rate mechanism of {001} and {011} at two scales 
0.5mL and 15mL 
 
The microscopy observations reveal that the crystal growth was clearly planar in nature. 
This, together with the appearance of crystals which are bounded by well-defined 
crystallographic surfaces which are not roughened would suggest that the growth 
mechanism would be either due to the BCF or B&S mechanism. This supposition is 
confirmed through examination of data presented in Figure 7.8 which show that there is 
a strong and non-linear dependence of the relative growth rates, on supersaturation 
ruling out models, such as the rough surface model for which a linear dependence of 
growth rate on supersaturation fitting would be expected. Data fitting has been carried 
out using nonlinear curve fit in Origin with user define functions (Birth and Spread 
model A*(x^(5/6))*exp(B/x) and BCF model A*(x^2)*tanh(B/x)). Plots of the 
measured crystal growth rate versus relative supersaturation together with fitting against 
these models are shown in Figure 7.8, summarised in Table 7.5. From this, an 
assessment was made to which model gave better fitted. 
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                  : Ethanol                 : Ethyl acetate                : Acetonitrile                   : Toluene 
Solid line: Birth and Spread model               Dotted line: BCF model 
Figure 7.8 Plots of  the growth rate versus supersaturation together with fitted B&S and BCF 
mechanism models for both {011} face (left) and {001} face (right) and for both 0.5mL (top) 
and 15mL (bottom). 
 
Table 7.5 Fitting parameters for the faces {011} and {001} of ibuprofen grown in ethanol 95%, 
ethyl acetate, acetonitrile and toluene with B&S model and BCF models together with the 
adjusted coefficient of determination adjusted R
2
 (adj.R
2
) 
 Vessel 0.5 mL Vessel 15 mL 
Face {011}                 Face {001}                   Face {011}              Face {001} 
B&S BCF B&S BCF B&S BCF B&S BCF 
Ethanol 
95% 
A 
B 
Adj.R
2    
  
41.782 
-0.962 
0.986 
16.540 
8.79E8 
0.966 
39.41 
-1.51 
0.94 
8.03 
4.2E11 
0.94 
29.13 
-0.40 
0.99 
33.97 
0.65 
0.99 
32.28 
-1.22 
0.996 
9.42 
3.30E8 
0.992 
EA (ζ = 
0.54-0.76)
    
  
A 
B 
Adj.R
2
 
152.62 
-0.88       
0.996 
65.02      
63.46 
0.973 
31.94    
-1.29 
0.994 
8.15         
2.2E9 
0.95 
162.55 
   -0.85 
0.97 
72.95 
61.89 
0.95 
41.57       
-1.36 
0.986 
10.16                   
8.31E12 
0.941 
EA (ζ = 
0.76-1.20)
 
  
A 
B 
Adj.R
2  
61.53 
-0.20 
0.995 
53.41 
49.22 
-0.22 
  
63.56 
-0.15 
0.998 
54.75 
48.74 
-0.28 
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Acetonitril
e 
A 
B 
Adj.R
2    
  
167.66 
-0.81 
0.937 
72.09 
37.45 
0.872 
70.88 
-2.38 
0.891 
6.05 
2.0E8 
0.70 
175.15 
-0.75 
0.99 
82.03 
32.75 
0.88 
91.95 
-2.47 
0.932 
7.69 
1.91E6 
0707 
Toluene A 
B 
Adj.R
2    
  
33.76 
0.078 
0.958 
45.25 
24.89 
-5.77 
9.56 
-1.00 
0.77 
3.51 
4.62E6 
0.76 
32.46 
0.21 
0.97 
39.82 
8.07 
-5.86 
6.902 
-0.528 
0.994 
5.858 
0.857 
0.994 
 
 
Figure 7.4 shows that there is a strong dependence of the relative growth rates, between 
the {011} and {001} faces, which control the crystal‟s aspect ratio, on supersaturation 
ruling out models, such as the rough surface model [70] that predicts a linear 
dependence of growth rate on supersaturation. Table 7.5 shows the fitting parameters A 
and B (see equation (2.35) and (2.36)) and the adj. R
2
 for the faces {011} and {001} 
grown in various solvents with the B&S model and the BCF model. Generally, the B&S 
model provides a better fit to the data than that for BCF model for most data measured. 
The main exception are for R{011} and R{001} in ethanolic solutions, which provided 
similar values for the fitting adj. R
2
  (0.97-0.99) for both models.   
 
In the case of ethanol, the increased viscosity of the solution inhibited mass transfer of 
the solute from solution to the crystal face thus it might contribute to reducing the 
crystal growth rate and the growth mechanism. According to Sherwood, there is a 
relationship between the mass transfer coefficient and diffusivity or diffusion coefficient 
and viscosity: 
 
   
 
 
(     (
   
 
  
)
   
     ) 
 
(7.1) 
where D is the diffusion coefficient, L is crystal size, εp is the average power input and   
is the kinematic viscosity, and Sc is the Schmidt number (Sc =    ). The diffusion 
coefficient, D, can be estimated using the Stokes-Einstein equation: 
 
   
  
     
  
(7.2) 
where K is the Boltzmann constant, T is temperature (K),   is dynamic viscosity of the 
solution, and dm is the molecular diameter. 
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Similarly, the effect of solvent composition on the growth kinetics and growth 
mechanism as  a function of solvent composition associated with surface roughness, 
selective absorption, solubility gradient and viscosity of solution responsible for the 
decrease of growth rate with the solvent composition was reported for the antisolvent 
crystallization of paracetamol in methanol and water mixtures [176]. 
 
In ethyl acetate, the growth rate was studied at lower range of supersaturations, i.e. from 
0.54 to 1.2. It was shown that at supersaturation ζ from 0.54 to 0.76 R{011} versus ζ 
fits well for both BCF and B&S model (the adj. R
2 
= 0.996 and 0.973, respectively). 
However, at ζ ranging 0.76 to 1.20 only the B&S shows acceptable fit (the adj. R2 = 
0.995 for B&S and -0.22 for BCF) consistent with the growth mechanisms where the 
BCF mechanism might be occur at low supersaturation. 
 
In this study, ibuprofen crystals grown from four solvents follow the B&S mechanism 
at moderate and relative high supersaturation (ζ = 0.54 - 1.22), except for some solvents 
and supersaturation BCF can equally fit and there is no mechanistic change with scale 
size.  
 
7.7 Correlation between the calculated α factor and the 
growth mechanism 
 
For a crystal face growing from solutions in different solvents, the value of the α factor 
might be expected to alter depending on the nature of solute-solvent interactions 
(interfacial roughness). The changes of the α factor due to the change of growth solvent 
can result in the change of the growth kinetics and growth mechanism of a crystal face 
and thus the growth rate of different crystal habit faces. These growth mechanisms are 
correlated to the values of the α factor given in Table 7.6 (ξhkl calculated from Ecrys and 
Elatt for a growth unit based on a monomer) and Table 7.7 (ξhkl calculated from Ecrys and 
Elatt for a growth unit based on a dimer). The surface entropy factor αhkl of ibuprofen in 
ethanol, ethyl acetate, acetonitrile and toluene calculated in two methods using 
equation    
   
  
 at 25
o
C (1) and     (
   
  
       ) (2) from 15 - 35
o
C. 
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Table 7.6 The surface anisotropy factors ξhkl calculated from Ecrys and Elatt for a growth unit 
based on a monomer and the surface entropy factor αhkl  
Face ξ1 Ethanol Ethyl acetate Acetontrile Toluene 
  
(1) (2) (1) (2) (1) (2) (1) (2) 
100 0.83 8.9 9.4 – 10.5 9.0 9.2 – 10.4 18.4 10.2 – 12.0 9.45 9.3 – 10.4 
110 0.45 4.7 5.0-5.7 4.8 5.0 – 5.6 9.9 5.5 - 6.4 5.01 5.0 – 5.6 
011 0.42 4.4 4.8-5.4 4.6 4.7 -5.3 9.4 5.2 – 6.1 4.8 4.7 – 5.3 
001 0.42 4.4 4.7- 5.3 4.5 4.7-5.2 9.3 5.2 - 6.1 4.8 4.7-5.3 
012 0.28 2.5 3.2 – 3.6 2.6 3.1 – 3.5 5.4 3.5-4.1 2.7 3.1 – 3.6 
112 0.31 3.4 3.5 – 3.9 3.6 3.4 – 3.9 7.3 3.8 – 4.5 3.8 3.5 – 3.9 
 
 
Table 7.7 The surface anisotropy factors ξhkl calculated from Ecrys and Elatt for a growth unit 
based on a dimer and the surface entropy factor αhkl  
Face ξ1 
Ethanol Ethyl acetate Acetontrile Toluene 
 (1) (2)  (1) (2)  (1) (2) (1) (2) 
100 0.80 8.3 9.0 -10.1 8.6 8.9 - 10.0 17.7 9.8 -11.5 9.08 8.9 - 10.0 
110 0.24 2.5 2.8 - 3.1 2.6 2.7 - 3.0 5.3 3.0 - 3.5 2.74 2.7 - 3.0 
011 0.23 2.4 2.7 - 2.9 2.4 2.5 - 2.8 5.0 2.8 - 3.3 2.57 2.5 - 2.9 
001 0.32 3.3 3.7 – 4.0 3.3 3.5 - 3.9 6.9 3.8 - 4.5 3.52 3.5 – 4.0 
012 0.17 1.7 2.0-2.1 1.8 1.9-2.1 3.7 2.1-2.4 1.9 1.9-2.1 
112 0.21 2.2 2.4-2.6 2.3 2.3-2.6 4.7 2.6-3.0 2.4 2.3-2.6 
 
The surface entropy factors αhkl calculated from the dimer model are smaller than these 
calculated from the monomer model. For the ξhkl calculated from Ecrys and Elatt for a 
growth unit based on a dimer (Table 7.7), the calculated surface entropy α factor for the 
{011} and {001} face has the value smaller than 5 (except for the case of acetonitrile 
using the method (1) so the B&S mechanism on these faces is expected to occur in these 
solvents, which agrees with the measured and fitted growth mechanisms from the 
experimental data.  
 
For the ξhkl calculated from Ecrys and Elatt for a growth unit based on a monomer, the 
values of α calculated for the {001} and {011} face using the method (1) are smaller 
than 5 and the α values calculated using the method (2) are between 4.7 - 5.3 (except for 
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the case of acetonitrile). For these faces whose α factor are nearly 5 or slightly higher 
than 5, which is in the border of B&S and BCF growth mechanism, both mechanisms 
were fitted (see Table 7.6).   
 
The surface alpha factor α calculated using (2) is slightly higher than from (1) and the α 
values of the {011} face is higher than that of the {001} face which indicates the 
surface of the {001} face is smoother than that of the {011} face. This agrees with the 
growth rate of the {011} face which is higher than that of the {001} face in this study. It 
has been shown that the assessment of the surface entropy factor α from the heat of 
solution and from the heat of fusion was in quite good agreement to the observed 
growth mechanism for ibuprofen in this study. The calculated surface entropy α factor 
has a value of smaller than or equal to 5 so the B&S mechanism on the {011} and 
{002} face is expected to occur in these solvents, which agrees with the measured and 
fitted growth mechanism from experimental data. Except for the α values for actonitrile 
calculated from (1) using the heat of solution from the solubility curve did not agree 
with the experimental data.  
 
Actually the heat of solution often depends on the solution composition which can be 
measured through the differential heat of solution using small amounts of solute in large 
volumes of solution. Hence, the differential heat of solution can be measured as a 
function of solution composition. The extrapolation will give the value of heat solution 
at infinite dilution. In this study, the heat of dissolution was obtained through the slope 
of the solubility curve (the plot of lnX versus 1/T) which gives the differential heat of 
solution at saturation. The plot lnX vs 1/T will give the true value of the enthalpy if the 
solution is ideal. For ethanol, ethyl acetate and toluene, the solutions are nearly ideal so 
the calculated α are quite accurate and reasonable for growth mechanism prediction. 
However, for the case of acetonitrile, the solution is negative ideality and the solubility 
showed a great dependence upon the temperature and thus resulting in the greater value 
of derived enthalpy of dissolution. Hence, the calculated α factor calculation using heat 
of solution failed to predict the observed growth mechanism. 
 
The calculated α factors for the face {001} in all solvents indicated that this face follow 
the BCF growth mechanism which is in good agreement with the fact that this face is 
the dominant face associated with the slowest growing rate. The entropy surface α is  a 
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useful data description for the effect of solute-solvent interactions and thus the nature of 
the surface based on the calculated α factor, which can be used to link the solution 
chemistry of the system and the growth mechanism of each surface. For a particular 
crystal face growing from solution in various solvents, the value of α may change 
depending on the solute-solvent interactions. The heat of solution might be expressed as 
ΔHs = ΔHfus + ΔHmix. The enthalpy of mixing ΔHmix is negative when the dissolution 
process is exothermic and vice versa and thus the value of α calculated from the 
equation    
   
  
 increases as the solute-solvent interactions become weaker [79]. The 
calculated α factor for growth from acetonitrile was higher than the values calculated for 
the growth from ethanol, ethyl acetate and toluene indicating the weaker acetonitrile and 
ibuprofen interactions. This is in good agreement with the solubility, solution ideality 
and the measured growth rate of the {001} and {011} in the solvents studied. 
 
7.8 Analysis of the re-entrant faces 
 
It is interesting to note that crystals presenting re-entrant faces appear (Figure 7.9) for 
all 4 solvents at both 0.5mL and 15ml scale-size at high levels of supersaturation. These 
faces have been confirmed and proved as a crystallographic face by measuring the 
angles between these faces and the {011} face. The measurements were carried out on 
30 crystals and the mean interfacial angle and standard deviation were calculated. It was 
shown that the angle is fairly consistent which is around the value of 166° ± 2.7. 
Standard deviation is quite low (1.6%) which can be due to the error of the manual 
measurements.  
 
 
 
                             
 
Figure 7.9 Schematic diagram (a) and ibuprofen crystals grown from ethanol (b), acetonitrile 
(c), ethyl acetate (d), and toluene (e) with high index re-entrant faces. 
 
(a) (b) (c) (d) (e) 
Growth sector 
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Also, it has been found that there is a critical supersaturation for this phenomenon 
occurring. The critical supersaturation for ethanol, ethyl acetate, acetonitrile and toluene 
are shown in Table 7.8.  For acetonitrile and toluene these re-entrant faces are present at 
ζcrit > 0.79. However, more needle-like crystals are produced in these solvents 
particularly in toluene due to this the side {011} faces are quite tricky to monitor the 
critical supersaturation for this phenomenon. Ibuprofen crystals with growing boundary 
sectors (Figure 7.10) show no evidence for substantial defects present like solvent 
inclusion, twining etc. 
 
Table 7.8 The critical supersaturation for the appearance of the re-entrant faces 
 Ethanol Ethyl acetate Acetonitrile Toluene 
Critical supersaturation ζ 0.66 0.69 > 0.79 > 0.79 
 
 
 
Figure 7.10 Ibuprofen crystal grown  in ethanol at ζ = 0.97(a), ζ =  0.79 (b) and ζ =  0.66 (c) 
showing these re-entrant faces are likely appear at high supersaturation and not present at lower 
supersaturation. 
 
In order to verify these crystals are twinned crystals or just single crystals, more detailed 
inspection of these crystals was performed using the crossed polarising microscopy 
technique which is powerful for the examination of twinned crystals due to changes in 
the optical properties [30]. It was shown that when crystals are rotated slowly in a 
clockwise direction in 360 degrees, the whole crystal body became darker or brighter, in 
which both parts are of equal brightness (Figure 7.11). Each half of the crystal (right or 
left) is not at extinction at any rotated angles or the individual crystals are at extinction 
(a) (b) (c) 
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at the same time (for isotropic material). This, and the fact that the images showed well-
resolved growth sector boundaries, is not consistent with any twinning mechanism. If 
there was a twin crystal, the extinction position for each crystal in twin crystals would 
be expected to be different (maybe several degrees of rotation) and there is a re-entrant 
angle which is a V-shaped groove [30].  
 
 
Figure 7.11 The series of polarized-light photographs of ibuprofen crystals in various optical 
rotation positions showing the whole crystal body became darker or brighter, in which both 
parts are of equal brightness. This proves that the re-entrant (concave) edges are not due to 
twinning. 
 
From this evidence, it can be concluded that the re-entrant (concave) edges are not due 
to twinning. The interpretation is sketched in Figure 7.12. The {011} and {012} or 
{112} are simply interchanged compared to the usual cases. Such interchange of faces, 
forming concave edges, is quite rare. This phenomenon has been observed in the case of 
lithium hydrazinium sulphate (point group mm
2
) grown from aqueous solution [177]. In 
this ibuprofen work, however, re-entrant edges occur between symmetrically equivalent 
faces (011) and (0-11). Analysis of the interplane angles for the experimental data using 
morphological simulation suggest that the high index face planes lies in a zone 
comprising the {012} or {112} and {100} faces ( see Figure 7.12 b and c). Obviously 
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the {100} face is ruled out but it is hard to see which specific plane is involved. (Eatt 
(012) = -35.72 (kcal/mol) and Eatt (112) = -33.89 (kcal/mol)). 
 
 
  
 
  
 
 
 
 
 
 
  
(a) 
 
 
                           (b)                                                                 (c) 
Figure 7.12 Schematic diagram showing the formation of re-entrant faces (a) The interfacial 
angle of the {011} and {012} face from the experimental morphology (b) and from 
morphological simulation (c). 
 
 
The surface chemistry analysis for the {012} and {112} faces were analysed to examine 
the molecular packing on these surfaces and are shown in Figure 7.13 and Figure 7.14 
respectively. 
Plate 
(011) 
(012) or (112) 
(2) 
Nucleation point 
(2) 
(2) 
(1) 
(2) 
(1) (1) 
(1) 
(2) 
(2) 
(2) 
(2) 
(1) (1)  
(1) (1) 
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Figure 7.13 Molecular packing on the {012} viewed along x axis (a) and along y axis (b). 
 
  
 
Figure 7.14 Molecular packing on the {112} viewed along x axis (a) and along y axis (b). 
 
The properties of the {012} and {112} face are quite similar to the {011} face in which 
-CH3 and COOH groups are exposed on the surface. However, the –COOH groups on 
the {112} face are more exposed and more accessible than –COOH groups on the face 
{012}. The intermolecular hydrogen bonds appear in two different directions on both of 
the faces and thus they are expected to be the fast growing faces. 
 
7.9 Analysis of the curved {001} faces of ibuprofen in 
toluene 
 
Ibuprofen crystal morphology in toluene was found to be grown in an elongated shape 
and to develop a tapering {001} face. Such behaviour is consistent with the blocking of 
surface terraces leading to a build-up of interfacial supersaturation close to the growing 
(a) (b) 
(a) (b) 
z 
y 
z 
x 
z z 
y x 
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surface. Given the narrow cross-section of the crystals it is hard to be specific on the 
origin of this effect but two scenarios are perhaps worthy of consideration: 
 
 The (001) growth surface is curved which might suggest interface roughening 
[77, 78]. However, this effect is also observed at low supersaturation and 
anyway the kinetic analysis (see Figure 7.8) is not consistent with this. 
 The (001) growth surface is tapered with respect to b-axis due to solvent-
induced step poisoning having the effect of presenting the (001)/(011) growth 
sector boundary within the external morphology. Such effects have been 
previously observed in trivalent metal ion doping in ADP and KDP crystal [178-
180] (Figure 7.15). Theses ions were identified as the factor responsible for the 
shape of KDP crystals from stubby to acicular due to the incorporation of ions 
on the prismatic (100) and (010) faces, resulting in these faces becoming 
tapered. This was clarified using X-ray absorption spectroscopy and molecular 
modelling showing the impurity occupied an interstitial site in the host crystal 
lattice associated with the formation of one hydrogen atom and two potassium 
ionic vacancies to maintain charge balance.  
                   
 (a)   Ibuprofen in toluene        (b) KDP grown from pure KDP and impurity-doped KDP 
 
Figure 7.15 (a) Morphology of ibuprofen in toluene was found to be grown in elongated shape 
with a tapering of the {001} face; (b) Schematic showing the typical growth morphology for 
KDP crystals with pure KDP and impurity-doped KDP. Crystal grow elongated associated with 
impurities, being preferentially incorporated into the (100) and (010) crystal growth sectors 
[178-180]. 
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7.10  Crystal population growth rate measurements at 7mL 
reactor scale 
7.10.1 Growth rate in 7mL non-agitated vessel 
 
A sequence of images of crystals grown from ethanol in a 7ml non-agitated jacketed 
vessel at ζ = 0.157 are showed in Figure 7.16 and the plots of equivalent diameter 
versus time are shown in Figure 7.17. Each line represents the growth rate of individual 
crystals over time. 
 
  
  
 
 
Figure 7.16 Ibuprofen single crystals growing in stagnant solution after seeding at ζ = 0.157. 
From these images, the area of crystals can be calculated and then the equivalent diameter. 
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Figure 7.17 Growth rate (in equivalence diameter) in a 7mL non-agitated jacketed reactor at ζ = 
0.157 and 0.105. 
 
7.10.2 Growth rate in 7mL agitated vessel 
 
A sequence of images of crystals grown in agitated 7ml crystallisers of CRYTALLINE 
in ethanol is showed in Figure 7.18. Upon completion of the experiments, Process 
Image Analysis Expert software developed at the University of Leeds was used to 
extract the crystal growth rate. The fundamental limitation of image analysis is the 
difficulty of segmenting crystals in a concentrated solution due to overlapped crystals. 
In order to overcome this problem, images were captured frequently (every 10 seconds) 
so images which captured clear and sharp crystal edges can be selected for the growth 
rate estimation in the event that the particular crystal in question was obstructed by 
another crystal or shadowed by background noise (Figure 7.18b). The equivalence 
diameter of ibuprofen crystals in a population of crystals over time are shown in Figure 
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7.19. The summary results of the growth rate in stagnant and agitated solutions at a 7ml 
reactor scale are shown in Table 7.9. 
 
 
  (a) 
 
 (b) 
Figure 7.18 A sequence of crystals grown in ethanol after seeding at ζ = 0.157 in an agitated 
reactor (a); the images of crystals before and after segmentation for image analysis (b). 
 
Crystals are plate-like in shape and non-agglomerated. These single crystals are similar 
in appearance to crystal morphology obtained from single crystal growth rate 
0second 264s 
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measurement and published images. The slopes of the straight lines give the values of 
the growth rate and show that the particle sizes are quite similar for both runs.  
 
 
 
Figure 7.19 Plots of equivalent diameter of ibuprofen crystals grown in ethanol versus time at ζ 
= 0.157 and 0.105. 
 
It was found that the overall growth rate increases as a function of supersaturation at ζ = 
0.157 and 0.105. In order to compare the growth rate obtained from the two different 
techniques, a sequence of crystals captured from microscope method studies were used 
to calculate overall growth rates. From the plots and captured images, the first 4-6 mins 
after introducing seed crystals into the solutions in agitated reactors, the captured 
images hardly showed any crystals due to only a few seed crystals introduced into 
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solutions. After that period of time, an amount of new nuclei produced from an intense 
secondary nucleation. The secondary nucleation may have occurred by different 
mechanisms e.g initial breeding, needle breeding, fluid shear.etc. The secondary 
nucleation rate can be expressed as        
      , where mT is the concentration of 
crystals in suspension; N is the hydrodynamic interaction between the crystals and 
solution such as stirrer speed.  
 
The secondary nucleation rate in the agitated reactor is expected to be much higher than 
that in non-agitated reactors. The results cannot be compared directly as one is single 
crystal measurements in stagnant solution (microscope) while the other is a population 
of crystals in agitated vessels (in CRYSTALLINE reactors) though they are measured at 
the same scale-size 7mL. However, the increase of growth rate trends as a function of 
supersaturation gives confidence that the data treatment were well-controlled in both 
techniques. The growth rate of ibuprofen in absolute ethanol was reported to follow a 
first order dependence on supersaturation . i.e. G = kG ζ
n  
with n = 1 and kG = 15. The 
growth of ibuprofen at ζ = 0.157 and 0.105 was calculated from the first order growth 
kinetics shown in Table 7.9. It was obvious that the growth rate measured in 
CRYSTALLINE is slightly lower than the calculated data. The slightly lower growth 
rate obtained from the agitated batch crystalliser may be partly due to the fact that a 
high number of new nuclei (secondary nucleation) are formed which leads to a large 
number of small crystals, and thus resulting in faster desupersaturation of the solution. 
In addition, the breakage, collision of crystals can occur when agitated, and the growth 
rate analysis based on the equivalence diameter of a population of different-size crystals 
including seed crystals and nucleated and broken crystals (much smaller) in the agitated 
reactors contribute to the uneven particle size distribution and lower growth rate in 
agitated vessels.  
 
Table 7.9  Overall growth rates obtained from microscopy method and CRYSTALLINE 
experiments at various supersaturation levels, ζ 
Supersaturation σ Stagnant 
solutions 
Agitated 
solutions 
Data after Rashid [15] 
0.157 
0.105 
2.14 ± 0.11 
1.78 ± 0.13 
2.06 ± 0.11 
1.53 ± 0.09 
2.35 
1.57 
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7.11 Discussion 
 
The solution mediated growth rates of the {011} and {001} faces of spontaneously 
nucleated ibuprofen crystals have been measured as a function of supersaturation and 
solvent under diffusion limited conditions at two scale sizes (0.5mL and 15mL). The 
results show that the mean growth rate of the {001} and {011} faces were found to 
increase with increasing relative supersaturation with R{011} being higher than R{001}. 
This is found particularly to be the case for crystals grown in ethyl acetate, acetonitrile 
and toluene solutions at the two different scale sizes. At a similar supersaturation level 
ζ, R{011} were found to be lowest in ethanol and highest in acetonitrile with R{001} 
lowest in toluene and highest in ethanol and ethyl acetate.  The difference in growth rate 
between different surfaces of a crystal and the growth rate of the same surface in 
different solvents might be a result of the differences in the surface chemistry of the 
crystal and the interaction of these faces with solvent molecules. Changes of the relative 
growth rate of the {001} and {011} faces with solvent-type and supersaturation level 
cause variation of aspect ratios of the crystals. Ibuprofen crystals become more 
elongated in ethyl acetate, acetonitrile and toluene in comparison to the crystals grown 
in ethanol. Aspect ratios at two scale-sizes, 0.5 mL and 15mL, are quite similar or 
slightly higher at the 15mL scale-size. 
 
The growth rate R{001} and R{011} in the 15mL vessel are greater than the growth rates in 
the 0.5mL cuvette cell due to the better temperature control in the 0.5mL cuvette and 
the supersaturation levels decrease quicker in the 0.5mL solution compared to that in 
the 15mL solution as crystals are nucleated and grow. However, the GRDs in the 15mL 
vessel are less than the GRDs in the 0.5 mL cuvette. At larger scale size, in the15mL 
jacketed-vessel, integrated with an ATR/UV-Vis spectrophotometer based on an 
inverted microscope, highlights a good technique to monitor supersaturation levels 
during the crystallisation process. Studies at the larger 15mL scale in a jacketed-vessel 
revealed solution supersaturation to be fairly constant during the growth process thus 
confirming this methodology as being reliable for determination of the growth kinetics 
and mechanisms. However only the supersaturation of the bulk solution, not the 
stagnant film of liquid adjacent to the growing crystal faces, was monitored and 
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measured during the experiments. This drawback can be improved by integrating an 
overhead stirrer to provide gentle agitation to the solution.  
 
The data also showed GRD occurs in both faces and at all supersaturation levels; 
however it is quite low (the average GRD is 12% of the mean growth rate) compared to 
the GRD in a stirred batch crystalliser measured from the crystal size distribution over 
time from the literature [15]. This study was carried out on single crystals in stagnant 
solutions so the growth process is mainly controlled by the volume diffusion. A volume 
diffusion controlled process should exhibit a low GRD. This might be due to stirred 
reactors which disturb the boundary layer (both the diffusion and the interface 
adsorption-boundary layer) leading to fluctuating mass  transfer whilst single crystals 
grow in stagnant solutions at the constant rate because the boundary layer was not under 
disturbance during the growth process [181]. This explanation is supported on single 
crystal growth observations published in previous studies [20, 182]. 
 
The B&S model has been found to best description the dependence of the growth rate of 
the {011} face and {001}face on the supersaturations ζ from 0.54 to 1.22, except for 
several cases both the B&S and the BCF mechanism are both well fitted. It was 
observed that the surface associated with the faster growth rate typically follow the 
B&S mechanism. These slower growth faces such as {001} of very needle-like crystals 
in toluene, {001} in ethyl acetate (1.8 - 4.4μm/min) at ζ from 0.54 to 0.76, both of the 
{001} and {011} in ethanol which can be fitted by both growth mechanisms. This 
agrees with the growth mechanism theory where B&S occurs when further growth units 
integrate into the existing monolayer to spread over the surface. The solubility in 
ethanol is highest resulting high viscosity and thus mass transport from solution to the 
surface is slow and surface diffusions plays an important role. 
 
In ethyl acetate, the growth rate was studied at a wider range of supersaturation, from 
0.54 to 1.2. It was shown that at ζ from 0.54 to 0.76, R{011} versus ζ fits well for both 
BCF and B&S model. However, at ζ ranging 0.76 to 1.20 only B&S shows an 
acceptable fit (the adj. R
2
 = 0.995 for B&S and -0.22 for BCF) which indicates 
agreement with the growth mechanism theory discussed in the chapter 2. The crystal 
growth rate mechanism taking place at the crystal/solution interface is expected to 
change as a function of supersaturation.  The spiral growth mechanism might be occur 
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at low supersaturation [70]. Hence, at intermediate supersaturation (ζ from 0.54 to 0.76) 
both B&S and BCF mechanisms were well fitted. However, at higher supersaturation (ζ 
from 0.76 to 1.20) the two-dimensional nucleation mechanism is dominant.  
 
Ibuprofen crystals grown from four solvents follow the B&S mechanism at moderate 
and relative high supersaturation (ζ = 0.54 - 1.22) and there is no mechanistic change 
with scale size. The relation of growth mechanism and the surface entropy α factor was 
shown in this study. It has been shown that the assessment of the surface entropy factor 
α from the heat of solution was in quite good agreement to the observed growth 
mechanism. The B&S is the main growth mechanism on the {011} and {002} face, 
except for R{011} and R{001} in ethanol, {001} in ethyl acetate and {001} in toluene. 
The growth mechanism was in good agreement with the values of the calculated α 
factor in the range from 2 to 5. 
 
The growth rate in the non-agitated jacketed vessel is quite similar or slightly higher 
than the growth rate in the agitated reactors which is counterintuitive due to the 
agitation accelerating the mass transfer and diffusion process. However it is 
understandable in this study because the agitated reactors retain higher secondary 
nucleation rates. Agitation causes the breakage of particles and the image analysis 
analysing the growth rate based on a population of uneven particle size distribution 
including seed crystals (big particles) and secondary nucleated and broken crystals 
(small particles). In the crystallisers, there are two growth kinetics proceeding 
simultaneously inside the reactor: the formation of new crystalline particles from 
secondary nucleation and their consequent increase in crystal size and the growth of 
seed crystals. Contacts between a growing crystal and walls of the crystalliser, the 
stirrer or other crystals result in the formation of contact nuclei. This nucleation is at 
quite a high rate, so a large numbers of nuclei were formed, resulting in broadening of 
the CSD.  
 
Klug and Pigford [172] also showed a sensible agreement between the growth rate in 
batch and single crystal measurement for anhydrous sodium sulphate. Maharan et al 
[183] reported good agreement of the growth rate of L-asparagine in batch crystalliser, 
single crystals and MSMPR.  
Chapter 7. Growth kinetic and mechanism 
 
192 
 
The drawback of this PhD study was the supersaturation was not controlled, particularly 
in 0.5ml cuvette. However, the data in both scale sizes are quite similar. This drawback 
can be improved in industrial crystalliser by connecting a computer program to decrease 
the temperature as the solution was desupersaturated to keep supersaturation constant.  
 
7.12  Conclusions 
 
Several important points can be concluded from this chapter: 
 
 The measured growth rate data in a series of solvents at both scale sizes; 0.5ml 
and 15ml, are quite consistent and showed a good methodology for studying the 
effect on crystallising conditions on the growth rate of single crystals as well as 
obtaining the fundamental kinetic data with taking into account of crystal shapes 
by measuring the growth rate of individual crystal habit faces.  
 
 Single crystal growth measurements provide useful information for studying the 
basic growth kinetics of a solute system.  They give more flexibility in 
investigating the influence of various key parameters such as temperature, 
supersaturation on the growth kinetics of crystal faces. However, industrial 
crystallisation is usually carried out in agitated batch reactors. In such 
crystalliser systems, the behaviour of individual particles in term of their 
velocity pattern and interactions with other crystals and the stirrer and the wall 
of rectors [183] as well as their nature in terms of shapes, crystal surface has not 
been well-understood. Hence, it is worthy to compare the growth kinetics 
obtained from single crystals and a population of crystals in agitated 
crystallisers. 
 
 The agitation and scale-up do not invalidate the growth rate data and growth 
mechanism. The overall rate data was calculated to be slightly higher than that in 
agitated reactor and thus the data obtained from single crystals can be used for 
scale-up. This proposed that the results of single crystals growth rate 
experiments can be useful in representative for the growth rate of a population of 
crystals in agitated crystallizers for particular chemical systems. 
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8 Technology transfer: Growth rate 
measurements in an industrial R&D 
workstream 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
This chapter presents the single crystal growth rate measurement technique for studying 
the effect of crystallising conditions on a new drug compound as part of the process 
research and workstream. 
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8.1 Introduction 
 
The development of novel and effective platforms for studying the influence of 
crystallisation environment on the crystal growth in terms of crystal morphology and 
growth rates of individual crystal faces as a function of processing conditions is one of 
key aims of this research. This instrumentation has enabled derivation of the 
fundamental process crystal growth kinetics and to provide an understanding of the 
crystalline forms, shapes (aspect ratio) in order to control the final products. As such, 
this work addresses directly the industry-wide demand for refined research and 
development processes. The reliable processing of particles with controlled physical 
properties is able to reduce the manufacturing time and the overall number of unit 
operations. The 0.5ml cuvette crystallisation cell was employed as a technology transfer 
to a practical drug compound in development and it has been used as a routine and 
useful measurement tool for the pharmaceutical and chemical industry. It is an easy-to-
use piece of equipment and consumes very small amount of materials, which is a 
suitable tool for developing drug compounds at the research and development stage. 
The case study shown here was compound A which appears as a mixture of needle-like 
and plate-like crystals of the same polymorph when it is recrystallised from batches at 
Pfizer pharmaceutical company.  
 
These experiments were carried out in 7 working days during a short internship in 
Pfizer, Sandwich, UK and Pfizer, Groton, US. Also, this 0.5ml cuvette crystallisation 
cell has been used in other projects at the University of Leeds for different studies. 
 
8.2 Solubility 
 
The solubility of compound A was obtained as a function of temperature provided by 
Pfizer shown in Figure 8.1 . 
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Figure 8.1 Solubility of compound A in 2-MeTHF and in a mixture of 99% 2-MeTHF  and 1% 
water. 
 
The solubility data of compound A in 2-MeTHF is experimentally measured data; 
however the solubility in 2-MeTHF 1% water was predicted from a quantitative 
validated model for the prediction of solubility as a function of water and temperature. 
It was shown that compound A is more soluble in 2-MeTHF than in the mixture of 99% 
2-MeTHF and 1% water. 
 
 
8.3 Growth rate determination for compound A  
8.3.1 Growth rate in 2-MeTHF 
 
A sequence of photomicrographs of spontaneously nucleated plate-like crystals grown 
in stagnant conditions at ζ = 0.65 (Figure 8.2) and ζ = 0.52 (Figure 8.3) and a sequence 
of needle-like crystals nucleated and grown after tilting the cuvette (turbulent 
conditions) at ζ = 1.00 (Figure 8.4) and ζ = 0.38 (Figure 8.5) together with an example 
of the plot of the length and width as a function of time (Figure 8.6) are presented to 
investigate the growth rates of compound A in 2-MeTHF.  
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Figure 8.2 A sequence of in-situ crystal growth observations of 4 crystals grown from 2-MeTHF 
at ζ = 0.65 with 10 minute intervals between images. 
 
 
 
Figure 8.3 A sequence of in-situ crystal growth observations of 2 crystals grown from 2-MeTHF 
at T = 25
o
C (ζ = 0.52) with 10 minutes interval between images. 
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Figure 8.4 A sequence of in-situ crystal growth observations of 3 crystals nucleated and grown 
from 2-MeTHF isothermal at T = 15
o
C (ζ = 1.00) after tilting the cuvette.  
 
 
 
Figure 8.5 A sequence of in-situ crystal growth observations of a crystal nucleated and from 2-
MeTHF isothermal at T = 28
o
C (ζ = 0.38) after tilting the cuvette with 10 minutes interval 
between images. 
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Figure 8.6 An example of the growth rate of the length and width of crystals grown from 2-
MeTHF isothermal at T = 22
o
C (ζ = 0.65) in stagnant conditions. Each line represents the 
growth rate of individual crystals over time. 
 
Table 8.1  The growth rate of the length and width at ζ = 0.65 and 0.52 in stagnant solutions 
Supersaturation  ζ = 0.65 ζ = 0.52 
Plate-like crystals Length Width Length Width 
Mean growth rate (µm/min) 0.41 ± 0.21 0.12 ± 0.04 0.23 ± 0.13 0.075± 0.03 
 
Table 8.2 The growth rate of the length and width at ζ = 1.00 and 0.38 in turbulent solutions 
Relative supersaturation  ζ = 1.00 ζ = 0.38 
Needle-like crystals Length Width Length Width 
Mean growth rate (µm/min) 10.17 ± 0.24 0.42 ± 0.02 2.21 0.31 
 
It has been shown that compound A recrystallises as plate-like crystals in different 
shapes in stagnant solution and needle-like crystals in turbulent conditions. In both 
stagnant and turbulent conditions, the growth rates, both in the length and in the width, 
increase with increasing supersaturation. For example, in turbulent conditions, at ζ = 
1.00, the growth rate for the length and the width is 2.21 and 0.3 (µm/min) and at ζ = 
0.38, the growth rate for the length and the width 10.17 and 0.42 (µm/min). Comparing 
the growth rate at ζ = 1.00 to the growth rate at ζ = 0.38, is 4.6 times faster in the length 
and 1.35 times faster in the width indicating crystals have higher aspect ratio at higher 
supersaturation which is in good agreement with microphotographs of crystal 
morphology shown in the Figure 8.4 and Figure 8.5. 
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8.3.2 Growth rate in a mixture of 99% 2-MeTHF and 1% water 
 
A sequence of images of crystals grown in 99% 2-Methyl THF and 1% water in the in-
situ crystallisation cell at ζ = 1.07  and 0.87 is shown in Figure 8.7. 
 
ζ = 1.07   
 
ζ = 0.87   
 
 
Figure 8.7 A sequence of in-situ crystal growth observations at ζ = 1.07 (above) and ζ = 0.87 
(below) with 10 minutes interval between images together with an example of the plot of the 
length and width versus time of crystals grown from the mixture of 99% 2-MeTHF 1% water. 
 
Table 8.3  Growth rate of length and width in 99% 2-MeTHF 1% water at ζ = 1.07 and 0.87 
Growth rate of crystals ζ = 1.07 ζ = 0.87 
Length 11.6 3.41 
Width 0.42 0.22 
y = 3.4079x + 418.56 
y = 0.2248x + 24.286 
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8.4 Discussion  
 
The morphology of compound A changes with the variation of the crystallising 
conditions. There were two morphologies: plate-like and needle-like crystals. Solvents 
and agitation showed a significant effect on the morphology of crystals. 
 
Mostly plate-like hexagonal or rhomboid crystals are produced from 2-MeTHF in a 
stagnant solution-state whilst needle-like crystals are obtained from 2-MeTHF in a 
turbulent solution (with tilting and shaking of the cuvette). The morphology can be 
changed slowly over time due to the different growth rate of crystal habit faces. The fast 
growth faces disappear and the slow growth faces become dominant. 
 
 
The mixture of 99% 2-MeTHF and 1% water only produced very needle-like crystals in 
both stagnant and turbulent solutions whilst the morphologies recrystallised from the 
pure 2-MeTHF were found to be plate-like in stagnant solutions and needle-like crystals 
in agitated solutions. 
 
Crystal growth kinetics: The crystal growth rate, both in the length and in the width 
direction, increases with increasing supersaturation. It is likely that compound A 
crystals are more needle-like at higher supersaturation (lower crystallising temperature). 
At similar supersaturation level ζ = 1.00 in 2-MeTHF and ζ = 1.07 in 2-MeTHF 1% 
water, the growth rate of the length and the width (11.6 and 4.2 μm) in the mixture of 
99% 2-MeTHF and 1% water  is quite similar or slightly higher than that (10.17 and 
0.42 μm) in 2-MeTHF. Due to the limited time, the measurements of the growth 
kinetics for compound A in 99% 2-MeTHF and 1% water were not able to repeat to 
obtain more accurate data. 
 
The growth rate dispersion in this material was found to be higher than in ibuprofen. It 
is postulated that this is probably due to the variation of the shape of crystals in a 
population of nucleated crystals. The growth rate of the length and width in the same 
crystallising conditions are also different depending on the shape of crystals (shape-
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dependant growth rate). The growth rate of the length is greater than the growth rate of 
the width, this is more apparent in more needle-like crystals. Furthermore, A has quite a 
low solubility in pure 2-MeTHF and 2-MeTHF 1% water thus local supersaturation 
levels are expected to decrease rapidly when small amounts of material are crystallised 
out. 
 
The study of effect of crystallisation (solvent, agitation, supersaturation) on the 
morphology and growth kinetics of compound A confirmed the application of this 
cuvette crystallisation cell in the pharmaceutical industry. The application of this 
routine, easy-to use and effective cuvette cell instrumentation for crystal growth rate 
measurements, is an example of an achievement of this PhD work, which can be 
employed not only for the pharmaceutical industry but also as a research tool for 
crystallisation study in academic research and teaching.  
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9 Conclusions and suggestions for future 
work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary: 
This chapter summarizes the research results and outcomes from this study together 
with the re-assessment of the thesis aims and objectives and provides some suggestions 
for future work in this area. 
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9.1 Introduction 
 
This work presented the study of influence of crystallisation conditions on the 
nucleation and growth of single crystals of (RS)-ibuprofen. The current practice in 
industrial crystallisation are aimed at measuring average growth rate values at large 
scale based on an assessment of a crystal population. In this study, the use of developed 
in-situ crystallisation platforms at different scale-sizes for a real-time study of the 
morphology and growth rate of individual crystal faces as functions of their crystallising 
conditions showed a potential for the rapid and reliable study of the crystal growth 
kinetics for drugs and fine chemicals in the early stage of research and development. 
Such measurements are helpful in that they provide baseline crystal growth kinetics 
from which the impact of agitation and mixing can be assessed. Drawing together the 
aspects of this PhD work has yielded a number of key outcomes in terms of: 
 Laboratory instrument development. 
 Studies of the influence of crystallisation environment on the nucleation and 
growth of single crystals.  
 A rationalization and correlation of the experimental data with molecular and 
solid state modelling including conformational analysis, morphological 
simulation in various solvents, and surface chemistry analysis.  
The aims and objectives set out initially are then reviewed and suggestions for future 
work are given to further develop this study. 
 
9.2 Conclusions for this study 
 
Each chapter plays an important part in this work and they are interdependent. 
Solubility and nucleation data in chapter 6 was useful in designing the growth rate 
measurement experiments in both non-agitated (spontaneously nucleated crystallisation) 
and agitated vessels (seeding crystallisation). The modelling work enabled calculation 
of the predicted morphology and from that dominant faces of the model compound can 
be identified and indexed for the measurements of the growth rate of individual faces. In 
addition, intermolecular interactions and surface chemistry analysis aided the 
rationalisation of the experimental observation and data to enable understanding in more 
detail the effect of crystallising environment on morphology, growth rate, shapes and 
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aspect ratio at the molecular scale.  The findings of this PhD can be summarised as 
follows: 
 
9.2.1 Molecular modelling  
 
A conformer search for an ibuprofen molecule was successful in showing the favoured 
conformational space of a free ibuprofen molecule. The molecule is located within a 
minimum energy space or is close to the minimum energy. The energy of a free 
molecule before and after geometry optimisation does not seem to change much for this 
material indicating it is a rigid molecule. 
 
The conformer population were calculated using a COSMOtherm software package and 
showed there was no significant solvent effect on the conformer distribution in different 
solvents. This indicates there is no conformational polymorphism for ibuprofen, which 
supports the polymorphism screening results in chapter 6. This methodology showed a 
potential in predicting and rationalising conformational polymorphism for many 
chemical compound models. It can also be used for solvent screening and selection 
based on the relative population of conformers in solvents. 
 
9.2.2 Solid-state and morphological simulation 
 
Morphological predictions for the growth unit based on the monomer and dimers were 
obtained and compared with the in-situ observations of the ibuprofen crystal 
morphology, recrystallised from various solvents. The calculated value of the lattice 
energy was found to be -28.93 kcal/mol, which reveals a sensible agreement with the 
experimental lattice energy calculated from the heat of sublimation; 30.10 kcal/mol 
[136]. Morphological simulation was quite successful in predicting the ibuprofen 
morphology; except that the over-prediction of the importance of the {110} face and the 
aspect ratio of crystals. The dimer growth unit calculation seems to provide a slightly 
better prediction of ibuprofen morphology than the monomer growth unit calculation. 
The dimer showed the less important {110} face present in the crystal morphology and 
the morphology grows more in the b axis direction. However, full correlation was 
limited mindful that the ibuprofen crystal habit can vary between needles and plates, 
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depending on the crystallising environment and conditions such as solvent-type, 
supersaturation etc.  
 
The rationalisation of the growth rate data of the {011} and {001} faces and the growth 
rate kinetics was shown in chapter 7. The intermolecular bonding in the bulk crystal 
lattice and on the dominant crystal surfaces was also analysed. Carbonyl oxygen (C=O) 
and hydroxyl hydrogen (O-H) atoms were found to account for the most energy in the 
lattice energy and the strongest intermolecular interactions are the hydrogen bond chain 
O---H bonds. It was found that most of the strong bonds contributes to the slice energy 
for the {100} face making this face one of the most morphologically important. The 
strongest bond (-7.47 kcal/mol) contributes to attachment energy on face {011} and to 
the slice energy of face {001}, which verifies the growth rate of face {011} is generally 
greater than the growth rate of face {001}. 
 
The surface property analysis was carried out by the examination of the interaction 
between solvent molecules and the structures of specific growing faces as characterized 
by molecular modelling, e.g.  polar protic solvents being likely to inhibit the growth rate 
of faces containing available binding sites and/or exposed groups for hydrogen bond 
formation such as carboxylic acid -COOH groups. This study revealed that: 
 Molecular packing on the {001} face shows a non-polar property with methyl 
groups -CH3 projecting out of the surface and -COOH groups exposed in one 
direction.  
 The {011} face is more polar and –COOH groups on the {011} face with two 
different directions that are more exposed and easier accessible than the exposed 
–COOH group on face {001}.  
 The {011} face provides good binding sites for polar solvent molecules. In this 
case, the use of polar protic solvents (ethanol which can act either as a hydrogen 
bond donors or acceptors) would inhibit the growth of the {011} face resulting 
in plate-like crystals. In contrast, a polar aprotic solvent such as ethyl acetate or 
acetonitrile or a non-polar solvent such as toluene can be expected to interact 
less with the {011} face compared to ethanol thus producing more elongated 
crystals. Moreover, bindings of less polar solvents with exposed alkyl groups on 
the {001} face might hinder the growth of this face. 
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9.2.3 Instrumentation for studying the growth kinetics  
 
A series of novel and effective platforms for the measurement of face-specific growth 
rates in crystalline systems at various scale-sizes include: a 0.5ml cuvette prototype 
crystallisation cell, a 0.5 ml peltier cell, a platform 8-cell crystalliser unit (sample 
volume ca. 100μl) based on Morphologi G3 and a 15ml jacketed vessel were developed 
in this PhD. The latter has been integrated with the use of an ATR UV/Vis 
spectrophotometer with the overall system being based on an inverted optical polarizing 
microscope for in-situ crystallisation studies were developed and improved throughout 
this PhD work. The use of these instruments enables characterisation of crystal 
morphology and analysis of the individual crystal face (hkl) growth rates and growth 
mechanisms during representative crystallisation processes of ibuprofen. Although 
based on small-scale laboratory work under diffusion limited conditions, the work has 
focused and has been optimised for enabling the design of reproducible processes; they 
would be designed for deriving the data needed for process scale-up to manufacturing. 
The 0.5ml cuvette crystallisation cell, is an effective and easy-to-use apparatus for 
screening studies, e.g. solvent(s) and /or solid form evaluation, studying and 
understanding effects of processing conditions (solvents, temperature, supersaturation, 
impurities, seeding etc.) and processing scale-sizes on final product forms and acquiring 
fundamental growth kinetics data for use in process scale-up. However, there was no 
direct measurement of the de-supersaturation of solutions in the cuvette cell during 
crystal growth and this is also coupled with the slightly slow temperature exchange with 
the heater/chiller bath. This problem was addressed with the design and development of 
a peltier system for rapid change of temperature, which can be used to measure the 
dissolution rate of crystals.  
 
9.2.4 Nucleation as a function of solvent 
 
The solubility, enthalpy and entropy of dissolution and activity coefficient of ibuprofen 
in various solvents at different temperatures were determined using ATR UV/Vis and 
gravimetric method and compared to the published data showing quite similar values. 
The experimentally measured solubility using ATR UV/Vis spectroscopy was found to 
be lower than that calculated by the van‟t Hoff equation showing a deviation from ideal 
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behaviour. This can be rationalised by the consideration of the component groups and 
also the polarity of solute and solvent molecules. ATR UV/Vis is a rapid and efficient 
technique for solubility measurements of strongly absorbing materials but it has some 
limiting value due to the refractive index in some solvents (in the case of toluene). 
 
Though consideration of the crystallisation temperature in polythermal crystallisation 
and the induction time in isothermal crystallisation which varied hugely for all solvent 
systems, it has been shown that the MSZW of ibuprofen is not very large (ΔT = 10.0-
13.9
o
C) which is not typical for many organic or pharmaceutical compounds. The 
nucleation order is 1.55, 3.27 and 0.94 in ethyl acetate, acetonitrile and toluene 
respectively. The interfacial energies were found to be in the range of 5.52*10
-3
 J/m
2
, 
5.33*10
-3
J/m
2
, 4.38*10
-3 
J/m
2
 and 2.56*10
-3 
J/m
2
 for acetonitrile, ethanol, toluene and 
ethyl acetate, respectively indicating that ibuprofen has the smaller MSZW in toluene 
and ethyl acetate compared to that in ethanol and acetonitrile.  
 
Owing to the limited time and compromise with other core objectives of this PhD work, 
the MSWZ determination experiments were not able to be repeated to obtain more 
reproducible induction time data. However, analysis does reveal the data exemplifies 
the induction time increases with increasing of temperature, which implies the critical 
nuclei radius increases with decreasing the degree of supersaturation and increasing 
temperature. These results are in good agreement with classic nucleation theory.  
 
9.2.5 Effect of crystallisation environmental conditions on the growth 
rate of individual crystal faces 
 
The growth rate measurements of the {001} and {011} faces on spontaneously 
nucleated crystals of ibuprofen under diffusion limited conditions (stagnant solutions) 
have shown that the mean growth rate of the {001} and {011} faces increases with 
increasing relative supersaturation.  R{011} has been measured to be higher than R{001} in 
ibuprofen crystals, in particular for crystals grown in ethyl acetate, acetonitrile and 
toluene (elongated and needle-like crystals) at two scale sizes: a 0.5ml cuvette 
crystallisation cell immersed in a water tank and a 15ml jacketed vessel. For 4 solvents 
at the same supersaturation solutions, R{011} in acetonitrile is the highest and R{011} 
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in ethanol is the lowest. R{001} in ethanol and ethyl acetate are quite similar and 
highest whereas R{001} in toluene is the lowest. The rate of change of growth rate with 
changing supersaturation, dR/dζ, for the {001} and {011} faces in four solvents was not 
found to be constant. R{011} in acetonitrile increases much more with increasing 
supersaturation compared to that in the other solvents. 
 
The difference of the growth rate between different surfaces and the growth rate of the 
same surface in different solvents was rationalized by surface chemistry and the 
interaction of the solvents on these crystal surfaces. Changes of the relative growth rate 
of the {001} and {011} faces with solvent-type and supersaturation level cause 
variation of aspect ratios of the crystals. Ibuprofen crystals become more elongated in 
ethyl acetate, acetonitrile and toluene in comparison to the crystals grown in ethanol. 
The aspect ratios at two scale-sizes; 0.5 ml and 15ml, are quite similar or slightly higher 
at a 15ml scale-size.  
 
The data also revealed evidence for a degree of GRD in the crystal growth behaviour for 
both faces and for all supersaturations. However it is comparatively low (the average 
GRD typically observed is 12% of the mean growth rate) compared to the GRD in a 
stirred batch crystalliser measured from crystal size distribution over time from Rashid 
[15] and it is also lower compared to some other organic and inorganic materials [20, 
21, 174, 175] .  
 
The growth rate R{001} and R{011} in the 15ml vessel were found to be slightly 
greater than those observed for the growth rates in the 0.5ml cuvette cell. At the 15ml 
scale-size, integration with an ATR UV/Vis spectrophotometer demonstrated this 
techniques capability to monitor supersaturation levels during crystal growth. 
Nonetheless, it should be noted that only the supersaturation of the bulk solution, not 
the boundary layer of liquid adjacent to the growing crystal faces, was monitored and 
measured during the experiments. This drawback can be improved by integrating an 
overhead stirrer to gently agitate the solutions.  
 
The B&S growth mechanism model was found to provide the best description of the 
dependence of the growth rate of the {011} face and {001} face on the solution. For 
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supersaturations from 0.54 to 1.22, this mechanism was found to provide a good fit to 
the data with no mechanistic change found upon scale-size.  
 
The calculated surface entropy α factor has a value smaller than 5 so the B&S 
mechanism on the {011} and {001} face is expected to occur in these solvents, which 
agrees with the measured and fitted growth mechanisms from the experimental data.  
 
Additionally, it was noted that, for all solvents (particularly in ethanol producing plate-
like crystals), re-entrant faces appear at high levels of supersaturation. Crystals showed 
no evidence for any substantial defects such as twinning being present. These re-entrant 
(concave) edges were confirmed which is not due to twinning through the polarizer 
microscopy technique.  The critical supersaturation for this phenomenon was found to 
be higher than 0.66 for ethanol and ethyl acetate and 0.79 for acetonitrile and toluene. 
This observation was consistent with surface nucleation at the boundary between the 
{011} and {0-11} growth sectors probably due to kinetic roughening. Analysis of the 
interplanar angles for the experimental data using morphological simulation by 
measuring interfacial angles of the {011} face and these re-entrant faces being 
consistent and reproducible propose that the higher index face planes are either the 
{012} or {112} face.  
 
The overall growth rate in ethanol in an agitated 7mL batch reactor of CRYTALLINE 
were also measured and compared to that in a non-agitated 7ml jacketed vessel. It was 
shown that the growth rate in the non-agitated jacketed vessel is slightly higher than the 
growth rate in the agitated reactors. It is sensible in this study because the agitated 
reactors retain higher secondary nucleation rates. Agitation causes the breakage of 
particles and the image analysis analyses the growth rate based on a population of 
uneven particle size distribution including seed crystals and secondary nucleated and 
broken crystals. In addition, the growth rate measured in an agitated 7mL batch reactor 
in this study is slightly lower than the calculated growth using the first order growth 
kinetics for the growth rate measurement for ibuprofen in ethanol in a stirred seeded 
batch crystallisation reactor reported in literature [15].  
 
 
Chapter 9. Conclusions and suggestions for future work 
 
210 
 
9.3 Review aims and objectives 
 
In accordance with the initial aims and objectives, this study has made progress in 
establishing methodology for investigating the influence of crystallisation environment 
on the crystal growth at the single crystal level and integrating this with the molecular-
scale understanding. The solution behaviour and nucleation kinetics of ibuprofen in 
solvents were revealed as a function of solvents and temperature. The growth rate of the 
{001} and {011} faces of spontaneous nucleated single ibuprofen crystals under 
diffusion limited conditions as a function of environment conditions such as solvent 
type, supersaturation and reactor scale-sizes were measured demonstrating a great  
impact of these factors on growth rate of the crystal habit faces. This experimental data 
was linked to and rationalized using molecular modelling including conformation 
analysis and morphological prediction. Yet the work has still not completed several 
objectives: 
 Measurement of the growth rate of the {100} faces. 
 Complete development of a medium throughput screening particle 
characterisation system facility using the Morphologi G3 and the automated 
image analysis. 
 Measurement crystal growth rate at 0.5L scale size. 
 Using grid-search based method to predict crystal morphology in growth 
solutions. 
 
9.4 Suggestions for future work 
9.4.1 The measurement of the growth rate for the {100} face 
 
Ibuprofen crystals show three important faces; {100}, {001} and {011} however in this 
work, growth rates of the {001} and {011} faces were measured. Growth rates of the 
{100} face can be measured using incident light such as an interferometry (fringes), 
Nomarski phase contrast, differential interfere contrast or AFM to measure the growth 
rates of  the surfaces (described in chapter 3). There is also a motivation to investigate 
the growth mechanism of the {100} face because it is a dominant face of the Ibuprofen 
crystals which is expected to possess a slow growth rate. 
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9.4.2 Development of a medium throughput screening particle 
characterisation system facility using the Morphologi G3 
 
From the 0.5ml cuvette crystallisation cell, a further development of a novel platform 8- 
cell crystalliser unit (sample volume ca. 100µl) (Figure 9.1a) which can be fitted on the 
stage of a Morphologi G3 automated particle size and shape measurement system 
(Figure 9.1b) for the measurement of face-specific growth rates and an integration of the 
image analysis code, potentially have significant value to industry notably in the 
pharmaceutical, agrochemical, personal products, detergents and energy materials 
sectors.  
 
The current particle shape software provided by the G3 system is optimised for the 
analysis of static powder samples rather than for the analysis of the time-dependant 
growth rates of polyhedrally shaped crystals located with a crystallisation cell. Hence, 
new image analysis software, developed in collaboration with Professor David Hogg‟s 
group in the School of Computing, now allows for automated image analysis from the 
cell which can be fed directly and correlated with the predictions provided by the 
HABIT software.  
 
Further work is needed to test this new multi-reactor crystalliser on the G3 instrument, 
to implement of the automated integration of the 8 individual growth cells within the 
system control software and integrate the Leeds image analysis software within the 
overall system. These technologies combined will enhance the value of the G3 product 
transforming it from e.g. being a static image off-line system used for QA purposes, into 
a fully automated platform for in-situ crystallisation and characterisation studies. 
Through measurement of the growth rate of individual crystal faces growing in the 
multi micro-reactors that will be integrated into the Morphologi G3, the new system 
will provide a highly effective system for the rapid and efficient development and 
manufacture of advanced particulate solids.  
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Figure 9.1 (a) Multi-micro-reactor (8-cell crystalliser) designed to be integrated with the 
Morphologi G3; (b) Malvern Instruments Morphologi G3; (c) Representative images of crystals 
captured in the in-situ cell. 
 
9.4.3 Development of software for automated image analysis 
 
Development of an automated image analysis software in collaboration with Dr. 
Ardhendu Behera and Prof. David Hogg of the Artificial Intelligence Group of the 
Computing School at the University of Leeds for developing image analysis software 
for analysis of the growth rates of individual faces of a population of crystals. Currently 
the automated image analysis has been able to analyse the growth rate of the 
surrounding faces of single crystals on the image (not a population of single crystals). 
The crystal detection procedure is briefly described as follows: An input image is 
processed with the Gaussian filter in order to remove noise and then converted into 
grayscale (8-bit single channel). A binary image from the resulting grayscale image is 
generated by thresholding. During the process, each pixel in the image is compared to a 
predefined threshold T. If the pixel value is greater than T then it is set to 1 else 0.  
Now, we obtain contours from the resulted binary image by using the algorithm 
described by Suzuki et al [184]. In the first stage of the detection process, the proposed 
algorithm approximates a contour with a hexagon, which is the actual representation of 
a crystal. The approximation process is done by using the Douglas-Peucker algorithm 
[185]. The provided contour will be considered for further processing if the 
approximation error is less or equal to the specified precision. The approximation error 
in the proposed algorithm is 0.8% of the maximum distance between the original 
contour and its approximated hexagon. In the following stage, the confirmation of the 
hexagon is carried out by computing angles between sides and the ratio of its length. A 
crystal hexagon consists of three pairs of parallel lines and the length of each individual 
line in each pair is the same length. The above-mentioned knowledge is used for re-
(a) (b) (c) 
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establishing a side of the hexagon if it is corrupted by the overlapping of other crystals. 
The same approach is used for a video sequence containing the growth of a crystal.  
Each frame in the video is considered as an input image to the algorithm.  
 
9.4.4 Measurement of the growth rate at 0.5L scale –sizes 
 
Crystal growth kinetics and the properties of the final product e.g. final crystal size 
distribution, morphology and purity etc. are profoundly affected by the hydrodynamics 
of the system (agitation and mixing). Hence, the scale-up for the crystallisation process 
is based on maintaining process similarity including geometry of reactor; flow 
characteristics, supersaturation profile, etc. should follow these rules [26, 186]: 
 Geometrically similar vessels (identical ratios of corresponding dimensions) 
upon scale-up. 
 Kinematic similarity and dynamic similarity: the slurry densities, contact times 
between the crystals and supersaturated solutions and the Reynolds numbers 
(    
    
 
 ) and the Froude number (    
   
 
) of the fluid etc. should be 
identical where d is the agitator diameter, n is agitator speed, ρ is the liquid 
density, μ is the dynamic viscosity of the fluid and g is gravitational acceleration 
 Maintaining constant specific power input to minimize excessive nucleation  
 Ensuring adequate agitation and mixing associated with vessel dimensions, 
baffles, impeller type, and agitation speed which determines the supersaturation 
gradient is dispersed throughout the vessel so that there is a homogeneous mass 
transfer from the bulk solution to the growing crystals and thus the CSD and 
crystal purity are optimised. 
 
However, it is usually impossible to achieve the exact scale-up crystalliser by satisfying 
all these criteria e.g. to achieve the homogeneous level of supersaturation or to replicate 
mixing parameters, constant Reynolds and Froude numbers together with geometric 
similarity at the same time. In addition, MSZW is likely to be effected during process 
scale-up which is worthy of consideration. Hence, a compromise has to be made and 
assessed when designing a scale-up of a batch crystalliser. Therefore, robust models 
need to be developed and improved using process analytical techniques such as ATR 
FTIR, FBRM and CFD modelling techniques.  
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A further measurement of the growth rate of ibuprofen should be carried on at larger 
scale-sizes e.g. use of an insertion optical probe (Perdix ISPV) at 0.5L vessel size 
(Figure 9.2) to compare with the data of the overall growth rate of ibuprofen in ethanol 
95% to evaluate the effect of scale-size in agitated reactors.  
 
 
(d)                                                                    (b) 
Figure 9.2  (a) Experiment set-up for 0.5L scale-size using a Perdix camera for the measurement 
of the size distribution of crystals versus time; (b) Perdix camera probe with 19mm diameter 
and 2.5 micron optical resolution. 
 
The growth rates in this work can be used as a reference for comparing to the growth 
rate of ibuprofen at bigger scale-sizes e.g. use of an insertion optical probe (Perdix 
ISPV) at the 0.5L vessel size or 0.2L crystallisation jacketed vessel with a small flat 
window on the wall of the reactor for a camera.  
 
9.4.5 Dissolution modelling using Peltier crystallisation cell 
 
The peltier crystallisation cell developed in this work can be used for dynamic studies 
of dissolution kinetics as its heating and cooling performance is rapid (30°C/min) and 
easily controlled. 
 
Perdix probe 
0.5L reactor 
Turbidity probe 
Agitator 
PT probe 
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The peltier cell design utilised an annular round block with a moulded space at its centre 
for a peltier device to fit in and a PTFE base with a tunnel for a cuvette cell containing 
Ibuprofen solution to slide in. The 2 parts assemble together so the cuvette cell contacts 
the peliter element which was used to rapidly heat and cool solutions for crystallisation 
studies. The brass block is connected with a water bath, contacting with the hot side of 
the peltier which is working as a heat sink to remove heat from the cold side of the 
peltier. A hole at the centre enables observation of the crystallisation process and also 
allows image capture of crystals in-situ.  
 
 
 
 
Figure 9.3 Peltier crystallisation cell based on an inverted microscope using a Labview program 
for controlling the temperature of the peltier. 
 
  
 
Figure 9.4 A sequence of in situ crystals grown from ethanol 95% at ζ = 0.79 in the peltier 
crystallisation cell with 4 minute intervals between images captured  
 
Table 9.1  Comparison of the growth rate of face {011} and {001} in ethanol in the 0.5ml 
cuvette crystallisation cell using a re-circulation bath and peltier heat-pump 
Relative 
supersaturation (ζ) 
Cuvette cell (re-circulation 
bath) 
Cuvette cell (Peltier heat-
pump) 
Face {001} Face {011} Face {001} Face {011} 
0.79 10.5 ± 1.3 4.6 ± 0.7 11.5 ± 1.2 4.3 ± 0.6 
Peltier device  Cuvette cell  Heat sink  
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The growth rate in the cuvette cell (using the peltier heat-pump) is similar to the growth 
rate in the cuvette cell (using the re-circulation bath), which validates the observed 
crystal growth data in the cuvette cell using the re-circulation bath and demonstrates the 
competence of the temperature control of the peltier cell. 
 
9.4.6 Modelling crystal growth in the {001} and {011} directions using 
morphological population balance 
 
The individual growth rates of the {011} and {001} faces produced can be imputed 
directly into a morphological population balance model which was developed by Ma et 
al. [27] for prediction of the evolution of crystal population in terms of surface area of 
individual crystal habit faces, crystal shapes and sizes. In this method, the crystal shape 
information for a single crystal either through predicted morphology or experimental 
morphology as the initial face locations together with the kinetic parameters for the 
crystal growth rates of each face to predict the shape evolution of the crystal population. 
At specific times during the crystallisation process, the prediction uses its shape at the 
previous time moment, and the growth rate for the specific crystal habit plane. This 
methodology was successfully demonstrated through potash alum [27]. In addition, the 
advantages are the resultant PBM can be integrated with Computational Fluid Dynamics 
and used to scale up the vessel size [187-190]. 
 
9.4.7 Integration with grid search to calculate solvent binding the 
surface  
 
The influence of solvent on crystal habit of ibuprofen might be predicted through the 
calculations of the interactions between the solvent and solute molecules at the surfaces 
of the crystals. These interactions can be predicted  using a computer program 
developed by Hammond et al (2003) known as the systematic search method [191]. In 
this, the competitive interaction between the ibuprofen solute and various solvents on 
the individual crystal surfaces can be predicted and from this the solvent-mediated 
growth morphologies calculated. The methodology is shown in Figure 9.5. 
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Figure 9.5 Schematic diagram for calculating specific surface energies of crystal surface in 
solution [192]. 
 
The calculated modified attachment energies representing for the relative growth rate of 
the crystal habit faces were used to predict a solvent-mediated crystal habit. 
Crystal structure 
Calculation of the most stable 
configuration for solute/solvent 
binding on crystal surfaces 
Scaling the interaction energy 
with respect to mole fraction of 
the equilibrium solution 
Calculation of solution interfacial 
tension from the solution binding 
energy and interfacial surface energy 
Selection of crystal habit 
surfaces and calculation of 
their attachment energy 
Calculation of vacuum 
interfacial surface energy from 
the attachment energy 
Calculation of solvent-mediated 
attachment energy from the 
solution interfacial tension 
Solution system 
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A1.2 Acetonitrile Solutions 
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A1.3 Ethyl Acetate Solutions 
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A2. Induction times 
A2.1 Acetonitrile Solutions 
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A2.2. Toluene Solutions 
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A2.3. Ethanol 95% Solutions 
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A2.4. Ethyl Acetate Solutions 
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APPENDIX B: 
 
 
 
CRYSTAL GROWTH RATE MEASUREMENT IN 
THE 0.5ML CUVETTE CELL AND THE 15ML 
JACKETED VESSEL 
 
 
 
 
 
 
 
 
 
The data presented comprises plots of growth rate versus time for the {011} and {001} 
faces for all the crystals measured together with a representative image set for one of 
these crystals. 
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B1. Data from the 0.5ml cuvette cell 
B1.1 Ethanol 95% Solutions 
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σ = 0.79 
 
  
σ = 0.66 
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B1.2 Ethyl Acetate Solutions 
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B1.3 Acetonitrile Solutions 
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y = 10.5x + 51.5 
y = 13x + 36 
y = 10.5x + 75.5 
y = 11.8x + 81.571 
y = 7.9x + 33.8 
0
20
40
60
80
100
120
140
0 1 2 3 4 5 6
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.12  
y = 77.0x + 209.9 
y = 70.2x + 839.2 
y = 98.4x + 841.9 
y = 67.7x + 416.17 
y = 88.2x + 830.83 
y = 77.8x + 1033.3 
0
200
400
600
800
1000
1200
1400
0 2 4 6 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 1.03 
y = 7.7x + 21.6 
y = 10.7x + 73.9 
y = 5.9x + 51.4 
y = 6.3x + 58.833 
y = 6.3x + 84.05 
0
20
40
60
80
100
120
0 2 4 6 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.03  
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σ = 0.93 
 
 
   
σ = 0.79 
 
    
y = 71x + 839.67 
y = 55.7x + 263.4 
y = 55.7x + 263.4 
y = 61.3x + 855.3 
y = 55.5x + 369.5 
0
200
400
600
800
1000
1200
0 1 2 3 4 5 6
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.93 
y = 5.5x + 57.667 
y = 4.8x + 35.35 
y = 4.6x + 38.85 
y = 5.1x + 100.1 
y = 4.9x + 33.15 
0
20
40
60
80
100
120
140
0 1 2 3 4 5 6
D
is
ta
n
t 
fr
o
m
 c
n
et
er
 t
o
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.93 
y = 49.8x + 326.4 
y = 48x + 329.8 
y = 48.7x + 329.2 
y = 60.5x + 282.76 
y = 50.3x + 220.81 
0
200
400
600
800
1000
0 2 4 6 8 10 12
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.79 
y = 4.8x + 18.2 
y = 3.4x + 40.3 
y = 3.3x + 37.2 
y = 3.2x + 39.3 
y = 3.7x + 24.381 
y = 2.9x + 16.19 
0
20
40
60
80
0 2 4 6 8 10 12
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.79 
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B1.4 Toluene Solutions 
σ = 0.86 
 
  
 σ = 0.78 
 
  
y = 38.9x + 351.8 
y = 37.4x + 354.7 
y = 38.5x + 354.0 
y = 29.2x + 581.4 
y = 29.7x + 211.3 
y = 32.6x + 1041.6 
0
200
400
600
800
1000
1200
1400
0 5 10 15 20
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.86  
y = 3.3x + 37.0 
y = 3.0x + 35.1 
y = 3.1x + 35.8 
y = 2.0x + 15.2 
y = 3.1x + 79.4 
y = 3.4x + 74.1 
0
20
40
60
80
100
120
0 10 20
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.86 
y = 27.5x + 629.9 
y = 31x + 239.6 
y = 34.4x + 317.1 
y = 30.5x + 524.6 
y = 29.0x + 509.3 
0
200
400
600
800
1000
1200
0 5 10 15 20
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.78 
y = 2.1x + 45.9 
y = 2.4x + 22 
y = 2.5x + 23.2 
y = 2.2x + 36.4 
y = 2.2x + 43 
0
20
40
60
80
0 5 10 15 20
D
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ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.78 
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σ = 0.70 
 
 
B2 Data from the 15ml jacketed vessel 
B2.1 Ethanol 95% Solutions 
σ = 1.15 
 
 
  
y = 28.9x + 534.6 
y = 25.6x + 427.3 
y = 27x + 205.6 
y = 30.8x + 438.6 
y = 26.4x + 400.4 
y = 28.9x + 306.2 
0
400
800
1200
1600
0 5 10 15 20 25 30
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.7 
y = 2.0x + 25.9 
y = 1.7x + 22.8 
y = 1.9x + 29.9 
y = 1.5x + 56.9 
y = 2.0x + 23 
0
20
40
60
80
100
0 5 10 15 20 25 30
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.7 
y = 22.1x + 163 
y = 25.6x + 198.8 
y = 22.4x + 155 
y = 31.5x + 186.4 
y = 21.6x + 272.8 
0
100
200
300
400
500
0 2 4 6 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 1.15 
y = 12.9x + 113 
y = 14.4x + 119.5 
y = 12.6x + 98.7 
y = 12.8x + 125.7 
y = 13.4x + 158.2 
0
50
100
150
200
250
300
0 2 4 6 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
fa
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.15 
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 σ = 0.97 
 
 
  
  σ = 0.89 
  
 
  
 
y = 22.5x + 174 
y = 25.8x + 146.8 
y = 27x + 157.33 
y = 26.6x + 280.7 
y = 20.9x + 289.8 
y = 25.5x + 246.3 
y = 28.3x + 238.2 
0
100
200
300
400
500
0 2 4 6
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.97 
y = 17.8x + 341.5 
y = 14x + 112.7 
y = 14.8x + 99.2 
y = 16x + 103.3 
y = 13.3x + 186.5 
y = 15.8x + 149.8 
0
100
200
300
400
500
0 2 4 6
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.97 
y = 16.6x + 335.4 
y = 16.9x + 592.6 
y = 16.1x + 182.9 
y = 16.4x + 426 
y = 18.3x + 609.4 
0
200
400
600
800
1000
0 2 4 6 8 10 12
D
is
ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.89   
y = 8.1x + 157.3 
y = 6.2x + 234.1 
y = 7.2x + 95.9 
y = 6.6x + 214.5 
y = 7.9x + 310.46 
0
100
200
300
400
500
0 2 4 6 8 10 12
D
is
ta
n
ce
 f
ro
m
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n
et
er
 t
o
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.89 
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σ = 0.66 
 
 
 
B2.2 Ethyl Acetate Solutions 
σ = 1.22 
 
 
y = 11.3x + 232.33 
y = 12.2x + 204.47 
y = 10.3x + 617.8 
y = 9.9x + 358.57 
y = 11.7x + 336.4 
0
200
400
600
800
1000
0 5 10 15 20 25 30
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.66 
y = 3.4x + 78 
y = 4.2x + 74.731 
y = 4.2x + 226.8 
y = 3.6x + 156.43 
y = 4.5x + 156.4 
0
100
200
300
400
0 5 10 15 20 25 30
D
is
ta
n
ce
 f
ro
m
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en
te
r 
fa
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.66 
y = 67.3x + 422.1 
y = 59.5x + 416.4 
y = 68.5x + 397.67 
y = 65.2x + 355.4 
y = 70.6x + 644.6 
y = 63.5x + 379 
y = 67.1x + 337.8 
y = 61.7x + 388.8 
0
200
400
600
800
1000
1200
0 1 2 3 4 5 6 7 8
D
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ta
n
ce
 f
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m
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te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 1.22  
y = 15.8x + 97.6 
y = 13.6x + 86.2 
y = 12.3x + 89.2 
y = 12.7x + 88.2 
y = 13.7x + 96.5 
y = 15.3x + 90.0 
y = 14.1x + 76.4 
y = 13.2x + 90.8 
0
50
100
150
200
250
0 1 2 3 4 5 6 7 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.22 
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σ = 1.06 
 
 
 
 
 σ = 0.97 
 
 
  
y = 53.8x + 499 
y = 58.6x + 241.1 
y = 56.5x + 254.5 
y = 59.1x + 231.7 
y = 58.1x + 133 
y = 62.1x + 207.8 
y = 62.3x + 245.1 
0
200
400
600
800
1000
0 1 2 3 4 5 6 7 8
D
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n
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m
 c
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te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 1.06  
y = 12.4x + 114.1 
y = 12.7x + 56.9 
y = 12.9x + 57.4 y = 12.9x + 56.5 
y = 13.0x + 59.6 
y = 12.2x + 52.6 
y = 11.8x + 52.8 
0
50
100
150
200
0 1 2 3 4 5 6 7 8
D
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ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.06   
y = 54.3x + 283.8 
y = 52.1x + 402.1 
y = 51.3x + 582.3 
y = 50.1x + 508.6 
y = 55.3x + 558.1 
y = 55.1x + 220.8 
0
200
400
600
800
1000
0 1 2 3 4 5 6 7 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
  
(μ
m
) 
 
Time (mins) 
The {011} face at σ = 0.97 
y = 10.8x + 55.7 
y = 10.1x + 78.4 
y = 9.4x + 113.4 
y = 11.4x + 102.7 
y = 9.2x + 113.4 
y = 9.8x + 48.2 
0
40
80
120
160
200
0 1 2 3 4 5 6 7 8
D
is
ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.97 
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σ = 0.85 
 
 
  
 
σ = 0.76 
 
 
 
y = 51.9x + 464.2 
y = 51.8x + 447.5 
y = 41.3x + 245.1 
y = 46x + 255.3 
y = 46.2x + 268.3 
y = 44.9x + 280.8 
0
200
400
600
800
0 1 2 3 4 5 6 7 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins)  
The {011} face at σ = 0.85 
y = 7.1x + 75.1 
y = 5.8x + 37.8 
y = 6.9x + 35.8 
y = 5.3x + 31.1 
y = 6x + 51 
0
20
40
60
80
100
120
0 1 2 3 4 5 6 7
D
is
ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.85 
y = 44.2x + 328.6 
y = 39.7x + 241.1 
y = 43.7x + 475.2 
y = 41.7x + 434.8 
y = 39x + 410.3 
0
200
400
600
800
1000
1200
0 4 8 12 16
D
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n
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r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.76 
y = 6.1x + 50.6 
y = 5.1x + 34.9 
y = 5.8x + 70.55 
y = 6.1x + 69.1 
y = 5.9x + 56.917 
0
50
100
150
0 4 8 12 16
D
is
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n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.76  
 259 
 
σ = 0.69 
 
 
  
 
σ = 0.54 
 
 
  
y = 33.3x + 475.83 
y = 40.3x + 450.17 
y = 38.1x + 338.2 
y = 38.76x + 328.8 
y = 36.6x + 484 
y = 37.3x + 498.5 
y = 31.84x + 246.2 
0
200
400
600
800
1000
1200
0 5 10 15 20
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.69 
y = 4.4x + 49.333 
y = 4.32x + 40 
y = 4.4x + 55.333 
y = 2.5x + 25.5 
0
20
40
60
80
100
120
140
0 5 10 15 20
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.69  
y = 20.3x + 329.6 
y = 18.6x + 254.4 
y = 24.8x + 625.2 
y = 16.6x + 480.2 
y = 15.4x + 429.6 
0
200
400
600
800
1000
1200
1400
0 5 10 15 20 25
D
is
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n
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 f
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m
 c
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te
r 
to
 f
a
ce
(μ
m
) 
Time (mins) 
The {011} face at σ = 0.54 
y = 2.2x + 30.5 
y = 1.8x + 24 
y = 1.5x + 41.6 
y = 1.9x + 51 
y = 1.9x + 47.2 
0
20
40
60
80
100
0 5 10 15 20 25
D
is
ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.54 
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B2.3 Acetonitrile Solutions 
σ = 1.31 
 
 
  
σ = 1.12 
 
  
y = 101.3x + 434.6 
y = 121.5x + 473.8 
y = 115.5x + 614 
y = 137.7x + 630.7 
y = 120x + 275 
y = 103x + 283 
y = 126x + 454 
y = 141.9x + 249.2 
y = 128.7x + 271.4 
y = 115.2x + 258.8 
y = 129x + 263.3 
200
400
600
800
1000
1200
0 1 2 3 4 5 6
D
is
ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 1.31 
y = 17.9x + 77.8 y = 18x + 93 
y = 14.5x + 42.2 
y = 18.3x + 50.5 
y = 16.5x + 62.8 
y = 16.0x + 51.0 
0
20
40
60
80
100
120
140
160
0 1 2 3 4 5 6
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.31 
y = 103.5x + 260.2 
y = 108.7x + 252.2 
y = 102.5x + 263 
y = 117x + 527.6 
y = 93.0x + 209.7 
0
200
400
600
800
1000
0 1 2 3 4
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} at σ = 1.12  
y = 12.9x + 37.5 
y = 13.4x + 38.7 
y = 12.5x + 39.9 
y = 13.8x + 81.3 
y = 10.8x + 24.5 
0
20
40
60
80
100
120
140
0 1 2 3 4
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.12   
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σ = 1.03 
 
 
  
 
σ = 0.93 
 
 
 
y = 83.1x + 526.7 
y = 86.2x + 424.4 
y = 74.6x + 470.6 
y = 78.8x + 344.5 
y = 84.8x + 442.5 
y = 98.7x + 312.9 
y = 91.6x + 301.9 
0
200
400
600
800
1000
0 1 2 3 4 5 6 7
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 1.03 
y = 9.5x + 64.1 
y = 9.9x + 45.4 
y = 9.2x + 48.9 
y = 8.1x + 35.6 
y = 9.8x + 49.5 
y = 9.3x + 33.4 
y = 10.2x + 38.1 
0
20
40
60
80
100
120
0 1 2 3 4 5 6 7
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.03 
y = 77.7x + 438.2 
y = 70.4x + 326.4 
y = 70.7x + 657.1 
y = 75.6x + 300.6 
y = 70.2x + 323.2 
0
200
400
600
800
1000
1200
0 1 2 3 4 5 6 7
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.93 
y = 6.3x + 36.7 
y = 5.7x + 25.2 
y = 5.9x + 44.6 
y = 5.6x + 22.4 
y = 5.6x + 24.3 
0
20
40
60
80
0 1 2 3 4 5 6 7
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.93 
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σ = 0.75 
  
 
   
 
B2.4 Toluene Solutions 
σ = 1.17 
 
   
y = 47.5x + 859 
y = 57.5x + 342.6 
y = 61x + 266.3 
y = 62.2x + 316.6 
y = 60.3x + 392.2 
y = 51.8x + 246.2 
y = 55.9x + 254.3 
y = 54x + 375.5 
0
200
400
600
800
1000
1200
0 2 4 6 8 10
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.75 
y = 2.9x + 40.417 
y = 5.7x + 27.143 
y = 5.35x + 25.45 y = 5.5x + 36 
y = 5x + 25.833 
y = 5.425x + 25.6 
y = 4.65x + 24.3 
0
20
40
60
80
100
0 2 4 6 8 10
D
is
ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.75 
y = 46.6x + 360.1 
y = 46x + 255.3 
y = 41x + 215 
y = 43.1x + 186.8 
y = 42.3x + 443.2 
0
200
400
600
800
0 2 4 6 8
D
is
ta
n
ce
 f
ro
m
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en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 1.17  
y = 4.4x + 36.2 
y = 5.3x + 35 
y = 5.1x + 29.8 
y = 5.5x + 27.9 
y = 4.8x + 54.6 
0
20
40
60
80
100
0 2 4 6 8
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 1.17 
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σ = 0.86 
 
  
 
σ = 0.78 
 
 
   
y = 40.1x + 386.5 
y = 40.1x + 386.51 
y = 36.6x + 483.6 
y = 43.3x + 265.9 
y = 37.4x + 239.4 
y = 34.5x + 598.1 
0
200
400
600
800
1000
1200
0 2 4 6 8 10
D
is
ta
n
ce
 f
o
rm
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {011} face at σ = 0.86  
y = 3.4x + 38.2 
y = 4.4x + 48.9 
y = 2.3x + 43.4 
y = 4.5x + 32.4 
y = 3.2x + 26.9 
y = 3.3x + 57 
0
20
40
60
80
100
120
0 2 4 6 8 10
D
is
ta
n
ce
 f
ro
m
 c
en
te
r 
to
 f
a
ce
 (
μ
m
) 
Time (mins) 
The {001} face at σ = 0.86  
y = 34.7x + 625.8 
y = 38.6x + 659.1 
y = 27.9x + 641.7 
y = 37.4x + 335.4 
y = 34.5x + 334.2 
y = 28.7x + 217 
0
200
400
600
800
1000
1200
1400
0 5 10 15 20
D
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n
ce
 f
ro
m
 c
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te
r 
to
 f
a
ce
 (
µ
m
) 
Time (mins) 
The {011} face at σ = 0.78 
y = 3.1x + 46.1 
y = 2.9x + 46.6 
y = 2.9x + 20.3 
y = 2.2x + 35.4 
0
20
40
60
80
100
120
0 5 10 15 20
D
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ta
n
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 f
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m
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en
te
r 
to
 f
a
ce
 (
µ
m
) 
Time (mins) 
The {001} face at σ = 0.78 
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